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Thesis Summary 
 
Since the first discovery of S100 members in 1965, their expressions have been affiliated with 
numerous biological functions in all cells of the body.  However, in the recent years, S100A4, a 
member of this superfamily has emerged as the central target in generating new avenue for 
cancer therapy as its overexpression has been correlated with cancer patients’ mortality as well as 
established roles as motility and metastasis promoter.  As it has no catalytic activity, S100A4 has to 
interact with its target proteins to regulate such effects.  Up to date, more than 10 S100A4 target 
proteins have been identified but the mechanical process regulated by S100A4 to induce motility 
remains vague.  In this work, we demonstrated that S100A4 overexpression resulted in actin 
filaments disorganisation, reduction in focal adhesions, instability of filopodia as well as exhibiting 
polarised morphology.  However, such effects were not observed in truncated versions of S100A4 
possibly highlighting the importance of C terminus of S100A4 target recognition.  In order to 
assess some of the intracellular mechanisms that may be involved in promoting migrations, 
different strategies were used, including active pharmaceutical agents, inhibitors and knockdown 
experiments. Treatment of S100A4 overexpressing cells with blebbistatin and Y-27632, non muscle 
myosin IIA (NMMIIA) inhibitors, as well as knockdown of NMMIIA, resulted in motility 
enhancement and focal adhesions reduction proposing that NMMIIA assisted S100A4 in regulating 
cell motility but its presence is not essential.  Further work done using Cos 7 cell lines, naturally 
lacking NMMIIA, further demonstrated that S100A4 is capable of regulating cell motility 
independent of NMMIIA, possibly through poor maturation of focal adhesion. Given that all these 
experiments highlighted the independency of NMMIIA towards migration, a protein that has been 
put at the forefront of S100A4-induced motility, we aimed to gather further understanding 
regarding the other molecular mechanisms that may be at play for motility. Using high throughput 
imaging (HCI), 3 compounds were identified to be capable of inhibiting S100A4-mediated 
migration.  Although we have yet to investigate the underlying mechanism for their effects, these 
compounds have been shown to target membrane proteins and the externalisation of S100 
proteins, for at least one of the compounds, leading us to speculate that preventing 
externalisation of S100A4 could potentially regulate cell motility. 
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Chapter 1:  Introduction 
 According to statistical data provided by Cancer Research UK, death caused by breast 
cancer account up to 7% of all cancers in both genders and is currently the second most common 
cancer among female after lung cancer.   A year after diagnosis and treatment, the patients’ 
survival rate is 95.8%, but this rate dropped to 85.1% after 5 years of treatment and 10 years post 
treatment, this rate dropped to 77.0% (http://www.cancerresearchuk.org/cancer-
info/cancerstats/types/breast/survival/).  The main cause of reduction in patients’ survival is due 
to the progression of benign tumour into malignant tumour through a process known as 
metastasis.  Generally, this process requires tumour to  1) breakdown basal membrane, 2) invade 
adjacent tissues, 3) infiltrate blood stream (intravasation), 4) invade into tissue (extravasation) and 
finally proliferate as secondary tumour by harvesting nutrients through angiogenesis (Chaffer and 
Weinberg, 2011, Leber and Efferth, 2009, Oppenheimer, 2006, Yokota, 2000, Gupta and 
Massague, 2006, Mack and Marshall, 2010).  In order to tackle tumour malignancies, a myriad of 
research have been dedicated to each of these chronological steps (evasion from immune 
systems, invasion, migration, angiogenesis and aberrant proliferations) to provide better 
understanding and ultimately, to generate new therapeutic avenues.  In this work, we focused on 
some aspect of cell migration and its relevancy in malignancy progression. 
 
1.1 S100 family proteins 
S100 gene family is the largest subgroup within the superfamily of the proteins, with more 
than 25 family members found specifically distributed in human tissue and characterised by 
possession of calcium binding EF-hand motif at either end of the protein (Barraclough et al., 
1987).  The name S100 is derived from the fact that they are soluble in 100% saturated 
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ammonium sulphate.  These 25 members of the S100 family share 22% to 57% sequence 
identity (Marenholz et al., 2004, Gross et al., 2013).  Although S100 family spans widely among 
vertebrates, no S100-like family has ever been detected in invertebrates, suggesting that this 
gene is a relatively new gene which only occurs during vertebrate evolution (Shang et al., 
2008). 
Most S100 proteins, with the exception of S100A10, bind to their intracellular target 
proteins in a calcium dependent manner (Rescher and Gerke, 2008).  The insensitivity of 
S100A10 to calcium is a result of mutations in both EF hand motifs (calcium binding sites  of 
helix E and helix F) causing the protein to remain in calcium-bound configuration (Lewit-Bentley 
et al., 2000).  As for the rest of the S100 members, conformational shifts from closed 
hydrophilic to hydrophobic were attained in the presence of calcium, with higher calcium 
binding affinity at the C terminus EF-hand motif than those of N terminus.  These motifs 
demonstrate highest levels of amino acid conservation throughout the protein (Donato, 1986, 
Gribenko and Makhatadze, 1998, Barraclough et al., 1990).  Binding of calcium to these motifs 
resulted in conformational change, which exposes a hydrophobic region with the least amount 
of sequence homology, suggesting their specificity in binding to other target proteins which has 
been shown to have direct interaction with lipid vesicles (Bhattacharya et al., 2004, Mueller et 
al., 1999).  For instance, S100G has been shown to directly interact with detergent dodecyl 
phosphocholine (DPC), S100B has been shown to bind to cardiolipin vesicles while S100A1 has 
been shown to increase L-type calcium channel current in cardiomyocytes which suggests the 
potential role of S100 proteins to bind to natural membranes (Malmendal et al., 2005, Zolese et 
al., 1988, Reppel et al., 2005) 
 Due to the vast diversity of S100 family proteins, they have been shown to be involved in 
various cell’s functions such as cell cycle, differentiation, survival, apoptosis, motility and 
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intracellular calcium homeostasis via intracellular and extracellular activities (Brozzi et al., 2009, 
Tsoporis et al., 2010, Cheng et al., 2008, Beccafico et al., 2011, Lin et al., 2010, Chen et al., 
2001, Donato et al., 2009).  Besides, S100 family proteins have been implicated in different 
pathological conditions such as cancer, hypertension, arthritis and neurodegeneration 
(Barraclough, 1998, Rudland et al., 2000, Ambartsumian et al., 2001, Donato, 2001, Donato et 
al., 2009).  For instance, it was reported that S100A1 has been linked to heart failure and 
hypertension whereas S100A4 has been linked to metastasis promotion (Most et al., 2013, 
Boye and Mælandsmo, 2010).  Recently, with the advancement of gene therapy, S100A1 has 
been introduced in clinical trials to treat patients with heart failure (Most et al., 2013) whereas 
S100A4 has been proposed to be used as a prognostic marker in breast cancer (Ismail et al., 
2008a).  Other members of S100 proteins has also been shown to be involved in cellular 
migration where S100A6 is thought to act as motility inhibitor whereas S100A7, S100A8, 
S100A9 and S100B as motility promoter (van Dieck et al., 2009, Wolf et al., 2011, Rescher and 
Gerke, 2008, Brozzi et al., 2009).   Due to the cosmic effects caused by S100 proteins, 
researches have been dedicated to provide in depth understanding of their mechanisms and 
functions.     
 
1.1.1 S100A4 
S100A4, one of the member of S100 protein superfamily, has been independently 
named as metastasin (Mts1), fibroblast-specific protein (FSP1), 18A2, pEL98, p9Ka, 42A, 
CAPL, calvasculin and Placental Calcium Binding Protein (reviewed by Mishra et al., 2012).  
Due association of S100A4 with different cancer types, this 101-amino acids-containing-
polypeptide generated much attention in the field of carcinogenesis.  Although S100A4 is 
expressed in various tissues, overexpression of S100A4 has been reported to correlates 
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with breast, esophageal, lung, gastric, colorectal, pancreatic and skin cancer (Rudland et 
al., 2000, Andersen et al., 2011, Goh Then Sin et al., 2011, Ninomiya et al., 2001, Kimura et 
al., 2000, Yonemura et al., 2000b, Takenaga et al., 1997b, Rosty et al., 2002, Andersen et 
al., 2004). 
 
1.1.1.1 Protein structure 
S100A4 is a relatively small molecule, with a molecular weight of 10 – 12 kDa and 
is expressed in cytoplasm, within the cell nucleus as well as secreted extracellularly 
(Barraclough, 1998, Flatmark et al., 2003).  This protein may present as a monomer, 
heterodimer, symmetric homodimer and oligomer where interaction with target proteins 
has only been associated with homodimeric conformation (Vallely et al., 2002, Kim and 
Helfman, 2003, House et al., 2011, Kiss et al., 2012).  S100A4 has been found to form 
heterocomplex with S100A1 through yeast two-hybrid system in the absence of calcium.  
Although no known cellular functions has been demonstrated as a consequence of this 
heterodimerisation, it was proposed that this heterocomplex could possibly have cellular 
targets different than those of the S100A4 and S100A1 homodimers as homodimerisation 
of S100A1 and S100B, in the presence of zinc, has been shown to inhibit the assembly of 
brain microtubule whereas S100A1 homodimer did not exhibited such effects (Tarabykina 
et al., 2000, Tarabykina et al., 2001, Donato et al., 1985).  Addition of exogenous S100A4 
oligomer has been shown to induce endothelial cell motility, stimulate the production of 
matrix metalloproteinases (MMPs) of synovial fibroblast, as well as induce differentiation 
of rat hippocampal neurons (Ambartsumian et al., 2001, Senolt et al., 2006, Novitskaya et 
al., 2000).  However, interactions of S100A4 oligomer with target proteins have not been 
established and their binding mechanisms have yet to be resolved.  On the other hand, 
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S100A4 homodimer is well characterised and a few of its target proteins will be mentioned 
in the preceeding sections.  S100A4 homodimer comprises of two alpha and two beta 
chains joined by noncovalent interaction.   
Dimerisation of S100A4 monomer occurs via antiparallel alignment of helix 1 with 
helix 1’ and helix 4 with helix 4’.  C terminus binding domain of S100A4, located between 
helix 1 and helix 2, contains 12 residues and has higher affinity toward calcium (Kd 10 - 50 
µM) than the 14 residues containing N terminus, located between helix 3 and helix 4 (Kd 
200 - 500 µM) (Kligman and Hilt, 1988, Vallely et al., 2002, Dutta et al., 2002).  S100A4 
undergoes conformational change in the presence of calcium where a hydrophobic 
binding pocket is formed by helices 3 and 4, the hinge region and the C terminal loop 
(Figure 1.1) (Garrett et al., 2006).   
 
Figure 1.1 Illustration showing the changes in position of helix 3 and helix 4 of S100A4 in 
a calcium-dependent manner.  This conformational change is needed for S100A4 to bind 
to target proteins such as Myosin IIA, p53, and annexin II.  Dimerisation of S100A4 
occurred through interaction of helix 1 with helix 1’and helix 4 with helix 4’.  (Prime (‘) 
indicating the other monomer) (Adapted from Garrett et al., 2006). 
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1.1.1.2 Expression of S100A4 in different pathological diseases 
S100A4 expression has only been implicated in a some of normal ovary and 
prostate cells and has not been detected in normal breast, colon, thyroid, lung, kidney and 
pancreas cells (Mazzucchelli, 2002).  Higher levels of S100A4 are detected in more motile 
cells such as monocytes, macrophages and leukocytes when compared to levels of S100A4 
detected in keratinocytes, melanocytes, Langerhans’ cells and sweat glands suggesting the 
possibility of S100A4 in regulating cell motility (Gibbs et al., 1995, Takenaga et al., 1994, 
Boni et al., 1997, Li et al., 2010).  Besides, up-regulation of S100A4 has been reported in 
most carcinomas as well as some pathological diseases which may emphasize the 
reputation of S100A4 as indicator of these abnormalities (Kimura et al., 2000, Lo et al., 
2011, Moriyama-Kita et al., 2005, Rosty et al., 2002, Saleem et al., 2006, Takenaga et al., 
1997b, Yonemura et al., 2000b, Zou et al., 2005). 
Overexpression of S100A4 has been found to be correlated to the severity of 
pulmonary arterial hypertension (PAH) disease (Greenway et al., 2004).  In S100A4 
transgenic mice, S100A4 was found to be concentrated in the endothelial cell lining of the 
occluded vessels with increased level of circulating inflammatory cells.  As inflammatory 
cells were found to highly express S100A4 protein, it was suggested that this could be the 
reason affecting S100A4 concentration in the vessels.  This hypothesis was supported by 
the finding demonstrating that in human pulmonary arterial smooth muscle cells (hPA-
SMCs), secretion of S100A4 to the extracellular matrix is dependent on both serotonin (5-
HT) receptor and serotonin transporter which increases human pulmonary arterial smooth 
muscle cells (hPA-SMCs) migration and proliferation (Lawrie et al., 2005).  
In another study, it has been demonstrated that cross-breeding of transgenic mice 
overexpressing S100A4 in the mammary gland with GRS/A mice (GRS/A strain is 
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characterised by high incidence of non-metastatic tumours) resulted in offspring 
developing metastatic tumours with a marked elevation of S100A4 in the blood 
(Ambartsumian et al., 2005).  These observations demonstrated that extracellular S100A4 
is responsible for stimulating tumourigenesis, metastasis and angiogenesis in the 
transgenic offspring via an unknown mechanism. 
Besides, expressions of S100A4 were detected in synovial fluid of rheumatoid 
arthritis patients and articular chondrocytes of osteoarthritis patients but not in  normal 
synovium suggesting that S100A4 may be involved in these pathological conditions (Senolt 
et al., 2006).  It was found that addition of exogenous S100A4 oligomer to normal 
synovium resulted in upregulation of MMPs in the cell culture supernatants which led to 
speculation of S100A4 may regulate osteoarthritis and rheumatoid arthritis via MMPs 
(Senolt et al., 2006, Yammani et al., 2006).  Decreased bone matrix mineralisation has 
been implicated in patients suffering from osteoarthritis where S100A4 may be involved as 
S100A4 was found to inhibit mineralisation (Cox et al., 2012).  It was found that 
periodontal ligament cells which remain unmineralised, has lower expression of 
osteopontin, osteocalcin and the osteoblastic-specific transcriptors (Runx2/Cbfa1 and 
Osterix) and inhibition of S100A4 expression led to restoration of the osteoblastic markers 
expression (Kato et al., 2005).  In another report, it was found that level of S100A4 
decreases as level of osteoblast extracellular matrix mineralisation increases.  These 
observations further strengthen the role of S100A4 in delaying mineralisation and/or 
differentiation of osteoblasts (Duarte et al., 1999, Duarte et al., 2003).   
Also, S100A4 was found to be expressed in astrocytes of the spinal cord and 
addition of oligomeric form of S100A4 has been found to coincide with differentiation of 
cultured hippocampal neurons (Kozlova and Lukanidin, 1999, Novitskaya et al., 2000, Belot 
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et al., 2002).  Oligomeric form of S100A4 was found to interact with Gαq/11 subunit of G-
protein coupled receptor (GPCR) which resulted in activation of phospholipase C β (PLCβ) 
and subsequently causing influx of calcium, leading to alteration of neuron’s morphology 
(Kiryushko et al., 2006). However, it was unknown whether this oligomeric form of S100A4 
is present in vivo, raising the speculation if S100A4 dimer could interact directly with 
GPCRs. 
 
1.1.1.3 S100A4 in tumourigenesis and metastasis through clinical evidences 
The reason behind much gained attention of S100A4-based research is due to its 
association with cancer and metastasis.  Evidently, S100A4 has been shown to promote 
metastasis in different carcinomas (Ismail et al., 2008a, Davies et al., 1994, Andersen et al., 
2011, Cabezón et al., 2007, Xue et al., 2003, Rudland et al., 2000, McKiernan et al., 2011). 
Using immunohistochemistry to test normal and malignant breast tissues from 216 
subjects, S100A4 was found to be absent in normal breast tissues whereas approximately 
50% of the cancer tissues overexpresses S100A4 (Ismail et al., 2008a).  In another report, 
349 breast cancer patients were assessed for S100A4 overexpression.  Similarly, less than 
half of the carcinogenic samples stained positive for S100A4.  In the follow up of the 
experiments which was conducted 19 years later, it was found that 80% of the S100A4-
negative patients and only 11% of the S100A4-positive patients are still alive (Rudland et al., 
2000).  Although these studies revealed the correlation between up-regulation of S100A4 
and severity of breast cancer, other proteins such as matrix metalloproteinases (MMPs), 
CD44, methionine aminopeptidase 2 (MetAP2), integrins and p53 has also been shown to be 
up-regulated in malignant breast cancer (Andersen et al., 2011, Sternlicht et al., 1999, Afify 
et al., 2009, Chou et al., 2013).  However, direct link between S100A4 and metastasis was 
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established when non-metastatic cancer cell lines acquired metastatic characteristic via 
specific introduction of S100A4 in vivo and ex vivo (Xue et al., 2003, Ismail et al., 2008b). 
Beside breast cancer, severity and overexpression of S100A4 has also been 
implicated in patients suffering from advanced gastric (Wang et al., 2010, Yonemura et al., 
2000b), pancreatic (Ikenaga et al., 2009), colorectal (Takenaga et al., 1997b), lung (Kimura et 
al., 2000) and thyroid carcinoma (Zou et al., 2004, Zou et al., 2005).  For instance, 
consequences of S100A4 overexpression in these carcinomas are; 1) gastric cancer patients 
have higher incidence of metastatic lesions, 2) pancreatic cancer patients have lower 
survival chances, 3) lung cancer patients have higher incidence of metastasis with poor 
survival rate and 4) thyroid cancer patients with high incidence of lymph nodes metastases.  
Collectively, these studies also revealed the inverse correlation of S100A4 expression with 
adhesion-associated protein expression such as E-cadherin, α-catenin, and tissue inhibitor 
metalloproteinases (TIMPs) (Andersen et al., 2011, Moriyama-Kita et al., 2005, Rodriguez et 
al., 2012, Yonemura et al., 2000b, Yonemura et al., 2000a, Bjornland et al., 1999, Kimura et 
al., 2000).  Although it is unknown whether S100A4 is capable of regulating the expressions 
of these proteins, it is confirmed that this inverse correlations promote epithelial-
mesenhymal transition (EMT), an important tumour progression and invasion event 
(Schneider et al., 2008, Lo et al., 2011, Matsuzaki and Darcha, 2012). 
 
1.1.1.4 S100A4 molecular mechanism 
As S100A4 possess no enzymatic activity, it is believed that the pathological effects 
observed due to S100A4 upregulation could possibly be due to its interactions with other 
target proteins such as S100A1, non muscle myosin (NMM) IIA and -IIB, actin, tropomyosins 
(TMs), p53, liprin β1, methionine aminopeptidase 2 (MetAP2), and CCN3 protein (Cysteine-
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rich protein, Cyr61, Connective tissue growth factor, CTGF, and Nephroblastoma 
overexpressed gene, Nov) (Figure 1.2) (reviewed by Boye and Mælandsmo, 2010).  The 
target proteins mentioned will be classified into non cytoskeletal proteins (p53, S100A1, 
CCN3, liprin β1 and MetAP2) and cytoskeletal proteins (actin and TMs) where their 
interactions with S100A4 will be briefly discussed here. 
 
1.1.1.4.1 S100A4 and non cytoskeletal proteins 
Tumour suppressor p53 is a transcriptional factor which plays an important role in 
maintaining and regulating overall cellular functions by inducing cell cycle arrest, 
repair of damaged DNA, apoptosis due to cell stress signals, angiogenesis, senescence 
and cell differentiation (reviewed by Sionov and Haupt, 1999).  P53 limits 
tumourigenic transformation by binding to DNA which led to stimulation of another 
protein known as p21.  The p21 protein in turn, forms a complex with cell division-
stimulating protein (cdk2), halting the G1 stage of cell division from proceeding to S 
phase (Gervais et al., 1998).  It has been reported that p53 mutation occurred in 
diverse human tumour types and mice with p53 deficiency are more susceptible to 
tumour development which led to speculation that cells with mutated p53 protein are 
unable to halt cell division resulting in replication of mutated DNA which may, 
ultimately, lead to tumour formation (Nigro et al., 1989, Donehower et al., 1992, 
Loayza-Puch et al., 2013, Tamaki et al., 2013).  N-terminal domain of p53 protein 
reveals a proline rich region (from 61 – 97 residues) which has been shown promote 
apoptosis, a central part which acts as DNA binding region (from 102 - 292 residues) 
and lastly, a C-terminal domain which contain nuclear localisation domain (313 – 332 
residues), tetramerisation domain (320 – 356 residues) and negative regulatory 
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domain (367 – 393 residues) (Cho et al., 1994, Venot et al., 1998).  S100A4 has been 
shown to bind to the 364 - 393 amino acid residues of C terminal region of p53, 
inhibiting phosphorylation by protein kinase C (PKC) in a calcium independent manner 
as opposed to S100B, S100A2 and S100A6 binding to p53 in which the presence of 
calcium is essential (Grigorian et al., 2001, Grigorian and Lukanidin, 2003, Chen et al., 
2001, Berge and Mælandsmo, 2011).  Binding of S100A4 to p53 has been shown to 
suppress the DNA binding activity of p53, proposing that the possible regulatory 
mechanism of S100A4 on p53 activity (Grigorian et al., 2001).  Immunohistochemistry 
of breast tumour specimens revealed higher percentage of positively-stained p53 
correlates with positive staining of S100A4 than the S100A4 negatively-stained 
specimens suggesting that these two protein may have inter-regulatory roles (Rudland 
et al., 2000).  Recently, through immunocytochemical staining, it was found that 
S100A4 colocalises with p53 in the nucleus and S100A4 knockdown increased the 
expressions of p53 associated proteins such as p21 and mdm21 without altering the 
expression level of p53 (Tamaki et al., 2013).  
As mentioned in Section 1.1.1.1, S100A4 has been demonstrated to form 
heterocomplex with S100A1 where S100A1 prevents the binding of S100A4 to 
NMMIIA and reduce S100A4 induced motility in vitro as well as reducing metastasis in 
vivo (Wang et al., 2004).  Although there was no structural analysis of this 
heterocomplex, it was revealed that specific mutations of S100A4 at Phe 71 and Tyr 75 
to glutamine resulted in complete abolishment of this heterodimerisation.  However, 
dimerisation of S100A4 was only partially disrupted in Tyr 75 mutants suggesting that 
S100A4 may not be binding to S100A1 monomer  as observed in homodimerisation of 
S100A4 (Wang et al., 2000). 
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Beside p53 and S100A1, CCN3 has also been identified as one of the target 
proteins of S100A4 through the yeast two hybrid system (Lin et al., 2003).  CCN3 is a 
matricellular protein which plays a pivotal role in internal/external cell signalling, 
inducing angiogenesis in vivo as well as promotes cell survival.  Its aberrant expression 
is thought to regulate tumourigenesis (Planque and Perbal, 2003, Gupta et al., 2001).  
As S100A4 has no enzymatic activities, it was proposed that S100A4-CCN3 interactions 
may be involved in tumourigenesis associated with CCN3 up-regulation (Lombet et al., 
2003, Gupta et al., 2001, Manara et al., 2002, Sin et al., 2009, Chen et al., 2013).  As no 
study has been conducted on direct consequence of this interaction on 
tumourigenesis, one can only speculate the possible results from this interaction.   
 Liprins are identified as the binding partner of the leukocyte common antigen-
related tyrosine phosphatase (LAR) receptor protein, which consists of α-liprins and β-
liprins where the subfamilies might form homo and heterodimers (Serra-Pagès et al., 
1998).  Although α-liprins are well characterised, the biological significance of liprin β1 
which has been shown to interacts with S100A4, remains unclear.  While LAR receptor 
protein is implicated in axon guidance and mammary gland development, liprins are 
known to regulate cell migration, adhesion as well as synaptic development through 
LAR receptor where the deactivation of liprins has been shown to impair motoneuron 
growth cone guidance and terminal differentiation of alveoli in Drosophila and mouse 
respectively (reviewed by Wei et al., 2011, de Curtis, 2011, Kriajevska et al., 2002, 
Krueger et al., 1996, Serra-Pages et al., 1995).  S100A4 has been shown to bind to the 
C-terminus of liprin β1 (938 – 1005 residues) which modulates in vitro 
phosphorylation of PKC (Thr 891, Ser 932 and Thr 962 residues) and inhibit CK2-
mediated phosphorylation of liprin β1 (Ser 997 residue) (Kriajevska et al., 2002).  As 
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Liprin α1-β1 heterodimer has been found to colocalise with LAR at the integrin-
mediated focal adhesion sites, the colocalisation of S100A4 and liprin β1 at the 
protrusion sites of the plasma membrane, proposed that binding of S100A4 to liprin 
β1 could inhibits its heterodimerisation with liprin α1, thereby affecting its subsequent 
interaction with LAR to promote LAR-dependent cell adhesion signalling (Kriajevska et 
al., 2002).   
 Another recently identified target protein of S100A4 is MetAP2 which catalyses 
the removal of methionine residue from nascent peptides in eukaryotes to prevent 
initiation of protein translation.  It was demonstrated that mammalian cell growth is 
strictly dependent on both MetAP1 and MetAP2 as treatment with MetAP inhibitors 
or knockdown of either MetAP1 or MetAP2 in HUVEC and A549 cells resulted in 
reduced cell proliferation (Chang et al., 1989, Bernier et al., 2005).  Interestingly, it was 
found that treatments with MetAP2 inhibitors (fumagillin and ovalicin), in vitro, led to 
inhibition of angiogenesis and synthetic analogs of fumagillin, TNP-470 and NC2213 
are currently undergoing clinical trial for treatment of various cancer types (Griffith et 
al., 1998, Selvakumar et al., 2009, Sin et al., 1997, Bhargava et al., 1999).  S100A4 is 
now known to be capable of binding to MetAP2 at N-terminus region (170 - 229 
residues) and colocalised at the perinuclear region of murine endothelial MSS31 cells.  
Upon stimulation with basic fibroblast growth factor (bFGF), a motility inducer, 
S100A4-MetAP2 was found to be distributed throughout the cytoplasm (Endo et al., 
2002).  Although the direct consequence of this interaction remained elusive, it was 
speculated that the redistribution of MetAP2 by S100A4 may be regulating endothelial 
cell growth and metastasis. 
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1.1.1.4.2 S100A4 and cytoskeletal proteins 
The cellular cytoskeleton is a dynamic network of intracellular filaments which is 
crucial for modulating/maintaining cell shape and functions such as division and 
migration (Howard, 2009, Wickstead and Gull, 2011).  This network consists of three 
groups of filamentous protein, known as filamentous actin (F-actin), microtubules and 
intermediate filaments which are assisted by extensive accessory proteins.  
Interactions of S100A4 with some these proteins have been reported and due to the 
involvement of these proteins to the cytoskeletal structure, it was speculated that 
these interactions could be the culprit behind the S100A4-induced metastasis. 
In an experiments conducted with NH3T3 cell line, it was found that S100A4 binds 
directly to non muscle tropomyosin 2 (TM2) (39 – 107 residues) and non muscle 
tropomyosin 5 (TM5) (81 – 107 residues) in a calcium dependent manner (Takenaga et 
al., 1994).  However, in another contradictory report using optic biosensor approach, 
it was found that there were no direct interaction between S100A4 and non muscle 
tropomyosin (TMs) either in presence or absence of calcium (Chen et al., 2001).  
Nonetheless, TMs will be briefly introduced here to speculate the effect of S100A4-
TM2/TM5 interaction, if any.  TM2 and TM5 belong to non-muscle tropomyosin (TMs) 
where they are classified into high molecular weight group and low molecular weight 
group respectively where they play an important role in organisation of actin filament 
during cell migration, division, and differentiation (Kee et al., 2004).   Moreover, it was 
demonstrated that TMs binds to actin in high affinity which resulted in recruitment of 
non muscle myosin IIA (NMMIIA) to the existing actin filaments to promote stress 
fibers formation (Bryce et al., 2003, Moraczewska et al., 1999).  One of the TM 
isoforms, Tm5NM1, antagonises the activities of ADF/cofilin by inactivating it through 
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phosphorylation and displacing it from the cell periphery as well as preventing Actin-
related protein (Arp) 2/3 complex from nucleating actin filament (Bryce et al., 2003, 
Ono and Ono, 2002).  From the mentioned functions of TMs, it is speculated that if 
S100A4-TMs interaction is valid, S100A4 may be regulating actin polymerisation 
through TMs which may subsequently affect cell motility. 
 Up to date, association of S100A4 with actin in calcium dependent manner has 
been demonstrated in two independent studies using co-sedimentation assay 
(Watanabe et al., 1993, Li et al., 2003).  Watanabe et al. demonstrated that S100A4, 
but not S100B is capable of bundling F-actin in vitro.   In the study conducted by Li et 
al., it was found that S100A4 binds to NMMIIA at the highest affinity (Kd  2.7 µM), 
followed by NMMIIB (Kd  23.1 µM) and finally F-actin (Kd  34 µM) proposing that 
S100A4 may preferentially exert its effect on cytoskeleton through NMMIIA rather 
than actin (Li et al., 2003).  However, discrepancy of this interaction has been 
demonstrated where S100A4 was only reported to interact with NMMIIA and p53 as 
well as weak association with tubulin, but not with actin using optical biosensor 
approach (Chen et al., 2001). Nonetheless, if S100A4-actin interaction is valid as 
proposed, S100A4 may be capable of remodelling the entire cytoskeletal structure to 
facilitate migration and metastasis as actin polymerisation is a crucial process of most 
protrusive structures as well as focal adhesions which will be further discussed in 
Chapter 1.3.  
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Figure 1.2 Schematic representation of consequences of S100A4 interacting with its target 
proteins.   
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1.2 Non muscle myosin II 
Myosin superfamily is divided into 15 classes where only 9 classes (I, II, III, V, VI, VII IX, X 
and XV) have been detected in mammals.  Myosin II, also known as ‘conventional’ myosins, 
were subclassified into four groups; 1) sarcomeric myosins, 2) smooth and non muscle 
myosins, 3) myosins from lower eukaryotic species and 4) myosins from fungi (reviewed by 
Sellers, 2000).   
The non-muscle myosin II (NMMII) complex is an ATP-dependent molecule containing six 
peptides chains; two of each heavy chain (NMMHCII), two essential myosin light chains (ELC) 
and two regulatory light chains (RLC).  NMMII is assembled into two bipolar filaments with 
globular head, a neck region consisting of ELC and RLC, and α helical coiled-coil region with a 
non helical C terminal tail piece (Figure 1.3) (Sellers, 2000, Bresnick, 1999).  The globular head 
of each NMMHCII consist of an ATP binding site as well as an actin binding region which allow 
it to move in anti parallel manner via conformational changes induced by ATP hydrolysis.  In 
the neck region, ELC serves to stabilise the NMMHC, while RLC acquire both stabilisation role 
and regulating NMMII functions via reversible phosphorylation activity (Bresnick, 1999).  In the 
rod-like helical coiled-coil region, alternating charge were distributed, which serves to 
assemble homodimers of NMMII into higher order filaments (McLachlan and Karn, 1982). The 
repetitive assembly of bipolar NMMII and actin filament form the actomyosin network 
resulting in formation stress fibres where bundles of actin filaments are localised at the 
plasma membrane (Matsumura, 2005, Burridge and Wittchen, 2013).  Such association forms 
belts of actin filament which encircle epithelial cells associated with adhering junctions.  
Similarly, during cytokinesis, actin filament bundles form a structure known as contractile ring 
(Asano et al., 2009). 
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Figure 1.3 Illustration of non muscle myosin II (NMMII) homodimer: comprises of two of each 
non muscle myosin II heavy chain (NMMHCII), essential light chain (ELC) and regulatory light 
chain (RLC) followed by an α helical coiled-coil region and a non helical tailpiece. 
 
1.2.1 Non muscle myosin II isoforms 
There are three NMMII isoforms found in mammals; -IIA, -IIB and -IIC each 
encoded by different genes, MYH9, MYH10 and MYH14 respectively, sharing 60 – 80% 
amino acid sequence identity (Simons et al., 1991, Golomb et al., 2004).  The two major 
isoforms of non muscle myosin, refer to NMMIIA and NMMIIB, are expressed at 
comparable levels in variety of vertebrate cells with an exception of neuronal cells in 
which NMMIIB is predominantly expressed (Lo et al., 2004, Sandquist and Means, 2008, 
Sandquist et al., 2006, Betapudi et al., 2006).  NMMIIC, on the other hand, may be induced 
during hemopoietic differentiation (Lo et al., 2004).   
Although comparable levels of NMMIIA and NMMIIB are expressed in mammalian 
cells, both have distinct distributions; NMMIIA is distributed around the edge of the cells 
and concentrated at the leading edge whereas myosin IIB is found to be distributed 
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around the perinuclear and concentrated at the rear end of migrating cells (Cai et al., 
2006, Kolega, 1998).  It has been demonstrated that NMMIIA is responsible for generating 
retraction force during cell migration whereas NMMIIB serves to stabilise the polarity and 
stress fibres of the cell (Cai et al., 2006, Betapudi, 2010, Kolega, 1998, Vicente-Manzanares 
et al., 2008).  As a consequence, NMMIIA exert higher contractile force (2.6 fold) at faster 
velocity (3.3 fold) than NMMIIB with NMMIIA being more dynamic and is involved in the 
initial stages of focal complex formations (Kelley et al., 1996, Vicente-Manzanares et al., 
2007).  
 
1.2.2 Regulation of non muscle myosin IIA 
Activity of NMMIIA is regulated through reversible phosphorylation of the RLC and 
globular domain of the bipolar NMMIIA.  Primary and secondary phosphorylation sites of 
RLC were located at Ser 19 and Thr 18 amino acid residues respectively.  RLC can be mono- 
and di-phosphorylated to enhance ATPase activity of the globular head which allow the 
association/dissociation of NMMII head with actin filaments (Vicente-Manzanares and 
Horwitz, 2010).  Reversible phosphorylation resulted in alteration of NMMII conformation 
hence generating actomyosin contraction.  In the presence of calcium, phosphorylation of 
RLC is catalysed by myosin light chain kinase (MLCK) which is activated through 
calmodulin.  In the absence of calcium, phosphorylation of RLC at Ser 19 can be mediated 
by Rho kinase or by myosin binding subunit (MBS) (which dephosphorylate RLC at Ser 19) 
of myosin protein phosphatase 1 (PP1M) (Kawano et al., 1999).  Beside phosphorylation at 
Thr 18 and Ser 19, RLC can be phosphorylated at 3 different sites by protein kinase C (PKC) 
at Ser 1, Ser 2 and Thr 9 which lower the affinity of MLCK to RLC, promoting reorganisation 
of actin filaments (Nishikawa et al., 1984). 
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 On the other hand, NMMHCII can be phosphorylated by PKC (at Ser 1917 (rat) or 
Ser 1916 (human)) or casein kinase II (CKII) (at Ser 1943 (rat) or Ser 1944 (human)) (Conti 
et al., 1991).  Phosphorylation of NMMHCII resulted in dissociation of myosin from actin 
filaments or prevents its assembly.   
 
1.2.3 Actomyosin contraction 
As it name suggests, actomyosin contraction requires the association of actin 
filaments and myosin which results in generation of powerstroke (Figure 1.3).  Actin exists 
as a globular monomer known as G-actin and in the presence of magnesium, potassium 
and sodium ions, ATP-bound G-actin subunits will polymerise into linear actin filaments 
known as F-actin from the barbed (+) end.  Binding of ATP-bound G-actin at (+) end of F-
actin resulted in loss of phosphate ion through hydrolysis resulted in linear chain of ADP-
bound F-actin.  The ADP-bound F-actin will dissociate from the pointed (-) end which result 
in a process known as actin filament treadmilling (Oda et al., 2009).  This constant 
polymerisation/depolymerisation process of actin results in actin dynamicity which is an 
important feature of cell polarisation and migration.  Actin crosslinker such as fascin, α-
actinin, myosin and filamin will bundle the F-actins into thicker filaments to generate 
different structures.  It has been demonstrated that crosslinking action of fascin results in 
the formation of filopodia (parallel alignment), a protrusive plasma membrane structure, 
whereas filamin results in formation of actin meshwork (Machesky and Li, 2010, Wang et 
al., 1975) 
Alternating crosslinking action of NMMII and α-actinin result in stress fibers 
formation, which is essential for maintaining cell shape and regulating cell migration 
(Pellegrin and Mellor, 2007).  Approximately 20 to 28 molecules of bipolar NMMII 
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homodimer bind to actin through its globular head domains and the ATPase activities of 
the heads enables conformational change which move actin filaments in anti parallel 
manner to facilitate locomotion or maintaining cell integrity (Verkhovsky and Borisy, 1993, 
Dominguez and Holmes, 2011).  When RLC is phosphorylated, ATPase activity of globular 
domain of NMMII is increased.  ATP-bound globular head of myosin resulted in 
dissociation of NMMII head domain from actin.   During hydrolysis, ‘cocking’ of NMMII 
head occurs.  When inorganic phosphate is released, weak association of NMMII head to 
actin occurs.  Release of ADP results in powerstroke as NMMII head binds tightly to actin.  
The cycle continues when ATP is bound to NMMII head again which relieve actin-myosin 
association (Figure 1.4) (Malnasi-Csizmadia and Kovacs, 2010, Takács et al., 2010, Vicente-
Manzanares et al., 2009b). 
  
Page | 39  
 
 
 
Figure 1.4 Actomyosin contraction.  1) Globular NMMII is attached to actin filament. 2) Addition 
of ATP resulted in dissociation of NMMII globular head from actin filament.  3) During hydrolysis, 
NMMII acquired ‘cocking’ conformation.  4)  ADP and Pi resulted from hydrolysis of ATP restore 
weak affinity of globular head of NMMII to actin filament.  5) Release of ADP and Pi resulted in 
tight association of NMMII head with actin filament generating powerstroke which moved actin in 
anti parallel manner. 
 
1.2.4 Myosin and S100A4 
Binding of both NMMIIA and NMMIIB to S100A4 has been shown to occur at 
approximate stoichiometry of 3 moles of S100A4 per mole of NMHC II in a calcium 
dependent manner (Ford et al., 1997, Kriajevska et al., 1994).  However, recent study of 
high resolution crystallography revealed that one dimer of S100A4 is sufficient to bind to 
one NMMIIA peptide to promote its conformational change to release actin (Kiss et al., 
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2012).  Although NMMIIA and NMMIIB shares 85% of amino acid identity in the globular 
domain and 72% in the helical rod, S100A4 has a 9-fold higher affinity for NMMIIA 
filaments than for NMMIIB filaments (Bresnick, 1999, Li et al., 2003).  It was demonstrated 
that the NMMIIA binding site of S100A4 dimer is located at the C terminus region of amino 
acid residues at 1909 – 1924 where NMMIIB shares only 34% of sequence homology 
(Figure 1.5)(Li et al., 2003, Kriajevska et al., 2000).  The low homology within this region 
could be the reason behind the lower affinity of S100A4 to NMMIIB than NMMIIA.  
Although the binding site on NMMIIA overlapped protein kinase C (PKC) phosphorylation 
site at Ser-1917, it was shown that the binding of S100A4 was not affected by PKC 
phosphorylation (Dulyaninova et al., 2007).  Instead, Ser 19  phosphorylation by casein 
kinase II (CKII) was shown to inhibit the binding of S100A4 (Kriajevska et al., 2000).  It has 
been further demonstrated that C terminus of S100A4 is vital for NMMII binding as 
deletion of the last 2 amino acids of its sequence is sufficient to increase the dissociation 
constant (Kd) of S100A4 to NMMII from  91nM to 680nM (Ismail et al., 2008b).  The 
binding of S100A4 to NMMIIA promotes the unassembled state of NMMIIA, as it inhibit 
the ATPase activity of myosin resulting in dissociation of whole myosin complex from actin 
(Ford et al., 1997).  This interaction is presumed to be, at least one of its properties, 
allowing S100A4 to regulate cell polarisation and directed motility where cells protrusions 
at the leading edge are observed (Li and Bresnick, 2006).   
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 Figure 1.5  Interaction of S100A4 dimer with 45-residue long NMMIIA tail fragment.  S100A4 
dimers are shown in green and blue whereas NMIIA peptide is in yellow (residues 1893-1913) and 
orange (residues 1914-1935) and calcium ions are in grey (Adapted from Kiss et al., 2012). 
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1.3 Migration 
Cell migration is not only limited to metastasis process in malignant cancer, in fact, 
it is required in many biological processes such as tissue repair and regeneration, embryonic 
development as well as immune responses (Condeelis et al., 2005, Bailly and Condeelis, 2002, 
Yamaguchi et al., 2005).  Following from a trauma or regeneration of lining of epithelial 
tissues, new cells will migrate up from the basal layer.  During embryogenesis, groups of cells 
migrate to form trilaminar known as gastrula, an essential early phase of gastrulation.  As for 
immune responses, leukocytes migrate to the site of inflammation to engulf microorganisms.  
In order for cell migration to take place, morphological as well as molecular changes played 
an important role in regulating this process.  Mechanism of migration can be divided into four 
chronological steps; 1) cell polarisation, 2) stabilisation of extended leading edge, 3) 
contraction of cell body and 4) retraction of trailing end and disintegration of focal 
complexes, four events that will be reviewed independently in the following section.   
 
1.3.1 Cell polarisation 
Generally, in stably adhered cell, its morphology usually appeared somewhat 
symmetrical or out-spread.  However, in order for migration to arise, the cell has to break 
its symmetrical shape to form a front and rear, termed as polarisation (Cramer, 2010).  
However, it remains unclear whether cell front or cell rear formed first or both at the same 
time during breaking of cell symmetry.  In experiments conducted with human 
neutrophils, it was observed that in the presence of uniformly distributed 
chemoattractants, protusion signalling occurred first, subsequently by cell rear (Zigmond 
and Sullivan, 1979, Wong et al., 2006).  Contrastingly, fibroblast and keratocytes has been 
shown to initiate formation of cell rear in the absence of chemoattractant (Mseka et al., 
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2007, Yam et al., 2007).  Nonetheless, cell polarisation is agreed universally as the first 
step to cell migration (Diz-Muñoz et al., 2010, Yamaguchi et al., 2005, Le Clainche and 
Carlier, 2008).   
 Cell polarisation occurred due to extracellular cues such as growth factors, 
cytokines and cell adhesion receptors, in combination with intracellular responses, which 
consists of numerous signalling proteins (Vicente-Manzanares et al., 2009a, Ridley et al., 
2003).  During cell polarisation, the cell front could extend into, at least, four different 
plasma membrane protrusions, known as  lamellipodia, filopodia, invadopodia or blebs 
whereas the rear end usually consist of retraction fibers (Diz-Muñoz et al., 2010, 
Yamaguchi et al., 2005).  These four protrusions are distinguished through their structures 
and shapes.  In the following sections, only lamellipodia and filopodia and their relevance 
in 2D culture will be discussed due to the nature of this project. 
 
1.3.1.1 Lamellipodia 
The term ‘lamellipodium’ was first used in the 1970s to describe a sheet-like 
cytoplasmic region with a thickness of around 2µm located at the leading edge of the cell 
(Abercrombie et al., 1970).  While bleb is formed on or within elastic substrate, 
lamellipodium is formed on rigid substrate.  The former structure occurs due to 
destabilisation of actin filaments whereas lamellipodium occurs due to polymerisation of 
actin filaments to enhance protrusions.  Other than acting as protrusive structure, 
lamellipodium are also involved in formation and maturation of focal adhesions.  
Numerous signalling proteins such as Rac, RhoA, Cdc42, Arp2/3 (Actin related protein 2 
and Actin related protein 3) complex, formin and Spire families have been shown to 
contribute to lamellipodium extension.  Rac, a member of the Rho family proteins, 
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stimulates actin polymerisation via Arp 2/3 complex which binds directly to existing actin 
filaments to form branches.  However, stimulation of Arp 2/3 complex by Rac consists of 
multi-interaction steps which involve various proteins.  First, Rac binds to insulin receptor 
tyrosine kinase substrate p53 (IRSp53) and the carboxy-terminal Src-homology 3 domain 
of IRSp53 binds to Wiskott-Aldrich syndrome protein (WASP) family verprolin-homologous 
protein (WAVEs) to form a trimolecular complex (Miki et al., 2000).  This trimolecular 
complex is capable of binding to both G-actin monomer and Arp2/3 complex and this 
affinity brings the two substrates into close proximity, hence increasing F-actin 
polymerisation rate.  Branching caused by nucleation of actin filaments by Arp2/3 complex 
causes spreading of cytoplasm termed lamellipodium.   
Also, Rac is capable of inducing actin polymerisation by uncapping the actin 
filament at the barbed (+) end via interaction with phosphatidylinostide 4-phosphate 5-
kinase (PIP 5-kinase) which stimulate the formation of phosphatidylinositol 4,5-
biphosphate (PIP2), a complex responsible to remove capping protein (CP).  As it name 
suggests, CP is responsible for capping the (+) end of F-actin filaments to prevent 
polymerisation and loss of actin subunits from (-) end  (Wear et al., 2003).  After removal 
of CP, formin prevents re-capping of the actin filaments and promotes monomeric 
elongation which produces unbranched actin filaments.  Besides Arp2/3, a member of 
Spire family known as Cordon-Bleu, has been shown to localise to lamellipodia and 
overexpression of this protein promotes lamellipodia formation in cells (Campellone and 
Welch, 2010). Although lamellipodial persistence is important for cell migration, its 
termination is just as important.  Indeed, when cells lamellipodia come in contact with 
each other, a process known as contact inhibition will retract to avoid collision of cells 
(Carmona-Fontaine et al., 2008, Groeger and Nobes, 2007). 
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Figure 1.6.  Formation of lamellipodia through various signalling proteins.  (A) Signalling proteins 
involved in lamellipodia regulation; 1) Rac stimulate the formation of PIP2 which remove capping 
protein on existing actin filaments, allowing Arp 2/3 complex to mediate branching. 2) Arp 2/3 
complex is activated by trimolecular complex consisting of WAVE, IRSp53 and RAC.  Polymerisation 
of G-actin monomer by formins through recruitment of profiling at Arp 2/3 branch point resulted 
in extension of branched actin filament network.  3) Formation of lamellipodia through actin 
nucleation independent of Arp 2/3 complex by formins (adapted from Ridley, 2011).  (B) R37 
S100A4 WT cell stained for fascin (FITC) and actin (rhodamine).  Methods are fully detailed in 
Chapter 2.6. 
1.3.1.2  Filopodia 
Filopodia are needle-like extensions where their roles as sensory structures to 
probe the microenviroment and act as sites for signal transduction have been well 
documented (Amieva and Furthmayr, 1995).  However, the roles of filopodia remained 
incompletely understood.  While actin and fascin are positioned along the shaft to stabilise 
the extended filopodia, integrins are located the the tip of the filopodia to serve as 
extracellular cues transducer to initiate formation of focal adhesions and facilitate cell 
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migration (Mattila and Lappalainen, 2008).  Similar to lamellipodia, formation of filopodia 
is regulated by Cdc42, but with different downstream effectors as it has been reported 
that fibroblasts devoid of N-WASP are capable of forming filopodia but incapable of 
forming lamellipodia (Lommel et al., 2001, Snapper et al., 2001, Mattila and Lappalainen, 
2008).  It has been demonstrated that Cdc42 interacts with the partial CRIB motif of the 
IRSp53 relieving IRSp53 from autoinhibitory conformation, thus allowing it to form 
complex with mammalian-enabled (MENA), a member of ENA/VASP family.  Although this 
interacting pathway remains elusive, localisation of MENA to the tip of filopodia and focal 
adhesion sites through EVH1 (ENA/VASP homology) domain indicated its role in filopodia 
formation mediated by Cdc42 (Krugmann et al., 2001, Pichot et al., 2010).  Beside Cdc42, 
another GTPase family protein known as Rho in filopodia (RIF) has been demonstrated to 
stimulate filopodia formation independent of Cdc42 (Pellegrin and Mellor, 2005).  RIF is 
thought to regulate filopodia formation through activation of mammalian Diaphanous –
related formins (formin mDia2) by promoting polymerisation of actin monomer 
subsequently stabilising actin cortex (Ellis and Mellor, 2000, Pellegrin and Mellor, 2005).  
Termination of flipodia is thought to be a consequence of direct binding of Dia interacting 
protein (DIP) to formin mDia2 as this interaction has been demonstrated to inhibit formin 
mDia2-dependent F-actin assembly and bundling (Eisenmann et al., 2007).   
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Figure 1.7  Formation of filopodium. (A) Signalling proteins involved in regulating filopodia 
formation; 1) IRSp53 and MENA (ENA/VASP family) form complex through formin mDia2 to recruit 
Cdc42 to stimulate actin polymerisation.  2) Myosin X clusters actin filaments containing Arp 2/3 
complex which may initiates filopodia extensions.  3)  Extension of filopodia mediated by fascin 
resulted in parallel alignment of actin filaments.  4) RIF or Formin homology of mDia2 associate 
with WASP which mediate actin polymerisation through recruitment of G-actin by profiling 
(adapted from Ridley, 2011).  (B) Rama 37 control cells stained for fascin (FITC) and actin 
(Rhodamine).  Immunofluorescence staining was carried out as described in Chapter 2.6. 
 
1.3.2 Stabilisation of extended leading edge 
After cell polarisation through membrane extension, the extended structures have 
to be stabilised for migration persistency.  There are many receptors involved in the 
migration of different cell types, but integrins are the major receptors in transducing 
extracellular cues into the cell to forming nascent and transient adhesions which are 
distinguished by its small size and short-lived adhesive properties respectively.  
Recruitment of adaptor proteins to nascent adhesions stabilises the adhesions site into a 
structure known as focal complex.   These focal complexes then matured into focal 
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adhesions through further recruitment of adaptor proteins and associating these 
adhesions to stress fibers which allow the extended structures to ‘clamp’ onto the 
extracellular matrix to prevent retraction and serve as traction points to facilitate cell 
locomotion (Small and Kaverina, 2003, Shemesh et al., 2009, Vicente-Manzanares and 
Horwitz, 2011b) (Figure 1.10). 
 
1.3.2.1 Integrins and downstream signalling 
As mentioned earlier, the extended structures consist of heterodimeric cell surface 
receptors known as integrins.  Integrins are made up of two covalently linked 
transmembrane glycoprotein α and β subunit, each comprises of an extracellular domain 
to interact with extracellular matrix, such as fibronectin (FN), collagen and laminin, and a 
cytoplasmic domain interacting with intracellular signalling proteins (Guan, 1997, Kumar, 
1998, Wiesner et al., 2006).  Up to date, 18 α subunits and 8 β subunits to produce 24 
different αβ-integrins combinations have been identified in mammalian genomes 
(Humphries et al., 2006).  Role of integrins is not only limited as transducer for cell 
migrations, they are also important for cell proliferation, survival and differentiation 
(Schwartz and Assoian, 2001, Cruet-Hennequart et al., 2003).  As integrins do not 
themselves possess a kinase domain or enzymatic activity, these cytoplasmic domains will 
bind to adaptor proteins such as α-actinin, talin, filamin, vinculin and paxillin which will be 
organised around activated integrin clusters (Figure 1.8).  Organisation of these adaptor 
proteins is known as focal complexes which will then mature into focal adhesions and 
linking integrins to the actin filaments either directly or indirectly (Wiesner et al., 2005).  
Clustering of integrins at the extended structures resulted in activation of focal adhesions 
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kinase (FAK) which further enhances nearby integrins activations (Mitra et al., 2005, 
Michael et al., 2009).   
FAK is a 125 kDa autoinhibited, non-receptor cytoplasmic tyrosine kinase 
containing five major domains, namely, kinase domain, FERM (protein 4.1, ezrin, radixin 
and moesin homology) domain, focal adhesion targeting (FAT) domain and two proline 
rich domains.  This cytoplasmic kinase has been implicated in cell proliferation, motility 
and survival (Zhao et al., 1998, Ilic et al., 1995, Renshaw et al., 1999).  When FERM domain 
interacts with the FAK kinase domain, the resulting activated protein binds strongly to the 
Arp2/3 complex to facilitate nucleation of actin filaments.  Activated FAK via integrins 
clusterings or binding of proteins to FAK-FERM domain led to autophosphorylation at 
tyrosine (Y) 397 which enable phosphorylated FAK to associate with Src family kinases 
(SFKs) at the SH2 domain.  This newly formed complex will then interact with 
phosphorylate linker protein p130 Cas with both of its proline-rich domains causing it to 
release its association with Arp2/3 complex.  Through p130 Cas protein, paxillin is 
phosphorylated by FAK to interact with actin cytoskeleton.  The released Arp2/3 complex 
will be recruited to the extended leading edge to assist actin filament nucleation. 
Paxillin, a 70 kDa phosphotyrosine-containing protein, is phosphorylated by 
binding to FAK at residue Tyrosine 397 located at the C terminal, which is also known as 
focal adhesion targeting (FAT) domain.  Activation of paxillin via FAK results in subsequent 
activation of extracellular signal-regulated kinase (ERK) and p21-GTPase-activated kinase 
(PAK) which serves to activate myosin light chain kinase (MLCK) (Klemke et al., 1997).  
Besides, paxillin can also be phosphorylated by the Src family of the tyrosine kinases at the 
LIM domain and phosphorylated paxillin permits recruitment of CT10 regulator of kinase 
(CRK) adapter protein to protein linker p130 Cas and Rac GTP-exchange factor (GEF) DOCK 
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180 (Cote and Vuori, 2007).  This trimolecular complex, in turn, activates Rac while 
inactivating Rho.  Rac activation further enhances p130 Cas phosphorylation which led to 
increase Crk-Cas association which in turn activates integrins, suggesting a positive 
feedback mechanism (Wozniak et al., 2004). 
Talin, an antiparallel homodimer with head and tail in each 270 kDa subunits, 
binds to FAK and cytoplasmic domain of integrins with its globular head subunits 
(Calderwood, 2004).  Binding of talin to integrins resulted in unwinding of talin rod domain 
which allows binding of vinculin and α-actinin (Tomar and Schlaepfer, 2009).  The 
antiparallel dimerisation of α-actinin results in exposure of two calponin homology (CH) 
domains which serves as actin binding domains (Ciobanasu et al., 2012). In an alternating 
arrangement, NMMIIA and α-actinin crosslinked actin filaments to form stress fibers, a 
structure responsible for the next mechanistic step.  It was found that vinculin is capable 
of binding to FAK, paxillin and directly to actin filaments, suggesting the cross talk between 
adaptor proteins (Mierke et al., 2008).  Vinculin binds to the N-terminal of paxillin at 3 
different sites known as paxillin binding sequence and any mutations within this sequence 
has been shown to completely abolish the interaction (Schaller, 2001).  Similar to FAK, 
vinculin exists in inactive conformation due to intramolecular associations between the 
head and the tail domains and will subsequently be activated upon binding to talin, actin 
or PIP2  (Humphries et al., 2007).  Due to low binding affinity of vinculin to talin, 
inactivated vinculin will form nascent focal adhesions with high turnover rate.  However, if 
vinculin is activated, binding affinity of vinculin to talin will increase leading to low 
turnover rate and stabilisation of integrins and ultimately growth of focal adhesion (Chen 
et al., 2006, Humphries et al., 2007). 
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Figure 1. 8  Integrin transducing extracellular cues which led to recruitment of cytoplasmic 
protein signalling.  Extracellular domains of integrins bind to extracellular ligands which activate 
the intracellular domains.  Talin or vinculin (which can be activated by PIP2) can bind directly to 
intracellular domains of integrins and actin filaments.  Clustering of integrins also activate FAK 
which binds p130Cas to release Arp 2/3 complex as well as phosphorylating paxillin which led to 
activation of Rac via the Rac GTP-exchange factor (CRK) of DOCK 180.  Activated Rac induces actin 
polymerisation through Arp 2/3 complex.  Activation of RhoGEF by integrins led to activation of 
Rho kinases which subsequently phosphorylate RLC of NMMII to increase ATPase activity and 
inactivating myosin protein phosphatase (adapted from Vicente-Manzanares and Horwitz, 2011b). 
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1.3.3 Contraction of cell body 
After stabilisation of leading edge via recruitment of adaptor proteins into 
matured focal adhesions, the cell has to proceed by ‘pulling’ its body forward in a process 
known as actomyosin contractility.  In order for actomyosin contractility to occur, matured 
focal adhesions have to be interconnected to bundled actin filaments, known as stress 
fibers to exert traction force.  Localisation of Ena/VASP at focal adhesion sites at leading 
edge stimulated actin polymerisation where this polymerisation serves to link focal 
adhesions to existing actin cytoskeleton or to adjacent focal adhesions to form different 
subtypes of stress fibers, owing to its two important domains; 1) N-terminal EVH1 domain 
which binds to FPPPP motifs of zyxin and resulted in localisation of Ena/VASP to focal 
adhesions, 2) C-terminus EVH2 domain which regulates both polymerisation of actin 
monomer and binding to F-actin (Reinhard et al., 1992(Bachmann et al., 1999, Bear and 
Gertler, 2009, Rottner et al., 2001).   
There are three types of stress fibers characterised by its association to focal 
adhesions; 1) ventral stress fibers, 2) dorsal stress fibers and 3) transverse arcs (Figure 
1.9).  Ventral stress fibers and transverse arcs are made up of 10-30 actin filaments 
crosslinked by α-actinin in which NMMIIs were integrated in the regions where α-actinin 
was depleted resulting in a α-actinin-NMMII alternating structure (Cramer et al., 1997).  
Ventral stress fibers are usually responsible for tail retraction as it is characterised by 
having focal adhesions located at both ends.  Transverse arcs are not directly connected to 
focal adhesions, but their contractile force can be transmitted through dorsal stress fibers 
as it appeared to be localised parallel to lamellipodium in a crescent, connected to dorsal 
stress fibers.  Dorsal stress fibers are characterised by having one end connected to focal 
adhesions and the other serving to polymerise actin monomer towards the cell center 
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linking this structure to the existing cytoskeletal network and/or transverse arcs.  Also, as 
the trunks of dorsal stress fibers do not contain NMMII, it was presumed that this 
structure does not generate traction force (Tojkander et al., 2012).  Dorsal stress fibers are 
thought to be the precursor to ventral stress fibers as it has been demonstrated that 
contractility generated by dorsal stress fibers-transverse arcs structures led to dissociation 
of region of transverse arcs that are not associated to the two dorsal stress fibers leading 
to formation of ventral stress fibers.  Organisation of these stress fibers allows interaction 
of focal adhesions to NMMII to generate actomyosin contractility through reversible 
phosphorylation of myosin light chain (MLC) at Thr 18 and Ser 19. 
MLC can be phosphorylated either by MLCK (calcium dependent process) or Rho-
associated protein kinase (ROCK) (calcium independent process) and recently, it has been 
proposed that MLCK phosphorylate MLC located at the cell periphery whereas 
phosphorylation by ROCK appears to be in the center of the cell.  As mentioned previously, 
MLCK is activated by matured focal adhesions via activation of MAP kinases (ERK) and P21 
activated kinase (PAK).  Phosphorylation of MLC by ROCK promotes the release of myosin 
II heavy chain (MHC) tail, allowing association of myosin head with the F-actin, resulting in 
pulling action or simply known as actomyosin contractility (refer to Section 1.2.3) (Olson 
and Sahai, 2009).  Besides, ROCK also inhibit ADF/cofilin, an actin filament severing protein 
via activation of LIM-domain kinase 1 (LIMK1), promoting actin filaments maintenance 
(Sumi et al., 2001).  Beside capable of directly phosphorylating MLC, ROCK is also capable 
of increasing phosphorylation of MLC via inhibition activity of myosin protein phosphatase 
1 (PP1M), whose role is to dephosphorylate MLC. 
In the presence of calcium, MLCK is activated through interaction with calmodulin 
and calcium.  Activated MLCK resulted in subsequent phosphorylation of MLC and 
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generation of actomyosin contractility (Katoh et al., 2001a).  It has been proposed that 
although both ROCK and MLCK are capable of phosphorylating MLC to generate 
actomyosin contraction, the calcium dependent pathway via calmodulin produces rapid 
and local response whereas calcium independent pathway via ROCK produces more 
sustained response (Tojkander et al., 2012). 
 
Figure 1.9 Different types of stress fibers distinguished by focal adhesions.  Ventral stress fibers 
are characterised by having a focal adhesion located at each end of the fiber, dorsal stress fibers 
having one focal adhesion at either end and transverse arcs void of focal adhesions.  Cos 7 cells 
seeded on coverslip pre-coated with fibronectin were transfected with PeGFP NMMIIA (FITC) 
encoding plasmid using Jetpei.  After 48 hours the cells were fixed, blocked, stained for actin 
(Rhodamine) washed and mounted with DAPI (blue) before viewing with confocal microscope.  
Fully detailed method is described in Chapter 2.5 and 2.6. 
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1.3.4 Tail retraction and disintegration of focal complexes 
In order for cell body to move forward through actomyosin contraction, new 
protrusions will be extended with formation of new adhesions.  However, if existing 
adhesions do not disassemble, it is impossible for the cell to move forward.  Therefore, as 
new protusions are formed, some of the existing adhesions will disintegrates while the 
remaining ones will further matured for cell adherence and will be positioned underneath 
the cell center as the cell move forward.  The mechanism underlying focal adhesions 
disintegration remains elusive, but it has proposed that extensions of microtubules to 
focal adhesions promote its disintegration by inducing FAK dephosphorylation (Ezratty et 
al., 2005, Watanabe et al., 2005, Small and Kaverina, 2003).  FAK dephosphorylation can 
be induced by phosphatases such as PTP-PEST and SHP-2.  Activation of ERK by Ras causes 
phosphorylation of FAK at Ser 910, exposing Pro 910 residue to peptidyl-proyl cis/trans 
isomerase (PIN1).  PIN1 brings FAK to close proximity with PTP-PEST hence 
dephosphorylating FAK. SHP-2, another FAK phosphatase, exists in autoinhibitory 
conformation due to interaction of two SH-domains at the N terminal.  This autoinhibitory 
conformation is relieved through association pleckstrin homology (PH) domain of Gab1 
(Nagano et al., 2012).  Besides, in a calcium dependent manner, m-Calpain, a member of 
calpain family of proteases has been shown to be capable of cleaving talin, FAK and 
paxillin.  Although little is known about the cleaving mechanism of m-Calpain, it was 
proposed that cleaving of these adaptor proteins led to disruption of crosstalk within the 
focal adhesion sites (Sieg et al., 2000, Franco and Huttenlocher, 2005, Nagano et al., 2012).   
Therefore, as cell move forward through actomyosin contraction, disintegration of 
focal adhesion at the trailing end of the cell led to retraction of tail.  
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Figure 1.10 Signalling proteins involved in regulating focal adhesion dynamicity through actin filaments to facilitate cell migration.  (Adapted 
from Vicente-Manzanares and Horwitz, 2011a).  
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1.4 Aims 
In the first part of the work, we aimed to demonstrate the consequences of S100A4 
overexpression on cell morphology, focal adhesions, as well as importance of C-terminus 
of S100A4 in mediating cell motility.   
Following that, we set out to investigate the link between S100A4 and NMMIIA on 
cell migration and morphology using three approaches; 1) inhibition of NMMIIA with 
chemical compound, 2) knockdown of NMMIIA using SiRNA transfection and 3) using 
cellular system where NMMIIA is completely ablated. 
Finally, utilising High Content Imaging (HCI) assay, we tested numerous chemical 
compounds for their ability to affect S100A4-induced migration through wound healing 
assay to provide more insight on the S100A4 activity. 
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2.1 Materials 
2.1.1 Equipments (and Softwares) 
BioRad, Hemel Hempstead, UK :   
Bio-Rad mini-Protean II gel system , Mini Trans-Blot Cell, PowerPac™ Basic Power Supply 
 
BioTek Potton, Bedfordshire,UK: 
 Plate Reader EL800 
 
Beckam Coulter Ltd., High Wycombe, UK: 
 Avanti J-E centrifuge 
 
Carl Zeiss Microscopy GmbH, Oberkochen, Germany:  
Confocal microscope (LSM710) -EC Plan-Neofluar 40x/1.30 Oil Ph3 objective (immunofluorescence 
staining), Cell Observer system with CCD camera (AxioCam MRm)-40x/1.3 Ph3 plan neofluar oil 
objective (Cell force measurements- Matlab software) 
 
Chip-Man Technologies Oy, Tampere, Finland:  
Cell-IQ MLF-(Imagen™ Software, Analyser™ Software-Machine Vision Technology) 
 
DJB Labcare Ltd, Buckinghamshire, UK:  
Eppendorf Centrifgue 5810R 
 
Geneflow, Staffordshire, UK:  
DNA Gel Cast 
 
Leica Microsystems Ltd, Milton Keynes, UK:  
Inverted epifluorescence microscope (DM14000B) (AxioVision Version 4.7 software)- N-Plan 10x 
/0.25 PH1 objective (immunofluorescence staining), confocal microscope (TCS SP5 II Confocal) 
(AxioVision Version 4.7 software)- HCX PL APO 63x/1.4-0.6 oilCS objective (immunofluorescence 
staining) 
 
Sigma-Aldrich, Poole, UK:  
Sigma 2-6E centrifuge (83/L rotor) 
 
Syngene, Cambridge, UK:  
G:Box-UV transilluminator 
 
Themoscientific, Loughborough,UK:  
ThermoScientific NanoDrop™ 1000 UV/VIS Spectrophotometer (NanoDrop Software) 
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2.1.2 Reagents 
Abcam, Cambridge, UK:  
Polyclonal Goat anti-Mouse Immunoglobulins/FITC, Polyclonal Goat anti-Mouse 
Immunoglobulins/TRITC, Polyclonal Goat anti-Rabbit Immunoglobulins/FITC 
 
Addgene, Cambridge, USA: 
Human CMV-GFP non muscle myosin II A heavy chain (Plasmid 11347) 
 
Appleton Woods, Birmingham, UK:  
Tissue culture flasks and plates (Cornings), Latex gloves, autoclave tapes, 200 µl pipette tips, 50 ml 
centrifuge tubes 
 
Bioline, London, UK: 
Molecular Grade Agarose 
 
BioRad, Hemel Hempstead, UK :  
Ethidium bromide, DC™ Protein Assay (Lowry method), Gel Loading Tips 
 
Biosera, East Sussex, UK: 
L-glutamine (100X) 
 
Carl Zeiss Ltd, Hertfordshire, UK:  
Immersol™ Immersion oil 
 
CEAC, Aston University, UK:  
Ethanol, Methanol, Propanol 
 
Covance Inc., Leeds, UK:  
Polyclonal affinity purifed non muscle myosin heavy chain II-A antibody anti-rabbit, polyclonal 
affinity purifed non muscle myosin heavy chain II-B antibody anti-rabbit 
 
Dako, Ely, UK:  
Polyclonal Rabbit Anti-Human S100A4 
 
Enzo Life Sciences, Exerter, UK:  
Blebbistatin 
 
Expedeon, Cambridgeshire, UK:   
Bradfordultra™ 
 
Fisher Scientific, Loughborough, UK:  
2 units of individual tube of SiRNA non muscle myosin IIA heavy chain-Rat (1-
GGUCAUCUCUGGCGUCCUU, 2-GCAGAUCGACCAAAUAAAC), SiRNA Buffer (5X), Fermentas mini-
prep kit, PageRuler Plus Prestained Protein Ladder, Whatman Filter Paper Grade 1573 Roll 
Cellulose Fast, Microscope slide, Gerhard Menzel,SuperFrost® Plus, Acetic acid glacial (HPLC 
grade), Sodium chloride, Tris Base Ultra Pure, microcentrifuge tubes (0.5 ml, 1.5 ml, 2.0 ml), Bottle 
Borosilicate Screw cap (250 ml, 500 ml, 1000 ml), Plastipak Syringe disposable (10 ml, 20 ml), 
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syringe filter 33mm Millex PES Pore Size 0.22µm, Parafilm, Aluminium foil, Cling Film, Weighing 
boat polysterene square (250ml), Virkon® 
 
Geneflow, Staffordshire, UK:  
EZ-PCR Mycoplasma test kit, DNA Gel Cast 
 
Greiner, Stonehouse, UK:  
Skirted, internal thread, blue cap, sterile cryovial (2.0 ml), Individual Wrapped Cell scraper 
 
Invitrogen, Paisley, UK:  
Alexa Fluor® 568 phalloidin, Monoclonal anti-paxillin antibody (mouse) Opti-MEM® Reduced 
Serum Medium (no phenol red) 
 
Melford Laboratories Ltd, Suffolk, UK: 
 Glycine, Acrylamide/bis-acrylamide (40% w/v), MTT, Nuclease free water 
 
Merck Chemicals Ltd, Nottingham, UK:  
G 418 Sulfate (cell culture tested) 
 
Milipore, Watford, UK:  
Monoclonal anti-fascin antibody (mouse), Polyclonal anti-VASP antibody (rabbit) 
 
New England Biolabs Ltd, Herts,UK:  
1-10kb DNA ladder 
 
PAA Laboratories Ltd., Somerset, UK:  
High Glucose DMEM (4.5g/l) liquid without L-Glutamine, MEM Non Essential Amino Acids (100X), 
Goat Serum, Penicillin (500,000Uml-1) /streptomycin (500,000μgml-1), Trypsin (10X),  Fetal Bovine 
Serum (FBS) 
 
Sarstedt Ltd, Leicester, UK:  
Individually wrapped sterile serological pipette (5ml, 10 ml, 25 ml), 1000 µl blue tips, petri dish, 
Tissue culture dish (60x15mm) 
 
SLS Ltd, Nottingham, UK:  
High Clarity polypropylene centrifuge tubes (15ml), round coverslips (12mm and 13mm) 
 
Starlab Ltd, Milton Keynes, UK:  
 Cordless pipette controller, 10 µl graduated tips 
 
Sigma-Aldrich, Poole, UK:  
Monoclonal anti-vinculin antibody (mouse), BDM, Fibronectin (human plasma), Dimethyl 
sulfoxide, Phosphate buffered saline tablets, Triton X-100, Kodak® GBX developer, Kodak® GBX 
fixer, Kodak® BioMax® light film, Hydrocortisone-Water Soluble, Insulin solution (human), 
Peroxidase-conjugated goat anti-rabbit immunoglobulins (whole molecule) polyclonal antibody, 
Peroxidase-conjugated goat anti-mouse immunoglobulins (whole molecule) polyclonal antibody, 
Ethylenediaminetetraacetic acid (EDTA), Kanamycin, Ampicillin, Ammonium persulphate (APS), 
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N,N,N',N'-Tetramethylethylenediamine (TEMED), Paraformaldehye (PFA), sodium dodecyl sulphate 
(SDS), Sodium hydroxide (NaOH) 
 
Tocris Bioscience, Bristol, UK: 
 Y-27632  
 
Vector Laboratories Ltd, Peterborough, UK: 
 Vectashield hard set mounting medium containing 4’-6-diamidino-2-phenylindole (DAPI) 
 
VWR International, Leicestershire, UK:  
jetPEI® HTS DNA transfection reagent, INTERFERin® siRNA transfection reagent 
 
All reagents were purchased from Sigma (Poole, UK), unless stated otherwise. Marvel dried milk 
powder was purchased from domestic outlets. And all solutions, reagents and utensils were 
sterilised by autoclaving at 121°C or by filtering through 0.22µm Millex PES Pore syringe filter. 
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2.2 Methods 
2.2.1 Cell Culture 
2.2.1.1 Culture of Rat mammary benign tumour (Rama 37) 
The rat mammary (Rama 37) non-metastatic benign tumour derived cell line 37 expresses 
barely detectable levels of S100A4 mRNA and protein (Dunnington et al., 1983, Davies et al., 1994, 
Lloyd et al., 1998). The four cell lines used during this work were: a) the control cells transfected 
with the empty pBKCMV vector (Rama 37 Control), b) the cell line transfected with the human full 
length S100A4 wild type open reading frame inserted in the pBKCMV expression plasmid (R37 
S100A4WT), c) R37 S100A4Δ2 cell line and d) R37 S100A4Δ6 cell line which were obtained by 
transfection of the expression vectors for S100A4 protein with C-terminal truncations lacking 
amino acids 100-101 or 96-101 respectively (Figure 2.2.1) (Ismail et al., 2008b, Ismail et al., 2010).  
These cell lines were kindly supplied by Prof. Philip Rudland and Dr. Roger Barraclough (University 
of Liverpool, UK) and level of S100A4 expressions were reconfirmed with western blot analysis 
(Figure 2.2.2).  
The cells were routinely cultured in a humidified atmosphere at 37ºC, 5% (v/v) CO2 in 
Dulbecco minimal Eagle’s medium (DMEM) supplemented with 4500mg/L glucose, sodium 
pyruvate (< 1%), sodium bicarbonate (< 0.37%), 2mM L-glutamine, 1% (v/v) non essential amino 
acids, penicillin/streptomycin (50 U/ml), 10% (v/v) fetal bovine serum (heat inactivated), 5ng/ml 
insulin, 5ng/ml hydrocortisone and 400µg/ml geneticin (G418).  
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Figure 2.2.1 Illustration of C terminus region of S100A4 protein.  A) C terminus of wild type 
S100A4 protein, B) truncation of the last two amino acids from C terminus of S100A4 protein and 
C) truncation of the last six amino acids from the C terminus of S100A4 protein. 
 
Figure 2.2.2 Western blot reconfirming level of S100A4 expression.  Rama 37 cell lines with a 
density of 1.5 x 106 were seeded into 60mm tissue culture dish 24 hours prior to harvesting.  Total 
protein for all cell lines were quantified and equal amount of total protein (80µg eEF1A1 and 
150µg S100A4) loaded onto SDS Page gels (10% (w/v) and 15% (w/v) respectively).  Resolved 
proteins were transferred onto nitrocellulose membrane before incubating with primary 
antibodies (eEF1A1 and S100A4) and then followed by secondary HRP conjugated antibody.  
Detection was undertaken using the customised detection system (Table 2.11).  Methods are fully 
detailed in Chapter 2.2.11 to 2.2.15. 
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2.2.1.2 Culture of African green monkey kidney cells (Cos 7) 
The wild type Cos 7 cells were a kind gift from Dr. Eric Hill (Aston University, UK).  This cell 
line originates from African green monkey kidney and derives from the CV-1 cell line by 
transformation with an origin defective mutant of SV40 which codes for wild type antigen T.  It has 
a fibroblast-like morphology and naturally lack of non muscle myosin IIA which is a vital part of this 
project.  In this work, this cell line is transfected with four different plasmids: a) the control cells 
transfected with the empty PeGFP C3 plasmid (PeGFP C3), b) transfected with human PeGFP full 
length non muscle myosin IIA (NMIIA) (Addgene, USA) c) transfected with PeCFP C1 plasmid 
(PeCFP C1) and d) transfected with human PeCFP full length S100A4 protein (PeCFP S100A4 WT).  
The PeCFP plasmid encoding full length of S100A4 WT protein is a kind gift from Dr. Roger 
Barraclough (University of Liverpool, UK) 
The wild type Cos 7 cells were cultured DMEM supplemented with 4500mg/L glucose, 2 
mM L-glutamine, 1% (v/v) non essential amino acids, penicillin/streptomycin (50 U/ml) and 10% 
(v/v) fetal bovine serum (heat inactivated).  Transfected Cos 7 cells were cultured as wild type Cos 
7 but with additional 300 µg/ml geneticin (G418) for selection purposes.  All cell lines were left for 
incubation in a humidified atmosphere at 37°C, 5% (v/v) CO2, 95% (v/v) air. 
 
2.2.1.3 Passage of cells 
Cells were grown until they reach 80% confluency in any sized flask before passaging.  The 
used media were pipette out and the cells were rinsed with serum free DMEM.  The cells were 
then trypsinsed by adding appropriate amount of trypsin (1 ml per 25 cm2) containing 2mM EDTA 
dissolved in PBS at pH7.4.  The flask is then placed in the incubator for 5 minutes and the 
dislodged cells were determined by visualising under light microscope.  The trypsin action was 
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inhibited by adding complete media which amount is twice of the amount of trypsin that has been 
added beforehand. The cells suspensions were centrifuged at 2000 rpm using 2-6E Sigma 
centrifuge for 5 minutes.  The supernatants were discarded and the cell pellets were resuspended 
in fresh complete media and appropriate amount of cells were reseeded.  If necessary, cell 
counting will be performed with a double chamber (refer to Section 2.2.2). 
 
2.2.1.4 Cryopreservation of Cells 
Centrifuged cells obtained while passaging cells (refer to Section 2.2.1.3) were 
resuspended in freezing mixture made up of 10% (v/v) DMSO and 90% (v/v) of fetal bovine serum.  
Cells were stored in pre-labelled cryovials and left in -20°c freezer for an hour before transferring 
them to -80°C freezer.  The cells were transferred into liquid nitrogen the next day. 
 
2.2.1.5 Cell Thawing 
Frozen cells were quickly thawed in 37°C water bath.  Cells were removed from the 
cryovial and placed into a T25 flask.  Immediately, pre-warmed medium is added drop-wise into 
the cell suspension and gently mixing them at the same time.  After 12-16 hours, depending on the 
rate of cell attachment, the used media is replaced with fresh ones. 
 
2.2.2 Cell Counting 
Numbers of cells were determined prior to every experiment conducted.  After 
trypsinisation, centrifugation, and resuspension in fresh medium (refer to Section 2.2.1), 10 µl of 
cell suspension was applied to double chamber haemocytometer (Haemocytometer Improved 
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Neubauers double ruled, Fisher,UK).  Cells in the four quadrants were counted and the average 
numbers of cells were multiplied by 104 to give the final number of cells per ml. 
 
2.2.3 Cell Viability Determination 
Viability of cells is determined by (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide) MTT assay.  This technique is based on the colour formation caused by respiratory chain 
activity of proliferating or living cells (Mosmann, 1983).  Tetrazolium salts measure the 
dehydrogenase enzyme activities, which is cleavage of tetrazolium ring in active mitochondria.  
This results in reduction of yellow MTT solution insoluble purple formazan (1-(4,5-dimethylthiazol-
2-yl)-3,5-diphenylformazan) by succinate-tetrazolium reductase  (Bernhard et al., 2003).  With the 
addition of dimethylsulphoxide (DMSO) solution, the insoluble purple formazan is solubilised into 
coloured solution and the intensity of product’s colour can be measured using a 
spectrophotometer where higher intensity indicates higher cells viability or cell number or 
mitochondrial activity.  
The cell numbers to be seeded into a 24 well plate were determined by seeding different 
initial cell numbers into each well and the one which reaches confluency at day 7 will be used.  The 
rationale behind this selection is that cells that were over-confluent will reduce cell growth rate 
hence interfering MTT determination.  In some of the experiments, where cells viability was 
measured for 72 hours, it is important to ensure that the wells will not be over-confluent by 72 
hours.  For these cell lines, the optimum number of cells to be seeded into each well of 24 well 
plate is 10,000.  The freshly seeded cells were left for 24 hours incubation prior to addition of 
inhibitors or other compounds.  40 µl of MTT (5mg/ml in PBS) is added to 400 µL of media and the 
cells were incubated at 37°C with MTT for 1 hour.  The media were then pipette out and the cells 
were washed with PBS and solubilised with 400 µl of DMSO.  The solubilised MTT were then 
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transferred to 96 well plate before reading at 550nm with a plate reader.  Any reading exceed the 
value of 1.1 is diluted with DMSO to obtain a more accurate reading.  
 
2.2.4. CellIQ Scratch Assay 
 Cells were counted (refer to Section 2.2.6) and seeded into 24 well plate and left to 
incubate for 48 hours until it reaches 100% of confluency (refer below for specific cell types 
density).  The used media were discarded and one scratch was done per well with a yellow tip.  
The scratched wells were then washed with serum free media to remove cell debris.  Fresh media, 
with or without drugs, were then added into each well.  The scored plates were left in the 
incubator for about 30 minutes with CellIQ customised lids prior to sealing them with sealing tape.  
Then, the plates were attached to the gas pipes within the CellIQ machine 37ºC incubator where it 
serves to maintain constant gas flow.  Three positions in different regions of each well were set 
with the CellIQ imaging software and images were taken for 24 hours.  Then, images were 
processed with CellIQ analyser software. 
Cell types Number of cells to be seeded in each well of 24 well plate 
Rama 37 control 150,000 
R37 S100A4 WT cells 200,000 
Cos 7 cells 100,000 
Table 2.1 Densities of different cell lines to be seeded in each well of 24 well plate for scratch 
assay. 
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2.2.4.1 Determining Mitotic Index with CellIQ 
 Images of cells taken with CellIQ were browsed carefully using CellIQ software and 
morphology in different phases was assigned into respective classes as described in 
manufacturer’s guide ; a) dividing cells, b) stable cells, c) dead cells and d) debris (Figure 2.2.2).  
Mitotic index were obtained by calculating the ratio between dividing cells and the total number 
of cells. 
 
Figure 2.2.3.  Representative image of Rama 37 control cells assigned into respective class using 
CellIQ imaging system. 
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2.2.5  Layout of Rama 37 cell lines seeding in 24 well plate for screening 
Rama 37 cell lines (150,000 for Rama 37 control cells and 100,000 R37 S100A4 WT cells) 
were seeded in each well of 24 wells plate for 48 hours to obtain a confluent monolayer of cells 
(Figure 5.2.1 and 5.2.2).  Cells were then wounded with a 200 µL pipette tip and washed with PBS 
prior to adding 800 µL of fresh media along with 5 µM of chemical compounds to be tested.  The 
plate was swirled gently to provide an even mixture before incubation for a maximum of 24 hours.  
The rest of the method is as mentioned in Chapter 2.2.4. 
 
Figure 2.2.4 Layout of cell types seeded on 24 well plate for preliminary screening 
 
Figure 2.2.5 Layout of cell types seeded on 24 well plate for secondary and tertiary screening 
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2.2.5.1  Calculation of wound closure rate (µm2 min-1) 
 Images taken during wound healing process were analysed using CellIQ Analyser Software.  
This software will provide information about time when the images were taken, total wound area, 
total wound closure area and percentage of wound area closure.  From this information, wound 
healing curves were obtained where percentage of wound closure is plotted against time (Figure 
2.2.2).   
From the raw data, the gradient of the curve is obtained as shown below: 
 
Figure 2.2.6 Illustration showing how a wound area closure rate is calculated from raw data 
obtained.   
 
In the calculation of wound area closure rate, the gradient of the curve, m, is obtained using the 
formula: 
Y = mX + C 
where  Y = y2- y1 (Wound area in pixel
2) 
 X = x2 – x1 (time in second) 
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The gradient of the wound healing curve was taken close to the mid section ( 50 %) with the 
following assumptions: 
1) Wound healing curve at T = 0 is ignored as compound used may have slower effect on cells 
2) Wound healing curve plateaus as it reaches 80 % of total closure 
It is worth noting that the wound width is taken as pixel instead of µm and the time is taken as 
second.  Hence, the area calculated correlates to pixel2.  Since 10X objective was used in the entire 
screen, it is given that: 
    1 pixel = 0.7 µm  
 
Therefore, the rate of wound area closure is in µm2min-1: 
    Rate = m x 0.49 (µm2) ÷ 60 (min) 
 
2.2.6 Transient Transfection  
Plasmid DNA or siRNA can be transfected into cells depending on manufacturer’s protocol.  
Throughout this work, Polyplus Jetpei transfection reagent was used unless mentioned otherwise.  
Depending on nature of experiment and cell types, different number of cells will be seeded into 
either 24 well plate, 6 well plates or 60mm tissue culture dishes (refer below for specific cell types 
in different wells).  The seeded cells were then left to attach for 24 hours before the used media 
were discarded, washed with serum free DMEM and replaced with fresh media void of antibiotics 
1 hour prior to transfection.  In two different eppendorf tubes, 100 µL NaCl (150mM) were added 
into each tube.  Then, the transfection reagent (JetPei®, VWR International, UK) and plasmid DNA 
were added into each tube respectively.  The ratio of Jetpei to plasmid DNA should be determined 
beforehand to get optimum transfection efficiency.  Both the tubes were vortexed for 10 seconds 
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and then centrifuged briefly.  Then, the tube containing transfection reagent was added gently 
(dropwise) to the tube containing plasmid DNA.  Again, the content were mixed thoroughly by 10 
second vortexing and then briefly centrifuged to bring the solution down.  The solution was left to 
incubate for 15 to 30 minutes at room temperature.  The solution was added dropwise to the cells 
and the plate (flask or dish) were gently mixed by swirling action.  After 24 to 48 hours, the cells 
should be transfected and ready for fixing or treatment. 
 
In each well of 24 well plate 
Cell types 
Number of cells to be seeded 
(wound healing assay-CellIQ) 
Number of cells to be seeded 
(immunofluorescence staining) 
Rama 37 control 80,000 10,000 
R37 S100A4 WT cells 80,000 10,000 
Cos 7 cells 80,000 10,000 
Table 2.2  Density of respective cells to be seeded in each well of 24 well plate for transfection. 
In each well of 6o mm culture dish (western blot) 
Cell types Number of cells to be seeded 
Rama 37 control 500,000 
R37 S100A4 WT cells 500,000 
Cos 7 cells 400,000 
Table 2.3 Density of respective cells to be seeded in 60 mm culture dish for transfection prior to 
conducting western blot. 
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2.2.6.1 Transfection efficiency  
Round glass coverslips measured at 13mm in diameter were placed into each well of 24 
well plate.  The plate was then exposed to UV for 10 minutes before coating the coverslips with 
4µg of fibronectin per well in sterilised PBS.  The plate was left for incubation for 1 hour in 37ºC.  
Unbound fibronectin was washed with PBS for three times and the counted cells were seeded in 
400 µl of complete media and left for 24 hours.  The media were discarded and replaced with 
fresh media void of antibiotics 1 hour prior to transfection.  Different transfections were done 
according to their customised protocols.  After 24 hours, cells were washed and fixed with 3.7% 
(w/v) PFA for 20 minutes.  Then, PFA was replaced with 30mM of glycine (solubilised in PBS) for 10 
minutes to counter left over PFA activity. Cells were then mounted with Hardset mounting 
medium, DAPI (Vector Laboratories Ltd, UK).  Images of cells were taken with inverted 
epifluorescence microscope (DM14000B, Leica) using a N-Plan 20x /0.25 PH1 objective (AxioVision 
Version 4.7 software).  Total cell count (number of nucleus stained with DAPI) against 
transfectants (GFP/CFP expressing cells) were calculated and plotted as transfection efficiency. 
 
2.2.7  SiRNA transfection 
Respective cell lines were seeded into individual culture vessel (either 24 or 6 well plate) 24 hours 
prior to transfection.  Used medium was replaced with Z Opti-MEM® and left for 4 hours prior to 
adding transfection mixture.  The transfection mixture was obtained by adding W µL of SiRNA to X 
µL of serum free DMEM before being gently mixed by pipetting motion.  Then, Y µL of 
INTERFERin® and the mixture were vortexed for 10 seconds and briefly centrifuged before being 
incubated for 10 minutes at room temperature.  The mixture was added to the cells and incubated 
for 72 hours prior to further analysis. 
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Culture vessel W (µL) volume of 
SiRNA added (20 µM 
stock concentration) 
X (µL) volume of 
serum free 
DMEM 
Y  (µL) volume of 
INTERFERin®  
reagent 
Z (µL) volume of 
Opti-MEM® 
24 well  1 100 3 1000 
6 well 3 200 9 2000 
Table 2.4 Ratios of different reagents to be added in either 24 well or 6 well transfection. 
 
2.2.8 Immunofluorescence Staining 
Round glass coverslips (SLS Ltd, UK) measured at 13mm in diameter were placed into each 
well of 24 well plate.  The plate was then exposed to UV for 10 minutes before coating the 
coverslips with 4µg of fibronectin (Sigma, UK) per well in sterilised PBS.  The plate was left for 
incubation for 1 hour in 37°C.  Unbound fibronectin was washed with PBS for three times and the 
counted cells were seeded in 400 µl of complete media and left for 48 hours.  Cells were washed 
with cytoskeleton buffer (CB buffer) (refer to Table 2.5) twice before fixing them with 3.7% (w/v) 
PFA in CB buffer at 37°C for 20 minutes.  Then, cells were incubated with 30mM Glycine in CB 
buffer at room temperature for 10 minutes.  Following this, 5% (v/v) Triton X-100 in CB buffer was 
added to the cells and left for 2 minutes to permeabilise and solubilise them.  The cells were then 
washed 3 times for 5 minutes with CB buffer at room temperature.  Blocking of cells was 
performed using 10% (v/v) goat serum in CB buffer for 30 minutes.  Primary antibody incubation 
(refer to Table 2.4) in 1% (v/v) goat serum in CB buffer was done at 37°C for 45 minutes.  The 
excess primary antibody is washed off with 1% (v/v) goat serum at room temperature for three 
times and 5 minutes for each wash.  Then, the cells were incubated with secondary antibody (refer 
to Table 2.4) in 1% (v/v) goat serum in CB buffer at 37°C for 45 minutes. Cells were washed again 
with 1% (v/v) goat serum in CB buffer for three times and twice with distilled water to remove salt.  
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The coverslips were carefully mounted onto slides with hardest mounting medium, DAPI before 
viewing under a microscope.  To avoid samples from drying out, nail varnish was applied around 
the edge of the coverslips and kept in 4°C. 
Types of antibody Dilution in CB buffer (1% Goat serum) 
Monoclonal anti-Vinculin antibody (mouse) 1:60 
Monoclonal anti-Paxillin antibody (mouse) 1:100 
Polyclonal anti-NMMIIA (rabbit) 1:2000 
Monoclonal anti-Fascin antibody (mouse) 1:500 
Polyclonal anti- VASP antibody (rabbit) 1:200 
Alexa Fluor® 568 phalloidin 1:40 
FITC/ TRITC secondary conjugate (mouse and rabbit 
each respectively) 
1:300 
Table 2.5  Dilutions of antibodies used for immunofluorescence staining. 
Making of 1 Litre of cytoskeleton buffer (CB buffer) 
Chemical compound Weight (grams) 
Sodium Chloride (NaCl) 8.766 
Magnesium Chloride (MgCl2) 0.476 
Ethylene Glycol Tetraacetic Acid (EGTA) 1.901 
Glucose 0.900 
MES (2-n-morpholino ethansulfon acid) 2.130 
Table 2.6 Formulations used for making  1L of cytoskeleton buffer (1x). 
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2.2.9 Live cell analysis 
For live cell analysis, the different cell lines were seeded with density of 500,000 cells in a 
50mm Petri dish and grown for 24 hours prior to pGZ21 GFP-vinculin expressing plasmid 
transfection with jetPei™ (a kind gift from Benjamin Geiger, Weizmann Institute of Science, 
Rehovot, Israel).  The transfectants were trypsinised and reseeded at a density of 5,000 cells into a 
customised 170μm-thickness glass bottom Petri dish, pre-coated with 2.5 μm/cm2 of fibronectin 
(BD Biosicences, Palo Alto, CA) for 30 minutes at 37°C.  The analyses were carried out 24 hours 
post seeding with confocal microscope (LSM710, Zeiss) using EC Plan-Neofluar 40x/1.30 Oil Ph3 
objective (Zeiss) at 37°C and 5% (v/v) CO2. The duration for single cell analysis was set to 20 
minutes per cell with 10 seconds intervals.  Phase contrast and GFP imaging were taken with argon 
ion laser line with a wavelength of 488nm and 2.4 - 2.8% of laser intensity.  All the parameters 
were kept constant throughout the analyses.  Images obtained were optimised (background 
subtraction and contrast adjustment) with ImageJ for better visualisation.  
 
2.2.10 Quantification of focal adhesion clusters and filopodia of fixed cells 
Immunofluorescence staining images were taken as mentioned in Chapter 2.2.6.  Single 
cell images were selected and open with ImageJ.  Quantifications were done by manually counting 
the filopodia or clusters with multipoint selection tool. 
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2.2.11 Quantification of focal adhesion clusters and filopodia of live cells 
Time-lapse images taken as mentioned in Chapter 2.2.7 were used.  Time frames were 
frozen to quantify newly formed focal adhesions or filopodia.  Using this method, the retracting 
fibers were distinguished form the filopodia by determining the rear and leading edge of the 
migrating cell. 
 
2.2.12 Cell force analysis 
Silicon wafer were cleaned in acetone, washed with methanol and then blow dried before 
being baked for 20 minutes at 120°C.  The wafers were then silanised with tirchrolo(1H, 1H, 2H, 
2H-perfluorooctyl)silane (Sigma).  The elastic silicone rubber substrates were made with two-
component silicone rubber (PDMS) formulation (Sylgard 184, Dow Corning GmbH, Wiesbaden, 
Germany) of either 55:1 or 50:1 (w/w) ratio of base material and cross-linker (with a Young’s  
modulus of 8 kPa or 15kPa respectively).   For micropatterning, red fluorescence beads 
(FluoSpheres, 0.2 µm, Crimson, Invitrogen, Karlsruhe, Germany) were mixed with one part of the 
silicone substrate and spread on the micro-structured silanised silicon dioxide wafer surface.  
Excess substrate on wafer was removed by wiping it off with lint-free tissue.  Then, two glass 
spacers (80-100 µm) were placed on each side of the wafer and the remaining subtrates without 
microbeads were added onto the wafer, in between the spacers.  A coverslip was placed on top of 
the substrate even the surface.  The sandwiched substrate was cross-linked by overnight baking at 
60°C and glued to the bottom of a 35mm Petri dish which has been predrilled with 15mm holes 
(Cesa et al., 2007, Claudia Schäfer, 2010). 
A density of 5000 cells (either Rama 37 control, R37 S100A4 WT, R37 S100A4 Δ2 or R37 
S100A4 Δ6) per dish were seeded respectively onto the customised Petri dish and left for 
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overnight incubation. The attached cells in respective dish were removed with a micro 
manipulator and the phase contrast image of the cells and the deformation of microbeads 
patterns were taken with 40x/1.3 Ph3 plan neofluar oil objective (Carl Zeiss) on a Cell Observer 
system (Carl Zeiss) equipped with a CCD camera (AxioCam, MRm, Carl Zeiss).   Complete removal 
of cell was demonstrated by taking a phase contrast image after cell removal.  Microbeads 
patterns were visualised with DsRed filter. 
The deformations of the beads caused by contraction force of the cells were calculated 
with Cellforce analysis software where the shifts of the beads before and after removal of the cells 
were calculated. 
 
2.2.13 Preparation of chemically competent E.coli 
E.coli (Dh5-Alpha strain) were grown overnight on an agar plate.  Then, using a yellow tip, 
a single colony was picked and inoculated in 5 ml of Lennox Broth (LB) (refer to Table 2.6) in a 
shaker incubator at 37°C for overnight.  Culture was diluted with a ratio of 1:1000 with fresh LB 
and left in the same incubator until the the absorbance at 600 nm was approximately 0.300.  The 
culture was then left on ice for 15 minutes before adding equal volume (5 ml) of 2X 
Transformation and Storage Solution (TSS) (refer to Table 2.6).  The culture was mixed gently and 
left on ice for a further 20 minutes.  The mixture was centrifuged at 1000g at 4°C and the 
supernatant is carefully decanted.  The pellet is resuspended in 1 ml of 1X TSS mixture (0.5 ml of 
2X TSS and 0.5 ml of LB).  The cells were then aliquoted and stored in -80°C for future use. 
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Chemical compound Amount 
Making of 1 Litre of Lennox Broth (LB) 
Tryptone 10.000 (g) 
Yeast extract 5.000 (g) 
Sodium Chloride (NaCl) 10.000 (g) 
Distilled water Top up to 1000 (ml) 
Making of 100 ml of 2X-Transformation and Storage Solution (TSS) (pH 6.5) 
Polyethylene Glycol 3350 (PEG3350) (20% w/v) 20.000 (g) 
Magnesium Chloride (MgCl2) (100 mM) 9.521 (g) 
LB Broth Top up to 100 (ml) 
Table 2.7  Formulations to prepare 1L of Lennox Broth and 100ml of Transformation and Storage 
Solutions (1X). 
 
2.2.14 E.coli Transformation for plasmid production 
To make transformants, 10ng of plasmid DNA was aliquoted into an eppendorf tube and 
left on ice.  Then, competent bacteria previously prepared and stored in -80°C were rapidly 
thawed. To the aliquoted plasmid DNA, 40-50µl of competent bacteria was added.  The mixture 
was left on ice for 30 minutes and shaking the tube at every 10 minutes interval. The tube was 
then placed in water bath at 42°C for 45 seconds and immediately kept on ice for 2 to 3 minutes.  
To the mixture, 800µl of pre-warmed LB liquid were added and left in shaker incubator for 
approximately 1 hour at 37°C.  Then, 50 to 100 µl of suspension was spread onto an agar plate 
containing suitable antibiotic and left for overnight culture at 37°C.  With a yellow tip, 1 colony 
was picked from the plate and dipped into 5ml LB containing antibiotic and again, left in shaker 
incubator (250 rpm) at 37°C overnight culture.  To store the transformants, 1ml of cell suspension 
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was placed in a labelled cryovial and gently mixed with 500µl of 60% (v/v) glycerol and store in -
80°C. 
 
2.2.15 Mini-prep (Plasmid extraction) 
 Mini-prep can be done from overnight growth in 5 ml of LB containing antibiotic selection 
and cultured for 16 hours at 37°C while shaking at 250 rpm.  Grown cultures were centrifuged at 
3000 rpm for 5 minutes (Sigma 2-6E centrifuge). The supernatant was then discarded and 
continued using Fermentas mini-prep kit according to manufacturer’s protocol (Fisher Scientific, 
UK).  Briefly, the pellets were resuspended with 250 µl of Suspension Buffer each and equal 
volumes of Lysis Buffer were added before inverting the tubes a few times.  350 µl of 
Neutralisation Buffer was added to each tube and mixed carefully by repetitive pipetting.  
Mixtures were transferred to eppendorfs and spun at 13000 rpm for 5 minutes.  The pellets were 
discarded and the supernatant were transferred into the column-eppendorfs and centrifuged at 
13000 rpm for 2 minutes.  The flowthroughs were discarded and 700 µl of Washing Buffer were 
added to each column and centrifuged again at 13000 rpm for 1 minute.  The columns were 
removed and inserted into new eppendorfs before adding 50 µl of distilled water and incubated 
for 5 minutes before centrifuging at 13000 rpm for 1 minute.  The purified plasmid DNA obtained 
was then stored at -20°C after running 5 µl on DNA electrophoresis for analysis. 
 
2.2.16 Agarose gel electrophoresis 
For different size of DNA fragment, different percentage of agarose gel should be used.  
For larger DNA fragments (5-10kb), gel of 0.7% (w/v) to 1% (w/v) should be used.  For smaller 
fragments (0.2-1kb), gel as high as 2% (w/v) should be used.  In this work, 1% (w/v) gel was made 
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by weighing 0.6 g of agarose powder and dissolving in 60 ml of 1X-Tris-Acetate-EDTA (TAE)(refer to 
Table 2.7) in a conical flask.  Following heating up of the solution in a microwave until a clear 
solution was formed, the solution was allowed to cool and 10 µg of ethidium bromide (Bio-Rad, 
UK) was added.  The solution was mixed by swirling the flask gently and the content was poured 
into the DNA Gel cast (Geneflow, UK).  After the gel was set, it was placed in the chamber filled 
with 1X TAE buffer, followed by loading of samples and run for approximately 20 minutes or until 
the tracking dye (refer below for details) reach the bottom of the gel.  The DNA sample was 
visualised with UV transilluminator (G: Box, SynGene, UK) using GeneSnap software. 
Chemical compound Amount 
Making of 1 Litre of 1-X Tris-Acetate-EDTA (TAE) 
Tris Base 4.840 (g) 
Glacial acetic acid 1.142 (ml) 
0.5M EDTA (pH8.0) 2.000 (ml) 
Distilled water Top up to 1000 (ml)  
Making of 10 ml of DNA Tracking Dye 
Bromophenol Blue 0.025 (g) 
Sucrose 4.000 (g) 
Distilled water Top up to 10 (ml) 
Table 2.8 Formulations of 1L of Tris-Acetate-EDTA (1X) and 10ml of DNA tracking dye. 
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2.2.17 Preparation of total cell lysate 
Cells were collected either by scraping or trypsinising.  After being grown in a 60mm tissue 
culture dish until 90% confluency, the used media were discarded and the cells were placed on ice 
which washing with ice cold PBS 3 times.  Then, 150 µl of homogenising buffer (0.25M sucrose, 
5mM Tris-HCl pH7.4, 2mM EDTA, 200mM PMSF) were added and scrapped.  Scrapped cells were 
transferred into eppendorf tubes and sonicated at  20 kHz (approximately 20% of power) for 10 
seconds with an interval of 30 seconds for 3 times. The samples were spun down to remove cell 
debris and the clear supernatants were then split into two groups, one for protein quantification 
(proceed to Section 2.12) and the other to be added with 4x Laemmli loading buffer (refer to Table 
2.10) and boiled for 2minutes prior to gel electrophoresis (proceed to Section 2.2.13).  
 
2.2.18 Protein Quantification (Lowry method) 
This Bio-Rad commercial kit is based on Lowry method (Lowry et al., 1951) where the total 
protein concentration is proportional to the colour change of the sample solution.  In this method, 
5 µl of BSA standard solution ranging from 0.1 to 1.5 mg/ml was used and 5µl of samples were 
added to 96 well plate (in triplicate), followed by 25µl of reagent A and 250µl of reagent B.  The 
samples were mixed by careful repetitive pipetting to avoid air bubbles and left for incubation for 
10 minutes before being read at 750nm using an BioTek- EL808 Elisa plate reader (BioTek Potton, 
UK) to produce calibration graph.   
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2.2.19 Polyacrylamide Gel Electrophoresis (PAGE) 
In this work, Glycine-SDS-PAGE (Sodium Dodecyl Sulphate PolyAcrylamide Gel 
Electrophoresis) was used where acrylamide forms linear polymers and bisacrylamide forms 
linkage between the linear polyacrylamide chains.  The polymerisation process is promoted by 
both ammonium persulphate (APS) and N,N,N',N'-Tetramethylethylenediamine (TEMED).   
The components used in assembling the gel are the Bio-Rad mini-Protean II gel system.  
Two different sizes of resolving gel casts were used in this work (80x60x0.75mm and 
80x60x1.5mm) depending on volume and number of samples used.  Glass plates and combs were 
cleaned with distilled water and ethanol and air dry before use.  Depending on the size of protein 
to be separated (refer to Table 2.8), acrylamide resolving gel prepared were mixed thoroughly to 
prevent gel channelling.  The resolving gel (refer to Table 2.9) was pipetted into the space 
between the glass plates, leaving approximately 0.5cm from the bottom of the comb.  Water-
saturated isopropanol was overlaid on top of the mixture immediately to ensure an even top 
surface and avoid meniscus formation.  After the gel was completely polymerised, the layer of 
isopropanol was removed and the 3% stacking gel mixture (refer to Table 2.9) was poured over the 
polymerised resolving gel and the appropriate comb was inserted into the unpolymerised stacking 
gel.   
Quantified samples (Section 2.11 and 2.12) were loaded into respective wells of 
polymerised gels and run at 90V for the first 15 minutes (with running buffer (Table 2.10)) to 
introduce the protein samples through the stacking gels.  Then, the samples were run at 120V 
through the resolving gels for 60 minutes or until the Bromophenol Blue tracking dye reached the 
bottom of the gel. 
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Protein Size (kDa) Gel Percentage (%) 
4-40 20 
12-45 15 
10-70 12.5 
15-100 10 
25-200 8 
Table 2.9 Appropriate percentage of gels to be used to separate different protein size. 
 
Reagents 
8% Resolving gel 
(ml) 
10% Resolving 
gel (ml) 
15% Resolving 
gel (ml) 
3% Stacking gel 
(ml) 
40% acrylamide 2.000 2.700 4.050 0.375 
1.5M Tris-Base pH 8.8 1.700 1.700 1.700 - 
0.5M Tris-Base pH 6.8 - - - 0.800 
10% (w/v) SDS 0.067 0.067 0.067 0.033 
Distilled water 6.200 5.500 4.150 1.725 
10% (w/v) APS 0.050 0.050 0.050 0.020 
TEMED 0.0033 0.0033 0.0033 0.0033 
Table 2.10  Appropriate amount of different reagents to make up specific gel percentage. 
Chemical compound Amount 
1 Litre of 1X-running buffer (pH 8.5) 
Tris Base  3.0 
Glycine 14.4 
SDS 1.0 
Making of 50 ml of 4X-Laemmli buffer 
Tris Base (pH 6.8) 20.00 (ml) 
Glycerol 20.00 (ml) 
β-mercaptoethanol 2.00 (ml) 
SDS 2.00 (g) 
Bromophenol Blue 0.02 (g) 
Table 2.11  Formulations to prepare 1L of running buffer (1X) and 50ml Laemmli buffer (4X). 
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2.2.20 Western Blot 
The gel obtained from gel electrophoresis was placed on 0.45 µm nitrocellulose 
membrane (Bio-Rad, UK) and sandwiched in between six layers of Whatman filter papers (Fisher 
Scientific, UK) and two foams and secured with a cassette.  The cassette along with an ice gasket 
were then inserted into Mini Trans-Blot Cell (Bio-Rad, UK) kit and filled with transfer buffer (refer 
to Table 2.11).  The kit was placed in a chamber filled with ice and left for transfer at 200mA for 2 
hours.  The membrane was removed and the transfer was stained with Ponceau red which was 
removed with TBS tween via repetitive washing.  The membrane was blocked with 5% (w/v) of 
dried milk (Marvel) in TBS tween for 30 minutes before incubating primary antibody solution 
overnight at 4°C on a shaker.  Following this incubation, the membrane was washed with TBS 
tween 4 times for 10 minutes each prior to incubation with secondary antibody solution (HRP-
conjugate antibodies polyclonal rabbit/mouse 1:1000 dilution in 1% (w/v) milk in PBS) for 2 hours 
at room temperature prior to another 45 minutes of washing with TBS tween.  Custom made 
Horseradish peroxidase (HRP) detection reagent (refer to Table 2.11) was added onto the 
membrane (2.5ml for each blot) and incubated for a minute before being wrapped with cling film 
and developed in the dark room by exposuring of blots with Kodak BioMax light film of varying 
lengths of time will produce different band intensities.  Films were developed in Carestream Kodak 
developer (Sigma) and then rinsed with warm water followed by fixing with Carestream Kodak 
fixer (Sigma) for a few minutes.  The fixed film was washed intensively before air drying. 
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Chemical compound Amount 
1 Litre of 1X-Transfer buffer (pH 8.3) 
Tris Base  3.025 (g) 
Glycine 14.400 (g) 
Methanol 200 (ml) 
Distilled water Top up to 1000 (ml) 
100 ml of 1X-Ponceau Red 
Ponceau S Stain 0.200 (g) 
Trichloroacetic acid (TCA) 0.400 (ml) 
Distilled water Top up to 100 (ml) 
1 Litre of 1X-TBS Tween 
Tris Base 1.210 (g) 
Sodium Chloride (NaCl) 8.770 (g) 
Distilled water Top up to 1000 (ml) 
5 ml  of 1X- Detection Reagent 
Tris Base (pH 8.5) 0.500 (ml) 
50 mM Coumaric acid (Sigma-ready made) 0.011 (ml) 
250 mM Luminol (Sigma-ready made) 0.025 (ml) 
37% (v/v) Hydrogen Peroxidase (H2O2) 0.0015 (ml) 
Distilled water Top up to 5 (ml) 
Table 2.12 Formulations for preparing different buffers used in Western Blot. 
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Types of antibody  Dilution in CB buffer (1% Goat serum) 
Monoclonal anti-Vinculin antibody (mouse) 1.1000 
Monoclonal anti-Paxillin antibody (mouse) 1:1000 
Polyclonal anti-NMMIIA (rabbit) 1:5000 
Polyclonal Anti-S100A4 (rabbit) 1:1000 
Table 2.13 Dilutions of different primary antibodies used in Western Blot. 
 
2.2.20.1 Blots Stripping 
A nitrocellulose blot that has been probed and developed can be reused by removing all the 
antibodies so that the same blot can be reprobe with different antibodies.  To conduct this, the 
used blots were submerged in stripping buffer (refer to Table 2.13) and incubated for 30 minutes 
at 50°C with occasional agitation.  The blots were washed with PBS twice to remove any remaining 
stripping buffer.  Finally, the blots were blocked with PBS containing 5% (w/v) dried milk product 
for 30 minutes at room temperature.  The stripped blot is ready for reprobing. 
Chemical compound Amount 
Making of 100 ml of Stripping Buffer 
10% (w/v) SDS 20.000 (ml) 
0.5M Tris HCl (pH6.8) 12.500 (ml) 
Distilled water 67.500 (ml) 
Β-mercaptoethanol (added in fumehood) 0.800 (ml) 
Table 2.13  Preparation of stripping buffer. 
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2.2.20.2  Quantification of bands intensity 
Intensities of the protein bands were quantified with ImageJ.  Intensities of bands of interest were 
normalised with intensities of the respective loading controls.  Percentage of protein expression 
reduction and knockdown, when applicable, were calculated after normalisation.   
 
2.2.21 Statistical analysis  
Data presented in this study are listed as mean ± standard error (s.e.). The data sets were 
compared using Kolmogorov–Smirnov test or student t-Test (or ANOVA) (Analyse-it software or 
Excel statistical analysis programme respectively) and evaluated at 95% confidence level (P < 0.05) 
where the data set would be considered statistically significant and represented with * on the 
bars. P < 0.01 represented as ** whereas P < 0.001 represented as *** on the bars. 
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3.1 Introduction 
Migrating cells are often distinguished by having a polarised structure which consists of a 
protruding leading edge and a retracting rear end; where the leading edge is characterised by four 
types of plasma membrane protusion known as filopodia, lamellipodia, blebs, and invadopodia in 
2 and 3D organisation (Le Clainche and Carlier, 2008, Ridley et al., 2003, Mack and Marshall, 2010, 
Diz-Muñoz et al., 2010).  Due to the relevancy of the work, only lamellipodia and filopodia in 2D 
organisation are highlighted in this chapter.  Both of these structures are driven by polymerisation 
of polarised actin filaments, while lamellipodia consists of highly branched actin filaments which 
are woven across one another, filopodia, on the other hand is an unbranched protusions linearly 
polymerised by fascin (Nobes and Hall, 1995, Claudia Schäfer, 2010).   
Filopodia is a thin spiky extension which functions as an extracellular sensor, consisting of 
tightly packed bundles of actin filaments cross-linked by fascin (Machesky and Li, 2010).  Fascin is a 
55 kDa actin bundling protein containing two actin monomer binding sites located in between 
amino acids 29 and 42 as well as 277 and 493 respectively, and phosphorylation by PKCα at 
residue Ser39 serves to inhibit its activity (Yamashiro et al., 1998).  Pivotal role of fascin in 
filopodia formation was further established using monospecific anti-fascin immunoglobulins which 
resulted in reduction of spike formation and cell motility as binding of fascin to actin was inhibited 
(Adams and Schwartz, 2000).  Although other actin bundling proteins such as α-actinin, filamin and 
ezrin have been discovered, none of these proteins were found in filopodia; proposing fascin as 
the most appropriate filopodia marker as it is directly linked to filopodia (DeRosier and Edds, 1980, 
Vignjevic et al., 2006). 
On the other hand, lamellipodia is a thin sheets-like region with microfilaments localised 
diagonally where its force for locomotion is generated laterally as actin polymerisation takes place 
(Ridley, 2011).  The large agglomeration of short branched actin filament is regulated by numerous 
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actin binding proteins coordinating the nucleation, polymerisation, severing and capping of actin 
filaments by Arp 2/3 complex, Ena/VASP, gelsolin and capping protein respectively.  In vertebrates, 
there are three Ena-related genes known as mammalian Enabled (Mena), Ena-VASP-like (EVL) and 
Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) and Ena/VASP was found to be 
concentrated at the anterior tip of lamellipodia at leading edge of the cell periphery but not in the 
trailing end (Rottner et al., 1999, Rottner et al., 2001).  Besides mediating actin polymerisation, 
Ena/VASP also acts as anti-capping protein which prevents capping of barbed end actin so 
polymerisation can take place (Bear et al., 2002, Bear and Gertler, 2009).  Due to this, Ena/VASP is 
considered as lamellipodium marker.  There are two Ena/VASP homology domains in this protein, 
each known as EVH1 domain and EVH2 domain located at N terminal and C terminal respectively 
(Ball et al., 2000).  EVH1 domain acts as vinculin and zyxin binding site while EVH2 serves as 
binding site to G-actin and F-actin to facilitate actin polymerisation (Rottner et al., 2001).  
Ena/VASP also contains a central poly-proline region (PPR) which interacts with profilin.  Profilin is 
a G-actin binding protein which mediates polymerisation of actin monomer to barbed ends of 
actin filaments via adding ATP to actin monomers (Bachmann et al., 1999, Benz et al., 2008).  
Immediately behind this dynamic structure is a more stable structure known as lamella where the 
actin network is coupled to NMMII to assist the formation of focal adhesion.   
Focal adhesion, found preliminary near the leading edge of the cell, is another important 
structure that drives cell migration (Cramer, 2010).  Two types of preliminary focal complexes 
formed are nascent and transient focal complexes.  Nascent focal complex refers to its small size 
whereas transient focal complex refers to short-lived focal adhesion which disassembles fairly 
quickly.  Nascent focal complex will undergo maturation as lamellipodium persist forward 
localising it to its rear.  Maturation of focal adhesion requires actin polymerisation, contractility of 
NMMII and numerous signalling proteins such as integrin, vinculin, talin, and focal adhesion kinase 
Page | 96  
 
(Vicente-Manzanares et al., 2009a, Pasapera et al., 2010, Mitra et al., 2005, Vicente-Manzanares 
and Horwitz, 2011a) .  As mature focal adhesion forms, they slow down the retrograde flow of 
lamella caused by the contractility force generated by NMMII and promote persistence in cell 
forward protrusion (Kuo et al., 2011, Wolfenson et al., 2009).  The retrograde flow will then merge 
with anterograde flow of actin filaments in a region known as convergence zone which is located 
at the base of lamella.  As cell body pushes forward, the focal adhesions were stationed to the rear 
of the cell where it moves centripetally and then disassemble, leaving trails of integrin on the 
substratum (Ezratty et al., 2005, Lim et al., 2010).   
The role of the S100A4 protein as a metastasis promoter is well described, due to its 
correlative expression during carcinogenesis of different tissues (as mentioned in Chapter 1) and in 
benign tumour of rat mammary epithelial cells where its overexpression induces metastatic 
characteristics (Davies et al., 1994).  Ability of S100A4 to promote metastasis has been linked to its 
calcium (Ca2+) dependent interaction with non muscle myosin II (NMMII) (Badyal et al., 2011, 
Elliott et al., 2012, Kiss et al., 2012) where S100A4 is capable of binding to both NMMIIA and 
NMMIIB; with higher affinity to NMMIIA (9 fold) than NMMIIB (Bresnick, 1999, Li et al., 2003).  
Interaction of S100A4 with NMMIIA at C terminal amino acid residues 1909 -1924 causes 
unwinding of NMMIIA α helical tail, preventing its assembly, subsequently disassemble actin stress 
fibers (Kriajevska et al., 1994, Li et al., 2003).   
 In this chapter, we aimed to show at molecular level, the consequences of S100A4 
overexpression on cell morphology, focal adhesions, as well as importance of C-terminus of 
S100A4 in mediating cell motility.   
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3.2 Results 
3.2.1 Overexpression of S100A4 increases cell motility 
In this work, scratch assays were used to determine whether the overexpression of 
S100A4 protein in cells has potential effect on wound healing motility.  Expression of S100A4 
protein was reconfirmed with Western blot analysis (Figure 2.2.2) and wound healing assays were 
conducted with CellIQ machine (Figure 3.2.1).   
To establish whether C terminus of S100A4 protein is important for promoting migration, 
wound healing assay with R37 S100A4 ∆2 and R37 S100A4 ∆6 cell lines were done in conjunction 
with R37 S100A4 WT and Rama 37 control cell lines.  Overexpression of wild type S100A4 protein 
showed elevation in cell migratory rate with initiation of gap closure starting 2 hours post 
scratching (Figure 3.2.1).  Quantification of wound closure 8 hours post scratching shows that R37 
S100A4 WT has an average of 98.7 ± 2.1 % of wound closed whereas Rama 37 control, R37 S100A4 
∆2 and R37 S100A4 ∆6 show 61.8 ± 18.2%, 66.6 ± 8.4% and 57.9 ± 7.3% respectively (Figure 3.2.1 
B).  While there is no significant difference between the percentage of wound closure amongst 
Rama 37 control, R37 S100A4 ∆2 and R37 S100A4 ∆6, drastic enhancement of migration (P < 
0.001) were observed when they were individually compared to R37 S100A4 WT. 
To show that the effect seen on wound healing properties were not due to cell 
proliferation, mitotic index with 6 hour intervals for 24 hours were calculated alongside with 
wound healing assay (Figure 3.2.2).  The mitotic indexes for all the four cell lines did not show 
significant differences among the different cell lines.  With the highest mitotic index being less 
than 0.15, as calculated in R37 S100A4 WT cells, this indicate that at most, only 15% of total cell 
population were undergoing mitosis at any time.  Since wound healing assays were conducted less 
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than 18 hours with wound healing percentage taken at 8 hours post initial wounding, it is unlikely 
that the observed wound closure rate is due to cell proliferation. 
 
Figure 3.2.1. Wild type S100A4 protein expression promotes cellular migration in wound healing 
assay.  Rama 37 control cells, cells expressing wild type S100A4, and cells truncated forms (S100A4 
Δ2 and S100A4 Δ6) were grown for 24 hours in 24 well plate to confluency prior to scratching and 
monitoring of wound healing using CellIQ. A) Representative time-lapse images of Rama 37 cells 
scratch assays immediately after the scratches had been made and then after 8 hours. Scale bar = 
200μm. B) Quantification of percentage of wound closure 8 hours post scratching.  Results are 
mean values ± s.e. from 3 independent experiments.  Student t-Test were done by comparing 
Rama 37 control cells, R37 S100A4 Δ2 and R37 S100A4 Δ6 respectively to R37 S100A4 WT ***p < 
0.001. Methods are fully detailed in Chapter 2.2.4. 
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Figure 3.2.2.  Low mitotic index during wound healing assay.  Respective cells were seeded in a 
density of 150,000 into each well of 24 well plate.  Using the CellIQ imaging system, cells 
morphologies at different cell cycle phase were selected manually and then analysed with CellIQ 
software where cell were assigned into respective phases.  Mitotic index (MI) values obtained are 
mean ± s.d. obtained from 3 different wells from one experiment. Methods are fully detailed in 
Chapter 2.2.4.1 
 
3.2.2 High level of S100A4 leads to reduction in focal adhesion formation 
As impacts of S100A4 overexpression at cellular level remained elusive, we sought to 
analyse S100A4 effects on specific cell structures via immunofluorescence.  Here, we used vinculin 
and paxillin as focal adhesion markers since they are recruited to activated integrins to form focal 
complexes which later mature into focal adhesions during cell adhesion and migration (Humphries 
et al., 2007, Schaller, 2001, Hynes, 1992).  Cells were seeded on coverslips pre coated with 
fibronectin for 48 hours prior to fixation, permeabilisation and staining.  Overexpression of S100A4 
was found to dramatically reduce the number of adapter protein clusters, vinculin, hence 
minimising focal contacts at the leading edge (Figure 3.2.3).  It was observed that in the Rama 37 
control cells, distinct localisation of vinculin clusters were exhibited at the cell periphery with non-
polarised morphology and much pronounced actin stress fibers surrounding the cell stroma 
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(Figure 3.2.4 A-A’).  Elevation of S100A4 protein level in R37 S100A4 WT cell line caused 
abolishment of foci formation around the cells (Figure 3.2.3 B-B’).  In S100A4 overexpressing cells, 
actin network was less organised and displayed more prominent polarisation with a define leading 
edge (Fig 3.2.3 B).  The expression of either S100A4 ∆2 or S100A4 ∆6 in Rama 37 cells (Figure 3.2.3 
C and Figure 3.2.3 D respectively) displayed similar phenotype to that of the Rama 37 control cells 
where vinculin clusters and actin organisation were more pronounced. 
As interaction between actin cytoskeleton and transmembrane protein of the integrin 
type is not only facilitated by vinculin (other adapter proteins such as paxillin, talin or FAK could 
also connect such bridges), we further confirm the effects of S100A4 on micro colocalisation of 
vinculin with paxillin.  Similarly, cells were seeded onto coverslips pre coated with fibronectin and 
left for 48 hours before proceeding to fixing, permeabilising and staining for paxillin localisation.  
The stainings of paxillin revealed similar trait as those of vinculin where total loss of focal contacts 
were observed in cells expressing high level of S100A4 (Figure 3.2.4).  In Rama 37 control, R37 
S100A4 Δ2 and R37 S100A4 Δ6, paxillin were localised in similar manner as vinculin where 
prominent paxillin clusters were found in cell periphery (Figure 3.2.4 A – A’, C – C’ and D – D’).   
Quantification of each adapter protein clusters, vinculin and paxillin, were done for 
statistical analysis (Table 3.2.1 and Table 3.2.2 respectively).  The quantification of both adapter 
proteins clustering at the periphery of individuals cells revealed similar trend where R37 S100A4 
WT cells displayed a significant reduction in both vinculin (2.8 ± 0.8) and paxillin (5.4 ± 3.6) clusters 
when compared to either of the other three cell lines.   Rama 37 control cells (27.4 ± 2.9 and 16.4 
± 4.1), R37 S100A4 ∆2 (27.8 ± 1.6 and 16.5 ± 3.5) and S100A4 ∆6 (28.2 ± 4.7 and 15.2 ± 3.0) show 
no significant differences in either vinculin or paxillin clusters respectively.   
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Figure 3.2.3 Overexpression of wild type S100A4 but not the C-terminal truncated forms of Δ2 
and Δ6 prevents the formation of mature vinculin clusters.  Respective cells were seeded onto 
coverslips pre-coated with fibronectin and incubate for 48 hours before fixing, permeabilising and 
incubating with vinculin (FITC).  Then, the cells were incubated with FITC-conjugate secondary 
antibody along with phalloidin for actin staining (rhodamine) and mounted with DAPI prior to 
viewing with confocal microscope.  Rama 37 control cells were labelled as A –A’, R37 S100A4 WT 
cells as B – B’, R37 S100A4 Δ2 as C – C’ and R37 S100A4 Δ6  as D – D’.  Panels A’, B’, C’ and D’ 
correspond to focused regions of the cell. Scale bar = 20μm. Images displayed for each cell line 
were representative image obtained from 3 independent experiments.  Methods are fully detailed 
in Chapter 2.2.8.  
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Figure 3.2.4 Maturation of paxillin clusters was observed in Rama 37 control, R37 S100A4 Δ2 and 
R37 S100A4 Δ6.  Immunofluorescence stainings were conducted as described in figure 3.2.3 but 
incubated with paxillin antibody (FITC) instead of vinculin.  Rama 37 control cells were labelled as 
A –A’, R37 S100A4 WT cells as B – B’, R37 S100A4 Δ2 as C – C’ and R37 S100A4 Δ6  as D – D’.  
Panels A’, B’, C’ and D’ correspond to focused regions of the cell. Scale bar = 20μm. Images 
displayed for each cell line were representative image obtained from 3 independent experiments. 
Methods are fully detailed in Chapter 2.2.8. 
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Rama 37 cell 
lines 
Number of focal adhesions 
(vinculin) per cell ± s.e. (n=36)  
P-value a P-value b P-value c 
Control 27.4 ± 2.9 8.055E-08   
S100A4 WT 2.8 ± 0.8    
S100A4 ∆2 27.8 ± 1.6 1.521E-09 0.794  
S100A4 ∆6 28.2 ± 4.7 2.143E-06 0.752 0.861 
 
Table 3.2.1 Overexpression of S100A4 protein resulted in loss of vinculin clusters.  
Immunofluorescence stainings were conducted as described in Figure 3.2.3.  Images obtained 
were quantified manually by counting the number of clusters localised at the periphery of each 
cell.  Results are the mean values ± s.e. from 5 independent experiments. 
a P-value obtain  from Student  t-Test where number of focal adhesions (vinculin) per cell present  
in R37 S100A4 WT were compared to Rama 37 control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t-Test where number of focal adhesions (vinculin) per cell present  
in Rama 37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of focal adhesions (vinculin)per cell present  
in R37 S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.10.  
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Rama 37 cell 
lines 
Number of focal adhesions 
(paxillin) per cell ± s.e. (n=36) 
P-value a P-value b P-value c 
Control 16.4 ± 4.1 1.255E-16   
S100A4 WT 5.4 ± 3.6    
S100A4 ∆2 16.5 ± 3.5 1.282E-18 0.935  
S100A4 ∆6 15.2 ± 3.0 1.170E-16 0.186 0.119 
 
Table 3.2.2 Significant reduction of number of paxillin clusters in cells expressing full length of 
S100A4 protein.  Immunofluorescence stainings were conducted as described in Figure 3.2.4.  
Images obtained were quantified manually by counting number of clusters localised at the 
periphery of each cell.  Results are the mean values ± s.e. from 5 independent experiments. 
a P-value obtain  from Student  t-Test where number of focal adhesions (paxillin) per cell present  
in R37 S100A4 WT were compared to Rama 37 control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t-Test where number of focal adhesions (paxillin) per cell present  
in Rama 37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of focal adhesions (paxillin)per cell present  in 
R37 S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.10.  
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3.2.3 S100A4 reduces filopodia formation 
Actin counterstaining in the previous experiments indicate noticeable modifications of cell 
morphology in S100A4 overexpressing cells (Figure 3.2.3 and Figure 3.2.4).  Indeed, cells 
expressing higher level of S100A4 protein presented polarised morphology with more pronounced 
lamellipodium at the leading edge, replacing filopodium projections observed around the 
peripheries of the less polarised three cell lines (Rama 37 control, S100A4 ∆2 and S100A4 ∆6).  To 
show the significance of filopodia reduction induced by S100A4 overexpression, the number of 
filopodia present in individual cell (n=14 for each cell line) was quantified by manually counting 
filopodia extended around the cell periphery.  From the quantification, it was shown that S100A4 
expressing cells demonstrated drastically reduced filopodia projections (39.1 ± 9.4) compared to 
Rama 37 control cells (105.2 ± 8.3), R37 S100A4 ∆2 (100.3 ± 13.5) and S100A4 ∆6 (113.2 ± 15.6) 
respectively (Table 3.2.3).  Rama 37 control cells, R37 S100A4 ∆2 and S100A4 ∆6 showed no 
significant differences in filopodia projections amongst themselves. 
Since filopodia extension is attributed to actin-bundling properties of fascin, the cellular 
localisations of fascin for the four cell lines were analysed.  Immunofluorescence staining 
performed against fascin depicted the localisation of fascin throughout the length of the 
filopodium projections with an accumulation at the tip in Rama 37 control cells and Rama 37 cells 
expressing the truncated forms of S100A4 ∆2 or S100A4 ∆6 (Figure 3.2.5).  R37 S100A4 WT cells, 
on the other hand, show little amount of fascin-mediated filopodial protrusions present at the cell 
periphery.  For each cell line, 14 images were randomly selected from 3 independent 
immunofluorescence stainings of fascin (counterstained with actin), quantitative analysis of the 
number of those stably adhered projections were carried out (Table 3.2.4).  S100A4 expressing 
cells demonstrated significantly lower protusions containing fascin (3.80 ± 1.5) compared to Rama 
37 control, R37 S100A4 ∆2 and R37 S100A4 ∆6 ( 41.2 ± 8.6, 35.4 ± 9.3 and 22.6 ± 8.8 respectively). 
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In order to further characterise the differences in cell polarisation and leading edge 
formation observed when S100A4 is overexpressed, further immunofluorescence analysis were 
performed with VASP, a marker for lamellipodium.  VASP immunofluorescence staining revealed 
its localisation at the tip of lamellipodium of R37 S100A4 WT cells.  However, in Rama 37 control 
cells, VASP was localised behind the filopodia projections which indicates that VASP is not found 
within filopodia shaft (Figure 3.2.6 A – A’).  In both R37 S100A4 Δ2 and Δ6, similar observation 
where no VASP were found to localised within the filopodia shaft (Figure 3.2.6 C –C’ and D – D’).  
This indicates that lamellipodia is a prominent structure in the leading edge of R37 S100A4 WT 
cells rather than filopodia as observed in the rest of the three cell lines. 
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Figure 3.2.5 Truncated forms of S100A4 protein (S100A4 ∆2 and ∆6) did not affect the 
localisation of fascin within filopodia as observed in Rama 37 control cells. Immunofluorescence 
stainings were conducted as before but incubated with fascin antibody.  Rama 37 control cells 
were labelled as A –A’, R37 S100A4 WT cells as B – B’, R37 S100A4 Δ2 as C – C’ and R37 S100A4 Δ6  
as D – D’.  Panels A’, B’, C’ and D’ correspond to focused regions of the cell. Scale bar = 20μm. 
Images displayed for each cell line were representative image obtained from 3 independent 
experiments. Methods are fully detailed in Chapter 2.2.8. 
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Figure 3.2.6  Cells expressing full length of S100A4 protein display prominent lamellipodium 
structure.  Immunofluorescence stainings were conducted as before but incubated with VASP 
antibody.  Rama 37 control cells were labelled as A –A’, R37 S100A4 WT cells as B – B’, R37 S100A4 
Δ2 as C – C’ and R37 S100A4 Δ6  as D – D’.  Panels A’, B’, C’ and D’ correspond to focused regions 
of the cell. Scale bar = 20μm. Images displayed for each cell line were representative image 
obtained from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Rama 37 cell 
lines 
Number of filopodia per cell ± s.e. 
(n=14)  
P-value a P-value b P-value c 
Control 105.2 ± 8.3 1.440E-13   
S100A4 WT 39.1 ± 9.4    
S100A4 ∆2 100.3 ± 13.5 8.206E-11 0.316  
S100A4 ∆6 113.2 ± 15.6 1.630E-11 0.148 0.051 
Table 3.2.3 Number of filopodia protusions was significantly lowered in R37 S100A4 WT cells.  
Cells were seeded, fixed, permeabilised and stained as described in Chapter 2.2.8.  Quantification 
of filopodia was done manually by counting the number of protusions around the periphery of 
cells after staining with phalloidin.  Results are the mean values ± s.e. from 7 independent 
experiments. 
a P-value obtain  from Student  t-Test where number of filopodia per cell present  in R37 
S100A4WT were compared to Rama 37 control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t-Test where number of filopodia per cell present  in Rama 37 
control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of filopodia per cell present  in R37 S100A4 
∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.10.  
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Rama 37 cell 
lines 
Number of fascin-mediated 
filopodia projections per cell ± s.e. 
(n=14)  
P-value a P-value b P-value c 
Control 41.2 ± 8.6 1.151E-05   
S100A4 WT 3.80 ± 1.5    
S100A4 ∆2 35.4 ± 9.3 7.135E-05 0.337  
S100A4 ∆6 22.6 ± 8.8 0.001 0.009 0.056 
Table 3.2.4 Overexpression of S100A4 protein reduced the number of fascin-mediated filopodia 
projections.  Cells were seeded, fixed, permeabilised and stained as described in Chapter 2.2.8.  
Quantification of fascin projections was done manually by counting the number of fascin localised 
within the filopodia around the periphery of cells after co-staining with fascin and phalloidin. 
Results are the mean values ± s.e. from 3 independent experiments. 
a P-value obtain  from Student  t-Test where number of fascin projections per cell present  in were 
R37 S100A4 WT compared to Rama 37 Control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t-Test where number of fascin projections per cell present  in Rama 
37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of fascin projections per cell present  in R37 
S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.10.  
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3.2.3 Increment of expressions of adapter protein (vinculin and paxillin) in cells expressing high 
level of wild type S100A4 protein 
From the immunofluorescence stainings, it was observed that the number of focal 
adhesion is influenced by the expression of wild type S100A4 protein.  Since paxillin and vinculin 
clusters were reduced specifically in S100A4 expressing cells, western blotting were performed on 
these cell lines to determine if the reduction of clusters were due to S100A4 affecting their 
localisation and/or expressions.  From the blots obtained, the level of vinculin and paxillin were 
quantified with densitometry.  The protein level expressed in R37 S100A4 WT cells were taken as 
100% while the level expressed in the three other cell lines were normalised from it.  It was found 
that although the level of vinculin expression is slightly higher in R37 S100A4 WT cells (100.0 ± 
0.0%) when compared to Rama 37 control (89.2 ± 7.7%), R37 S100A4 Δ2 (90.9 ± 5.5%) and R37 
S100A4 Δ6 (88.2 ± 8.2%), no significant difference were observed (P = 0.138, P = 0.103 and P = 
0.131 respectively) (Figure 3.2.7 B).  However, quantification on paxillin expression level, revealed 
significant increment of paxillin expression in R37 S100A4 WT (100.0 ± 0.0% )  as opposed to Rama 
37 control (82.9 ± 4.3%), R37 S100A4 Δ2 (76.3 ± 5.4%) and R37 S100A4 Δ6 (80.9 ± 5.0%) (P = 0.020, 
P = 0.017 and P = 0.021 respectively) (Figure 3.2.7 B). 
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Figure 3.2.7  Elevation of vinculin and paxillin expressions in R37 S100A4 WT cells.  Rama 37 cell 
lines with a density of 1.5 x 106 were seeded into 60mm tissue culture dish 24 hours prior to 
harvesting (as described in Chapter 2.2.17 to 2.2.20).  Total protein for all cell lines were quantified 
and equal amount of total protein (150µg vinculin and 80µg paxillin and eEF1A1) loaded onto 10% 
SDS Page gels.  Resolved proteins were transferred onto nitrocellulose membrane before 
detection for specific protein required. A) Blots shown are representative data obtained from 3 
independent experiments.  B) Densitometry showing level of vinculin and paxillin expressed in 
respective Rama 37 cell lines quantified with ImageJ.  Results obtained are mean values ± s.e from 
3 independent experiments.  Student t-Tests were done by comparing normalised value of R37 
S100A4 WT cells to Rama 37 control cells, R37 S100A4 Δ2 and R37 S100A4 Δ6 respectively.  *P < 
0.05.  
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3.2.4 Dynamicity of focal adhesion is linked to high expression of wild type S100A4 protein 
Following the previous experiments, elevation of S100A4 protein resulted in diminishing 
localisation of vinculin and paxillin clusters at the foci around the cell periphery.  Hence, 
experiments were conducted in live cells to further validate this observation in real time and along 
with determining the dynamicity of these clusters.  To confirm this, all cell lines were transfected 
with GFP-vinculin expressing plasmid and analysed over time using confocal microscopy.  In Figure 
3.2.8, a representative image of Rama 37 cell were frozen in different time frames to allow 
quantification of focal adhesions formation over time.  From the 20 minutes time-lapse video 
collected for each transfected cell lines, newly formed focal contacts (black arrows) were 
distinguished from those that were already present.  It was clearly observed that formation of 
focal adhesion was initiated by stably adhered filopodium and subsequently overgrown by 
lamellipodium (Figure 3.2.8 B). 
The quantification of focal adhesions from live cells showed that Rama 37 control cells, 
R37 S100A4 Δ2 and R37 S100A4 Δ6 (Supplementary video 1, 3 and 4 respectively) exhibited 
similarities in overall number of focal adhesion present over the duration of 20 minutes (89.4 ± 
13.4, 93.6 ± 6.3 and 83.6 ± 12.1 respectively) (Table 3.2.5).  However, when S100A4 protein was 
overexpressed, remarkable reduction of number of GFP-vinculin were incorporated into focal 
adhesion (50.2 ± 11.5) (Supplementary video 2).  This observation is consistent with the data 
obtained from immunofluorescence staining, highlighting the loss of overall vinculin clusters in the 
presence of high level of S100A4.   
However, the above quantification only demonstrated the overall number of vinculin 
clusters present during the 20 minutes duration, but not considering the number of vinculin 
clusters formed within the 20 minutes period.  To assess more specifically the rates of focal 
adhesion assembly, the number of focal adhesions formed over the duration of 20 minutes was 
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quantified (Table 3.2.6).  This analysis showed that the rate of focal adhesion formation of R37 
S100A4 WT cells (11.4 ± 3.5), was significantly lower than cell lines expressing either S100A4 Δ2 or 
S100A4 Δ6 proteins (28.2 ± 6.9 and 23.6 ± 6.6 respectively).  Conversely, Rama 37 control cells did 
not show significant difference in focal adhesion formation (14.4 ± 2.1) when compared to R37 
S100A4 WT cells (P=0.071).  However, the overall mean value of focal adhesions observed in Rama 
37 control cells, R37 S100A4 Δ2 and R37 S100A4 Δ6 were still higher than that of R37 S100A4 WT 
cells (Table 3.2.6).   
So far, we have shown that S100A4 overexpressing cells has lower focal adhesions 
formation rate which is consistent with the overall reduction of focal adhesions observed in 
immunofluorescence stainings of paxillin and vinculin.  Since maturation of focal adhesion is 
dependent upon tension produced via myosin-generated force and filopodia adherent to 
extracellular matrix, it is important to investigate whether reduction of focal adhesions is due to 
inability of S100A4 expressing cells to form filopodia or stabilisation of filopodia is inhibited.  To 
assess this, the quantification of filopodia on live cells was carried out by randomly halting images 
at a single time point as shown in Figure 3.2.9.  Through this analysis, it is possible to monitor the 
dynamicity of filopodia, distinguishing retraction fibers from filopodia (Figure 3.2.9 B) as well as 
discriminate nascent (Figure 3.2.9 C) from stable filopodium (Figure 3.2.9 A).  Surprisingly, this 
analysis showed that the wild type S100A4 expressing cells have higher formation of filopodia 
(17.3 ± 7.2) within the 20 minutes as opposed to Rama 37 control cells (10.9 ± 2.71, P=0.027) and 
R37 S100A4 Δ6 cells (10.9 ± 4.5, P=0.031) (Table 3.2.7).  Although the filopodia quantified in 
S100A4 Δ2 shows no significant difference (P=0.546), the mean value is still lower than those of 
the R37 S100A4 WT cells.  
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Figure 3.2.8 Distinguishing matured from nascent focal adhesion in Rama 37 cells.  Control Rama 37 cells transfected with pGZ21 GFP-vinculin 
expressing plasmid were seeded on fibronectin coated coverslips for 24 hours before analysis. Cells were analysed over the duration of 20 
minutes in (A) phase contrast and in (B) fluorescence. Red box in the overview indicates the zoomed area shown in the time series. Time points 
are recorded in seconds. The black arrow highlights the same filopodium position over time. For better visualisation, phase contrast images were 
sharpened and GFP-images were background-subtracted and the contrast was adjusted before overlaying the images. Scale bar = 20μm.  Time 
lapse image shown is a representative image of a Rama 37 control cell used to distinguish nascent from stable filopodia.  Five time-lapsed images 
were done on each individual cell lines in 2 independent transfection experiments.  Methods are fully detailed in Chapter 2.2.9.
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Figure 3.2.9 Establishment of stably adhered filopodia, retraction fibers and unstable filopodia in 
Rama 37 cells.  Rama 37 cells transfected as described in figure 3.2.8. Cells were analysed over the 
duration of 20 minutes in phase contrast and in fluorescence to quantify (A) stably adhered 
filopodia (white arrow), B) retraction fibres and (C) unstable filopodia (yellow arrow).  Area A was 
enlarged to show the formation of stable filopodia (top panel), the subsequent maturation of FA 
(middle panel) and the overlay of both time lapse images (bottom panel) over time (A). Area B was 
enlarged with a white line drawn above to show the retracting FA right behind the retraction 
fibers over time (B). Area C was enlarged to show the unstable formation of filopodia over time 
(C). For A, B and C, the top panel is shown in phase contrast, the middle panel in fluorescence and 
the bottom panel as overlays of both images. Time points are given in seconds. Note that the time 
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lapse has shorter intervals for C whereas A and B have a similar time lapse. First image of all 
analysis corresponds to the main figure (time zero) and then subsequent time lapse images are 
shown. For better visualisation, phase contrast images were sharpened and GFP-images were 
background-subtracted and enhanced in contrast before overlaying the images. Scale bar = 20μm. 
Time lapse image shown is a representative image of a Rama 37 control cell used to distinguish 
nascent from stable filopodia.  Five time-lapsed images were done on each individual cell lines in 2 
independent transfection experiments.   
Methods are fully detailed in Chapter 2.2.9. 
 
Rama 37 cell 
lines 
Number of focal adhesions present 
per cell (over 20 minutes) ± s.e. (n=5) 
P-value a P-value b P-value c 
Control 89.4 ± 13.4 0.003   
S100A4 WT 50.2 ± 11.5    
S100A4 ∆2 93.6 ± 6.3 0.002 0.629  
S100A4 ∆6 83.6 ± 12.1 0.033 0.606 0.153 
Table 3.2.5 Significantly lower count of focal adhesions observed in live cell analysis of R37 
S100A4 WT cells.  Respective cell lines were transfected with pGZ21 GFP-vinculin expressing 
plasmid were seeded on customized glass bottom dish, pre-coated with fibronection for 24 hours.  
Cells were then analysed over the duration of 20 minutes with both phase contrast and 
fluorescence.  Results are the mean values ± s.e. from 5 individual cells from each cell lines in 
single experiment. 
a P-value obtain  from Student  t-Test where number of total focal adhesions present over 20 
minutes  in R37 S100A4 WT were compared to Rama 37 Control, R37 S100A4 ∆2 and R37 S100A4 
∆6. 
b P-value obtain  from Student  t-Test where number of total focal adhesions present over 20 
minutes  in Rama 37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of total focal adhesions present over 20 
minutes  in R37 S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.9 and 2.2.11.  
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Rama 37 cell 
lines 
Number of newly formed focal 
adhesions per cell (within 20 
minutes) ± s.e. (n=5) 
P-value a P-value b P-value c 
Control 14.4 ± 2.1  0.071   
S100A4 WT 11.4 ± 3.5     
S100A4 ∆2 28.2 ± 6.9  0.011  0.009  
S100A4 ∆6 23.6 ± 6.6  0.004  0.000 0.216 
Table 3.2.6 R37 S100A4 WT displays lower focal adhesion formation.  Respective cell lines were 
transfected with pGZ21 GFP-vinculin expressing plasmid were seeded on customised glass bottom 
dish, pre coated with fibronection and left for incubation for 24 hours.  Cells were then analysed 
over the duration of 20 minutes with both phase contrast and fluorescence.  Results are the mean 
values ± s.e. from 5 individual cells from each cell lines in single experiment. 
a P-value obtain  from Student  t-Test where number of newly formed focal adhesions within 20 
minutes  in R37 S100A4 WT were compared to Rama 37 Control, R37 S100A4 ∆2 and R37 S100A4 
∆6. 
b P-value obtain  from Student  t-Test where number number of newly formed focal adhesions 
within 20 minutes  in Rama 37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of newly formed focal adhesions within 20 
minutes  in R37 S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.9 and 2.2.11.  
Page | 119  
 
Rama 37 cell 
lines 
Number of filopodia present per 
cell (at any given time) ± s.e. (n=9) 
P-value a P-value b P-value c 
Control 10.9 ± 2.71  0.027    
S100A4 WT 17.3 ± 7.2     
S100A4 ∆2 14.6 ± 6.9  0.546 0.168  
S100A4 ∆6 10.9 ± 4.5  0.031  1.000 0.204 
Table 3.2.7  Cells overexpressing full length of S100A4 protein show higher filopodia dynamics.   
Live cells videos taken over the duration of 20 minutes with both phase contrast and fluorescence 
were halted at random intervals and the filopodia present at that particular time frame was 
quantified.  Results are the mean values ± s.e. from 9 individual cells from each cell lines in 3 
independent live cell experiment. 
a P-value obtain  from Student  t-Test where number of filopodia present per live cell at any given 
time  in R37 S100A4 WT were compared to Rama 37 Control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t-Test where number of filopodia present per live cell at any given 
time  in Rama 37 control were compared to R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where number of filopodia present per live cell at any given 
time in R37 S100A4 ∆2 were compared to R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.9 and 2.2.11. 
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3.2.5  S100A4 expressing cell has lower generation of cell force  
So far, all the data indicated the possibility of S100A4 protein affecting the localisation and 
maturation of focal adhesions as well as stabilisation of filopodia.  One of the possible 
explanations at molecular level for the low focal adhesion could be due to interaction of S100A4 
protein with NMMIIA which resulted in disassembly of stress fibers and ultimately affecting focal 
adhesions formation and maturation.  Indeed, myosin-generated tension has been shown to 
promote focal adhesion maturation and the disassembly by S100A4 could possibly reduce this 
tension.   
To demonstrate the connection between myosin generated tensions and focal adhesions, 
all the four cell lines were seeded on both 8kPa and 15kPa custom-made micropatterned silicone 
elastomer respectively.  In the 8kPa micropatterned elastomer, it was observed that there was no 
significant difference between the forces generated by the four cell lines tested (data not shown).  
However, on 15kPa micropatterned elastomer, it was observed that R37 S100A4 WT cells 
exhibited significantly lower contractile force (17.5 ± 6.02nN) when compared to either of Rama 
37 control cells (63.6 ± 32.0nN, P < 0.001), R37 S100A4 Δ2 cells (49.4 ± 32.5nN, P = 0.002) or R37 
S100A4 Δ6 cells (50.2 ± 24.1nN, P < 0.001) (Table 3.2.8).  This results correlates with the lack of 
matured focal adhesions observed in either live cell analysis or immunofluorescence stainings of 
R37 S100A4 WT cell lines.   
Next, we proceeded to investigate if the level of NMMIIA expressed in the four cell lines 
differs using western blot and densitometry analysis (Figure 3.2.10 A).  It was found that the level 
of NMMIIA expressed in R37 S100A4 WT cell lines was lower than other three cell lines.  
Quantification of NMMIIA expression level showed that Rama 37 control cells, R37 S100A4 Δ2 and 
R37 S100A4 Δ6 exhibited higher level of NMMIIA (232.5 ± 16.5%, 234.2 ± 25.4% and 224.0 ± 37.7% 
respectively) when compared to R37 S100A4 WT cells (100%) (Figure 3.2.10 B).  
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Rama 37 cell 
lines 
Average contractile force exerted 
per cell (nN) ± s.e. on 15kPa 
elastomer (n= 15) 
P-value a P-value b P-value c 
Control 63.6 ± 32.0 0.000   
S100A4 WT 17.5 ± 6.02    
S100A4 ∆2 49.4 ± 32.5 0.002 0.240  
S100A4 ∆6 50.2 ± 24.1 0.000 0.209 0.940 
 
Table 3.2.8 R37 S100A4 WT cells exerts significantly lower contractile force.  Cells were seeded 
onto micropatterned silicone elastomer and left to incubate for 24 hours prior to detaching each 
cell with needles under fluorescence microscope (to capture the position of fluorescent beads 
embedded within elastomer) as well as phase contrast (to capture the shape of the cells).  Results 
are mean values ± s.e of 15 cells obtained form 4 independent experiment. 
a P-value obtain  from Student  t-Test where total for contractile force per cell in R37 S100A4 WT 
were compared to those of Rama 37 Control, R37 S100A4 ∆2 and R37 S100A4 ∆6. 
b P-value obtain  from Student  t- Test where total for contractile force per cell in Rama 37 control 
were compared to those of R37 S100A4 ∆2 and R37 S100A4 ∆6. 
c P-value obtain  from Student  t-Test where total for contractile force per cell in R37 S100A4 ∆2 
were compared to those of R37 S100A4 ∆6. 
Methods are fully detailed in Chapter 2.2.12. 
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Figure 3.2.10.  Reduction of NMMIIA expressions in wild type S100A4 expressing cells.  Rama 37 
cell lines were seeded 24 hours prior to harvesting.  Total protein for all four cell lines were 
quantified and equal amount of total protein (80µg NMMIIA and eEF1A1) loaded onto 10% SDS 
Page gels.  Resolved proteins were transferred onto nitrocellulose membrane before detection for 
specific protein required.   A) Blots shown are representative data obtained from 3 independent 
experiments.  B) Densitometry showing level of NMMIIA expressed in respective Rama 37 cell lines 
quantified with ImageJ (Chapter 2.15.2).  Results obtained are mean values ± s.e from 3 
independent experiments.  Student t-Tests were done by comparing normalised value of R37 
S100A4 WT cells to Rama 37 control cells, R37 S100A4 Δ2 and R37 S100A4 Δ6 respectively.  *P < 
0.05. Methods are fully detailed in Chapter 2.2.17 – 2.2.20. 
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3.3 Discussion 
Malignancies of cancer ranging from melanoma to non-small cell lung carcinoma and 
cancers of oral, breast and stomach due to overexpression of S100A4 protein has been 
demonstrated in various reports (Andersen et al., 2004, Rudland et al., 2000, Yonemura et al., 
2000b, Moriyama-Kita et al., 2005).  Furthermore, down-regulation of cellular motility through 
reduction in S100A4 protein expression in tumour cells has also been demonstrated (Takenaga et 
al., 1997a, Bjornland et al., 1999).  There is, therefore, a clear link between overexpression of 
S100A4, cell motility and metastasis. Yet, at molecular level, the biological consequences of 
S100A4 elevation remain vague.  Here, we aimed to provide further evidences correlating 
overexpression of S100A4 protein and modification of intracellular structures such as actin and 
focal adhesions to facilitate cell motility.   
The effect of S100A4 protein on cell motility was first identified through wound healing 
assay (Figure 3.2.1).  Using the truncated C-terminus versions of S100A4 proteins in the same cells, 
we demonstrated that the S100A4-induced motility was abolished.  This indicated that C-terminus 
of S100A4 protein is an essential part of the protein which could possibly hold the key to modify 
intracellular structures to facilitate migration.  Previous work done by Ismail et al. in 2008, has 
demonstrated that deletion of C-terminus in S100A4 increases dissociation constant (Kd) of 
S100A4 with rNMMHC-IIA, hence may indirectly regulates cytoskeletal structures.  Through their 
work, the authors demonstrated that wild type S100A4 protein has higher affinity for rNMMHC-IIA 
(Kd  100nM) compared to S100A4 Δ2 and S100A4 Δ6 (Kd  680nM and Kd  6.2µM respectively).  Due 
to this reduced affinity, it is speculated that inability of truncated versions of S100A4 protein to 
modify actin via NMMIIA interaction resulted in appearance of highly organised actin filaments 
observed in the immunofluorescence staining performed which was not observed in cell 
expressing full length S100A4 protein (Figure 3.2.3, 3.2.4, 3.2.5 and 3.2.6).  It is unclear whether 
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truncation of 2 or 6 amino acids from the C terminus of S100A4 protein could affect the ability of 
the protein to dimerise, a conformation proved to be essential for regulating NMMIIA since single 
mutations at any one of the two calcium binding motifs reduce its calcium binding properties by 
30 to 60 fold.  Thus, we could not rule out the possibility of the effect observed were due to 
inability of S100A4 protein to dimerise.  While dimerisation of S100A4 has been shown to induce 
invasiveness, S100A4 monomers did not exert such effect (House et al., 2011).  However, it has 
been shown that dimerisation of S100A4 in vitro is only affected when amino acid residues 
between 72 to 91 were mutated whereas in vivo, only Phe72, Tyr75, Phe78 and Leu79 were 
essential for S100A4 dimerisation (Tarabykina et al., 2001, Ismail et al., 2010).  Due to this, it is 
possible that truncation of 2 or 6 amino acids from C terminus of S100A4 protein did not affect 
dimerisation, but may possibly limits it target protein range or reduces its affinities to certain 
proteins, thereby reducing its effects on cell motility. 
In order to facilitate cell migration, cytoskeletal structures undergo modification at their 
leading edges in 3 chronological steps; projections of filopodia and/or lamellipodia, followed by 
attachment of leading lamella to extracellular cues and formation of focal contacts that matured 
through production of tensile forces (Vicente-Manzanares and Horwitz, 2011a).  
Immunofluorescence stainings of S100A4 expressing cells showed significant reduction of 
filopodia; replaced by out-spread lamellipodium (Figure 3.2.3).  Minimal matured focal contacts 
formed via paxillin and vinculin were exhibited by R37 S100A4 WT cells and lost of distinct stress 
fibers were observed (Figure 3.2.4).  All of these modifications were consistent with enhancement 
of cell motility, where S100A4 has been shown to induce forward protusions during chemotaxis 
and disassembly of NMMIIA filaments by S100A4 led to recruitment of S100A4-NMMIIA complex 
to the leading edge of polarised cells (Li and Bresnick, 2006, Kim and Helfman, 2003).   
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In the fixed cells analysis, it was observed that Rama37 control, R37 S100A4Δ2 and R37 
S100A4Δ6 cells displayed higher number of filopodia protrusions when compared to R37 S100A4 
WT cells (Table 3.2.3).  Co-staining of actin with fascin, a well-known actin cross-linking protein 
that localises to filopodia revealed that filopodia projections in Rama37 control, R37 S100A4Δ2 
and R37 S100A4Δ6 cells consist of fascin co-localising with actin throughout the filopodia shaft 
with accumulation at the tip of microspike and the quantification of this localisation was 
consistent with the observation where higher level of filopodia containing fascin was found in 
Rama37 control, R37 S100A4Δ2 and R37 S100A4Δ6 cells (Table 3.2.4).  The higher number of 
paxillin and vinculin clusters in cell lines that exert higher number of filopodia is within expectation 
as formation of focal contacts were initiated by adherence of filopodia where is it overgrown by 
lamellipodium and its maturations is assisted by the tensile strength exerted through actomyosin 
contraction (Geiger et al., 2009, Vicente-Manzanares and Horwitz, 2011a).  Interestingly, the 
expression levels of adapter protein, vinculin and paxillin are higher in R37 S100A4 WT cells but 
focal adhesions clusters containing these proteins were significantly reduced in the 
immunofluorescence stainings (Figure 3.2.3, 3.2.4 and 3.2.7).  This indicates that although 
expression levels of the proteins were increased, the proteins failed to be recruited or activated to 
the adhesion sites.  Although there are no studies done on effects of S100A4 on focal adhesion 
reduction, it was demonstrated that overexpression of S100P in Rama 37 cells, could led to 
reduced focal adhesion, as demonstrated in this work, via an unknown mechanism (Du et al., 
2012). 
Through live cell analysis, contrasting results showing formation of filopodia extensions in 
R37 S100A4 WT was higher than Rama37 control, R37 S100A4Δ2 and R37 S100A4Δ6 cells.  It is 
possible that during the fixation procedure, the usage of detergent resulted in the loss of nascent 
and unstable filopodia, but not the stably adhered ones.  This contrasting filopodia quantification 
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of live and fixed cells suggested that the S100A4 protein somehow prevents adherence of 
filopodia rather than inhibiting its formation.  It has been demonstrated that myosin X is involved 
in formation of filopodia where upon dimerisation, it acts as actin bundling protein to initiate 
filopodia protrusion (Watanabe et al., 2010).  Although interaction of S100A4 with myosin X has 
not been demonstrated in any studies, its interaction with NMMIIA and NMMIIB suggests the 
possibility of S100A4 interaction with myosin X to regulate filopodia formation (Li et al., 2003, Ford 
et al., 1997).  Furthermore, through blastp protein alignment, it was found that NMMIIA and 
myosin X shared 36% of amino acid identity which spans between 3 regions; 1) 32 to 820, 2) 1444 
to 1504 and 3) 1033 to 1117.  However, these regions were not found to be identical to the 
binding sequence of S100A4 on NMMIIA which spans from 1909 to 1924 amino acids which led to 
speculations of S100A4 interacting with other target proteins to promote filopodia instability. 
Through cell force analysis where 15 kPa elastomer substrates were used, it was found 
that R37 S100A4 WT cells generated lower contractile force when compared to those exerted by 
the control or those expressing truncated versions of S100A4 protein (Table 3.2.8).  As contractile 
force is aroused from tension generated by NMMII coupling with actin, the lower overall 
contractile force in S100A4 expressing cells suggested that the capability of S100A4 to disassemble 
NMMIIA could directly weaken the contractile force or indirectly by inhibiting organisation of 
stress fibers through NMMIIA disassembly which weakens the actomyosin force, hence preventing 
the maturation of focal adhesions, ultimately leading to lower overall contractile force exerted 
(Hotulainen and Lappalainen, 2006, Bershadsky et al., 2006, Shutova et al., 2012, Grosheva et al., 
2006).   Since mature focal adhesions are essential to slow down retrograde flow to prevent 
filopodial retraction while persisting protrusion, this could be the underlying reason as of why 
S100A4 overexpressing cells lack of stable filopodia.  Also, acceleration of filopodia formation in 
Page | 127  
 
R37 S100A4 WT cells indicated that actin polymerisation rate is not affected (Figure 3.2.9) (Cai et 
al., 2006, Parsons et al., 2010).   
However, it remained uncertain if the lower contractile forces generated by S100A4 
overexpressing cells were due to reduced NMMIIA expression or reduced focal adhesion (Figure 
3.2.10).  We speculated that the reduction of NMMIIA expression level could be S100A4-mediated 
as numerous reports have demonstrated that overexpression of S100A4 through transfection 
resulted in down-regulation of E-cadherin and tissue inhibitor of metalloproteinases (TIMPs) and 
up-regulations of matrix metalloproteinases (MMPs) (Andersen et al., 2004, Kimura et al., 2000, 
Moriyama-Kita et al., 2005, Yonemura et al., 2000b, Andersen et al., 2011, Bjornland et al., 1999, 
Lu et al., 2004, Yammani et al., 2006, Zhang et al., 2011).  However, the mechanism regarding 
expression regulation by S100A4 remained to be investigated. 
In another independent work which utilises Rama 37 cell system transfected with S100P 
protein, we demonstrated the consistency where S100P-induced motility correlates with reduced 
focal adhesion clusters along with disorganised actin filaments.  S100P, a member of S100 
superfamily, has been shown to interact with NMMIIA and its overexpression has been linked to 
poor survival of breast cancer patients in which S100A4 protein has shown similar correlations 
(Basu et al., 2008, Parkkila et al., 2008, Wang et al., 2006, Du et al., 2012).  In the presence of 
calcium, S100P protein undergoes conformational changes, forming hydrophobic cleft which 
serves as an active site for target protein binding (Gribenko and Makhatadze, 1998, Koltzscher and 
Gerke, 2000).  It has also been shown that transfection of S100P into Rama 37 cell system induces 
metastatic characteristics as displayed by S100A4 transfected Rama 37 cells (Wang et al., 2006).  
Due to the analogous characteristic exhibited by these proteins, similar experiments were done on 
Rama 37 cells, but transfected with plasmid encoding wild type S100P and also their C-terminus-
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mutant counterparts (A-mutant, replacement of lysine residue to alanine and Stop-mutant, 
deletion of lysine residue).   
Quantification of focal complexes (paxillin) and wound healing rates from these cell lines 
revealed that number of focal complexes correlates with wound healing rate where (as observed 
in the R37 S100A4 WT cell system); the lower the number of focal complexes, the faster the 
wound healing. In this experiment, it was observed that R37 S100P WT (Wound Closure (WC) = 
37.5 ± 4.9%, Focal complex (FC) = 3.1 ± 1.7) has the highest percentage of wound closure 6 hours 
post wounding but lowest focal contacts, followed by A-mutant (WC = 24.9 ± 10.4, FC = 8.2 ± 3.4), 
Rama 37 control cells (WC = 28.6 ± 8.0%, FC = 17.4 ± 3.6) and Stop-mutant (WC = 8.88 ± 3.28, FC 
=21.2 ± 2.8) (data not shown).  In our collaborative work with Liverpool University, our 
observations also correlated with their affinities to NMMIIA using optical biosensor approach.  In 
their work, it was shown that the binding affinities of S100P to NMMIIA was significantly increased 
(Kd  300 - 400 nM) when compared to Stop-mutant and A-mutant (Kd  6µM and Kd  4µM 
respectively) (in preparation data).  These data obtained from S100P transfected Rama 37 cell 
system further strengthen the observation obtained using S100A4 transfected Rama 37 cell 
system where reduction of focal adhesions as well as disorganisation of stress fibers may lead to 
enhancement of cell motility. 
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4.1 Introduction 
Numerous studies have aimed to decipher the structural and mechanical roles of non 
muscle myosin II (NMMII).  The NMMII complex comprised of three pairs of peptides; two heavy 
chains (230kDa), two regulatory light chain (RLC) (20kDa) and two essential light chains (ELC) 
(17kDa).  The heavy chains, which contain the globular heads, bundle actin filaments via their C-
terminal domains to generate actomyosin forces whereas the two regulatory light chains upon 
phosphorylations, result in alteration of the globular heads and ATPase activities of the 3 isoforms 
of NMMII; NMMIIA, -IIB and -IIC (Betapudi et al., 2006, Sandquist et al., 2006).  Phosphorylation of 
RLC of NMMII at Thr 18 or Ser 19 promotes binding of ATP at the globular heads and results in its 
dissociation from actin.  During hydrolysis, NMMII changes its conformation and releases ADP and 
inorganic phosphate which increases its affinity to actin.  The reassociation of NMMII globular 
heads to actin complete a cycle of actomyosin contraction and the continuous cycle enable cells to 
drive forward locomotion.  Although NMMIIA and NMMIIB shares 85% of amino acid identity in 
the globular domain and 72% in the helical rod and have been shown to be simultaneously 
expressed in variety of vertebrate cells, its distinct but overlapping distributions suggested 
different roles for these complexes (Lo et al., 2004, Kolega, 2006, Cai et al., 2006, Togo and 
Steinhardt, 2004).  NMMIIA is found localised to the front of migrating cells and knockdown via 
SiRNA resulted in loss of stress fibers and focal adhesion maturation and size (Cai et al., 2006, 
Bresnick, 1999).  NMMIIB, on the other hand, is found to be concentrated at the rear and 
important for maintaining stress fibers integrity (Cai et al., 2006, Kolega, 1998). 
In stable stress fibers, dissociation and association of NMMII with actin is in equilibrium 
due to intermediate level of ATPase activity.  Consequently, activation of ATPase activity of 
NMMIIA resulted in increased association with actin filaments to form stress fibers whilst 
dissociation of NMMII from actin is dominant when ATPase activity is low (Watanabe et al., 2007, 
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Iwasaki et al., 2001). In the studies to demonstrate the importance of NMMII ATPase activity to 
regulate its activity, two common NMMII inhibitors have been used; blebbistatin and Y-27632.  
Blebbistatin is a selective membrane permeable NMMII ATPase inhibitor which exists in two forms 
(+)-blebbistatin and (-)-blebbsitatin where (-) enantiomer is found to be the active form (Limouze 
et al., 2004).  This inhibitor interacts with the actin-bound NMMII, slowing the phosphate release 
(Pi) and indirectly foiling the formation of actomyosin complex (Takács et al., 2010, Ramamurthy 
et al., 2004, Limouze et al., 2004).  Such properties are not due to blebbistatin competing with ATP 
binding to NMMII, but rather affecting the inorganic phosphate release. (Ramamurthy et al., 2004, 
Kovács et al., 2004).  Consequently, treatment with blebbistatin has been shown to induce 
dramatic changes at the cellular levels, resulting in severe reduction in stress fibers as well as focal 
adhesions (Liu et al., 2010, Lucas-Lopez et al., 2008, Pasapera et al., 2010).   
Y-27632 is a ROCK kinase inhibitor, inhibiting both the two isoforms ROCKI and ROCKII, 
sharing approximately 90% identity.  Y-27632 has also been shown to inhibit other kinases such as 
protein kinase C (PKC), cAMP-dependent kinase and myosin light chain kinase(MLCK) with 
however, a 100 fold lower efficiency, suggesting that its primarily target in cell is the ROCK 
proteins (Uehata et al., 1997).  Phosphorylation status of RLC (at location Ser-19 and Thr-18) has 
been shown to result in significant increase of ATPase activity (Ikebe and Hartshorne, 1985, Ikebe 
et al., 1988, Asano et al., 2009, Kondo et al., 2011, Vicente-Manzanares and Horwitz, 2010, Kanda 
et al., 1985).  It is therefore thought that ROCK can equally contribute to myosin ATPase activities 
through regulating phosphorylation of RLC (Amano et al., 1996, Kureishi et al., 1997, Kimura et al., 
1996).  Accordingly, inhibition of ROCK by Y-27632 results in loss of stress fibers and modifications 
in focal adhesions size (Kawano et al., 1999, Amano et al., 2010), suggesting a direct link between 
ROCK, RLC phosphorylation and NMMII activities.  It has also been shown that prolong incubation 
of Swiss 3T3 cell lines with Y-27632 induces a long neurite or dendritic morphology in 
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concentration dependent manner and enhancement of wound healing properties by 67% was 
observed after inhibitor treatment (Ishizaki et al., 2000).   
Another common myosin inhibitor, with myosin phosphatase-like activity is the cell 
permeable compound 2,3-Butanedione monoxime (BDM).  BDM has been shown to inhibit the 
ATPase activity of muscle myosin II , resulting in the reduction contraction force by promoting the 
formation of myosin-ADP complex or myosin-ADP-Pi complex (McKillop et al., 1994).  It is, 
however unclear whether this inhibitor can similarly regulate the activities of NMMII and 
therefore demonstrate myosin contractibility effects in other cells (Ostap, 2002, Cramer and 
Mitchison, 1995).  For instance, BDM has been shown not to inhibit the ATPase activity of NMMII 
in Swiss 3T3 and BS-C1 cells instead preventing the localisation of actin and other partners (VASP, 
Arp 2/3 complex and WAVE) at their leading edge whereas in other cases, it has been shown to 
specifically inhibit NMMII activities in Walker carcinosarcoma resulting in reduced cell motility and 
polarity (Yarrow et al., 2003, Cheung et al., 2002, Keller et al., 2002).   
Over the years, NMMII has been established as one of the main binding partner for 
S100A4, possibly linking their association towards changes in cell motility (Li et al., 2003, Li and 
Bresnick, 2006, Ismail et al., 2008b).  Although NMMIIA and NMMIIB displayed high sequence 
homology, S100A4’s affinity for the two complexes are very different; with 9-fold higher binding 
capacity for NMMIIA filaments than for NMMIIB filaments (Bresnick, 1999, Li et al., 2003).  The 
binding site on NMMIIA for S100A4 has been shown to lie within the amino acid residues stretch 
from 1909 to 1924, at C terminus end of NMMIIA, a region that is approximately 34% conserved 
between the two isoforms. This interaction appears to be regulated in a calcium dependent 
manner (Li et al., 2003, Kriajevska et al., 2000), resulting in the inhibition of NMMIIA ATPase 
activity and the dissociation of the actomyosin network, at least in vitro (Ford et al., 1997).  
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In this section, we aimed to investigate the link between S100A4 protein and NMMIIA 
protein on cell migration and morphology.  For this purpose, different strategies were adopted, 
using either NMMII inhibitors or cellular systems where NMMIIA had been knocked down or 
completely ablated. 
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4.2 Results 
4.2.1 Determination of optimal blebbistatin, Y-27632 and BDM concentration in Rama 37 cell 
system 
To investigate the roles of S100A4 protein and its independency of NMMII in cell 
migration, three different NMMII inhibitors were used; (1) Blebbistatin, (2) Y-27632 and (3) 2,3-
Butanedione monoxide (BDM). 
 Viability of Rama 37 control cells after 24 hours pre-treatment with blebbistatin (0 µM to 
125 µM), Y-27632 (0 µM to 100 µM) and BDM (0 mM to 20 mM) was determined using MTT assay 
(Figure 4.2.1).  While treatment with blebbistatin and BDM resulted in concentration dependent 
reduction of cell viabilities, Y-27632 did not show any effects.  It was found that reduction of cell 
viability after blebbistatin treatment started from 25 µM (74.6 ± 15.2%) while BDM effects started 
from 10 mM (78.1 ± 0.2%) (Figure 4.2.1 A and 4.2.1 B respectively).  As the standard error for MTT 
assay of 25 µM of blebbistatin is high, this concentration is repeated with 10 µM of blebbistatin.  
Further viability assay carried out over 24 hours with an interval of 2 hours using 10 µM or 25 µM 
blebbistatin treatments showed that cell viabilities for both concentrations were not affected 
(Figure 4.2.1 D).  The lower increment of cell viability in 25 µM treated cells compared to 10 µM 
and untreated cells could possibility be due to lower cell number as blebbistatin has been shown 
to affect cytokinesis where multinucleated cells were observed.  Due to incapability of MTT assay 
to determine optimal concentration for Y-27632 on Rama 37 control cells, changes in cell 
morphology as well as actin organisation through immunofluorescence staining against actin were 
used.  It was observed that 50 µM of Y-27632 treatment and onwards resulted in changes in cell 
morphology as well as disorganisation of actin filaments (Figure 4.2.2).  Also, similar stainings were 
done on blebbistatin (10 µM and 25 µM) and BDM (5mM and 10 mM) treated Rama 37 control 
cells (Figure 4.2.2) where was found that 10 µM of blebbistatin and both 5mM and 10 mM of BDM 
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did not cause any significant changes in actin filaments and cell morphology.  Thus, the established 
concentrations of blebbistatin and Y-27632 are 25 µM and 50 µM respectively.  As BDM did not 
cause any effects on cell morphology but significantly reduce cell viability, this inhibitor was not 
used in proceeding experiments. 
 
Figure 4.2.1  Blebbistatin and BDM, but not Y-27632 post 24 hours treatment on Rama 37 
control cells reduces cell viability.  Rama 37 control cells were seeded into 24 well plates and left 
to grow for 24 hours before treatment with different concentration of respective inhibitors; (A) 
Blebbistatin, (B) Y-27632 and (C) BDM into each well.  After 24 hours, 4µL of MTT (5mg/ml) 
dissolved in PBS were added into each well and incubated for one hour before solubilising the 
precipitate in 400µL DMSO.  (D) Either 10 µM or 25 µM of blebbistatin were added into each well 
and at every 2 hours interval and 4 µL MTT were added and solubilised as mentioned before.  The 
absorbances were read at 550 nm wavelength and the untreated readings were taken at 100% 
viable.  The absorbance value were converted to percentage and plotted against respective 
inhibitors concentration used.  Results are mean ± s.e taken from 3 individual wells.  
Methods are fully detailed in Chapter 2.2.3. 
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Figure 4.2.2.  Blebbistatin (25 µM) and Y-27632 (50 µM) resulted in alteration of cell morphology 
and actin filaments disorganisation.  Rama 37 control cells were seeded onto coverslips pre 
coated with fibronectin and left to incubate for 24 hours prior to addition of blebbistatin.  Cells 
were fixed, stained with phalloidin and mounted with DAPI 24 hours post blebbistatin treatment.  
Cells were then view with immunofluorescence microscope.  Images displayed for each cell line 
were representative images obtained form 3 independent experiments.  Scale bar = 25 µm.  
Methods are fully detailed in Chapter 2.2.8.
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4.2.2 Inhibition of NMMII failed to prevent S100A4-induced migration 
After establishing the optimum concentration for blebbistatin and Y-27632 (25 and 50 µM 
respectively), the cells were pre-treated before performing scratch assay using CellIQ machine 
(Figure 4.2.3 A).  Images obtained were analysed and depicted in corresponding histograms shown 
in Figure 4.2.3 B which demonstrated that untreated R37 S100A4 WT cells closed wound 
significantly faster (68 ± 13.0%) than untreated Rama 37 control cells (55 ± 6.3%, P =0.033), as 
previously shown in Chapter 3 (Figure 4.2.3 B).  However, after treatment with blebbistatin and Y-
27632 the percentage of wound closure of Rama 37 control cells significantly increases to 91 ± 
4.6% (P < 0.001) and 85 ± 12.2% (P < 0.001) respectively as opposed to 55 ± 6.3% of the untreated 
cells.  On the other hand, the similar treatment also increased wound closure percentage of R37 
S100A4 WT cells to 96.6 ± 3.7% (P < 0.001) and 99.4 ± 0.7% (P < 0.001) which were significantly 
faster than its untreated controls; 68 ± 13.0%.   
Improvement of cell motility after treatment with NMMII inhibitors to demolish NMMII-
actin integrity highlighted the dispensable acto-myosin contraction in promoting cell motility.  In 
fact, the improvement in motility suggested that NMMII may be more important in cell adhesion 
and acceleration of wound closure in S100A4 overexpressing cells after treatment suggested that 
NMMII may not be the only target protein of S100A4 in promoting cell motility. 
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Figure 4.2.3.  Inhibtion of NMMII with blebbistatin or Y-27632 promotes wound healing in both Rama 37 control cells and R37 S100A4 WT 
cells.  Equal numbers of cell were seeded into 24 well plate and left for 48 hours of incubation to create a confluent monolayer of cells.  The cells 
were scratched, washed and fresh medium containing either 25 µM of blebbistatin or 50 µM of Y-27632 were added into the respective wells.  
The plates were placed in CellIQ machine and time lapse images were taken until the gap closes.  (A) The time lapse images on the indicated time 
point were chosen.  Scale bar = 200 µm.  Images obtained are representative images from 3 independent experiments. (B) Time lapse images 
were analysed with CellIQ Analyser software and percentage of wound closure after 9 hours post scratching for each cell lines and its treatments 
were calculated and plotted as above.  Data shown in each treatment are mean values ± s.e. of 3 regions of triplicates and is representative data 
from 3 independent experiments.  Student t-Tests were done by comparing the treatment of each cell line to its respective untreated controls 
and also between the untreated samples of both cell lines.  * p< 0.05, ** p < 0.01, *** p < 0.001.  Methods are fully detailed in Chapter 2.2.4.
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4.2.3 Inhibition of NMMII reduces focal adhesions 
From immunostaining of paxillin, actin and NMMIIA conducted in the previous chapter, it 
was demonstrated that promotion of cell migration by S100A4 protein resulted in reduction of 
focal adhesions and actin filaments disassembly.  Therefore, we sought to determine if treatment 
with either blebbistatin or Y-27632 poses similar effects.   
Immunofluorescence staining of paxillin in Figure 4.2.4 demonstrated that treatment with 
25µM of blebbistatin resulted in changes of cell morphology.  After treatment with 25µM of 
blebbistatin Rama 37 control cells displayed polarised morphologies with a prominent 
lamellipodium found at the leading edge of the cells along with significant reduction of paxillin 
clusters.  This treatment also causes disassembly of dorsal stress fibers, but transverse arcs 
remained intact around the perinuclear of the cells (Figure 4.2.4 A – A’ and B – B’).  On the other 
hand, R37 S100A4 WT cells treated with blebbistatin demonstrated less prominent transverse 
arcs, thinner actin filaments and actin residues were dispersed throughout the cytoplasm (Figure 
4.2.4 C – C’ and D – D’).   
Consistent with the results following treatment with blebbistatin, addition of Y-27632 also 
resulted in overall loss of focal adhesions (paxillin) in Rama 37 cells (Figure 4.2.5).  Treatment of 
Rama 37 control cells with 50 µM of Y-27632 resulted in the loss of dorsal stress fibers, but 
transverse arcs were still visible (Figure 4.2.5 A – A’ and B – B’).  Unlike inhibition with blebbistatin, 
there were no prominent lamellipodium present but projections of filopodia were clearly visible 
(Figure 4.2.10 B – B’).  Under similar treatment, prominent lamellipodium present in the untreated 
R37 S100A4 WT cells were replaced by numerous projections of filopodia around the cells (Figure 
4.2.10 C – C’ and D – D’) with speckles of actin filaments dispersed throughout the cytoplasm of 
the treated cells. 
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This noticeable reduction of paxillin clusters were quantified in Table 4.2.1.  When 
compared to untreated Rama 37 control cells (16.4 ± 4.1), cells that were treated with blebbistatin 
(2.3 ± 1.6) and Y-27632 (1.6 ± 1.4) show significant paxillin clusters reduction (P < 0.001).  Similarly, 
paxillin clusters in untreated R37 S100A4 WT cells (5.4 ± 3.6) reduced to 0.2 ± 0.4 and 0.6 ± 1.1 
after treatment with blebbistatin and Y-27632 respectively (P < 0.001). 
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Figure 4.2.4  Reduction of paxillin clusters and disassembly of actin stress fibers in Rama 37 cells 
as a consequence of NMMII inhibition by blebbistatin.   Rama 37 cells were seeded onto 
coverslips pre coated with fibronectin and left for 48 hours before further incubation with 25 µM 
of blebbistatin.  After 4 hours, the cells were fixed, blocked, incubated with primary antibody 
(paxillin), and followed by secondary antibody (FITC) along with phalloidin incubation.  Then, the 
cells were washed and mounted with DAPI before viewing with confocal microscope. Untreated 
Rama 37 control cells were labeled as A - A’ whereas treated cells were labeled as B – B’.  
Untreated R37 S100A4 WT cells were labeled as C – C’ and those treated were labeled as D – D’.  
Panels A’, B’, C’ and D’ correspond to focused regions of the cell. Scale bar = 25μm. Images 
displayed for each cell line were representative image obtained from 3 independent experiments. 
Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.5  Reduction of paxillin clusters and disassembly of actin stress fibers in Rama 37 cells 
as a consequence of NMMII inhibition by Y-27632.   Cells were prepared as mentioned in figure 
4.2.4 but treated with 50 µM of Y-27632. Untreated Rama 37 control cells were labeled as A - A’ 
whereas 50 µM Y-27632 treated cells were labeled as B – B’.  Untreated R37 S100A4 WT cells were 
labeled as C – C’ and those treated with 50 µM of Y-27632 were labeled as D – D’.  Panels A’, B’, C’ 
and D’ correspond to focused regions of the cell. Scale bar = 25μm. Images displayed for each cell 
line were representative image obtained from 3 independent experiments. Methods are fully 
detailed in Chapter 2.2.8. 
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Table 4.2.1  Inhibition of NMMII resulted in loss of paxillin clusters.  Cells were seeded and 
stained as described in figure 4.2.5.  Images obtained were quantified manually by counting the 
number of clusters localised at the periphery of each cell.  Results are mean values ± s.d. from 3 
independent experiments (n=10).  
P-values were obtained from Student t-Test where number of focal adhesions (paxillin) per 
respective treated cell line was compared to its untreated control. 
Methods are fully detailed in Chapter 2.2.10. 
  
Treatment Cell Lines 
Number of focal adhesions (paxillin) per 
cell ± s.e. 
P-value 
Untreated Rama 37 control 17.8 ± 5.1 
 
 
R37 S100A4 WT 4.5 ± 3.2  
 
25 µM Blebbistatin Rama 37 control 2.3 ± 1.6 4.3377E-13 
 
R37 S100A4 WT 0.2 ± 0.4 5.88905E-05 
50µM Y-27632 Rama 37 control 1.6 ± 1.4 8.6876E-14 
 
R37 S100A4 WT 0.6 ± 1.1 0.000195951 
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To establish the effects of blebbistatin and Y-27632 on localisation and structures of 
NMMIIA, immunofluorescence stainings of NMMIIA with actin were done on both Rama 37 
controls and R37 S100A4 WT cells.   
Immunofluorescence staining demonstrated that untreated Rama 37 control cells showed 
NMMIIA colocalised with the actin filaments found across the cytoplasm, but after treatment with 
blebbistatin, this localisation of NMMIIA was lost and appeared to be dispersed throughout the 
cytoplasm of the cells (Figure 4.2.6 A – A’ and B – B’).  The treated cells also acquire polarised 
morphology with prominent lamellipodium found at the leading edge of the cells.  Similar traits 
were observed in Rama 37 control cells after Y-27632 treatment (Figure 4.2.7). 
In the untreated R37 S100A4 WT cells, NMMIIA were found to be concentrated at the 
transverse arcs where actin was most concentrated (Figure 4.2.6 C – C’).  After blebbistatin 
treatment, R37 S100A4 WT cells displayed loss of transverse actin arcs and NMMIIA were found to 
be localised throughout the cytoplasm of the cells (Figure 4.2.6 D – D’).  Treatment with Y-27632 
displayed similar traits (Figure 4.2.7 D – D’). 
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Figure 4.2.6  Treatment with 25 µM of blebbistatin resulted in loss of transverse arcs and 
distribution of NMMII throughout the cytoplasm of the cells.   Cells were seeded and stained as 
described in figure 4.2.4 but incubated with NMMIIA primary antibody.  Untreated Rama 37 
control cells were labeled as A - A’ whereas 25 µM blebbistatin treated cells were labeled as B – B’.  
Untreated R37 S100A4 WT cells were labeled as C – C’ and those treated with 25 µM of 
blebbistatin were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused regions of the 
cell. Scale bar = 25μm. Images displayed for each cell line were representative image obtained 
from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.7  NMMII inhibition by Y-27632 resulted in loss of actin stress fibers and distribution 
of NMMIIA throughout the cytoplasm of the cells.   Cells were seeded as described in figure 4.2.4 
but treated with 50 µM Y-27632 and stained for NMMIIA.  Untreated Rama 37 control cells were 
labeled as A - A’ whereas 50 µM Y-27632 treated cells were labeled as B – B’.  Untreated R37 
S100A4 WT cells were labeled as C – C’ and those treated with 50 µM of Y-27632 were labeled as 
D – D’.  Panels A’, B’, C’ and D’ correspond to focused regions of the cell. Scale bar = 25μm. Images 
displayed for each cell line were representative image obtained from 3 independent experiments. 
Methods are fully detailed in Chapter 2.2.8. 
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4.2.4 Knockdown of NMMIIA affects migration 
 Due to the further reduction of focal adhesion clusters (paxillin) (Table 4.2.1) and 
enhancement of wound healing in both Rama 37 control cells and R37 S100A4 WT cells (Figure 
4.2.3) after treatment with blebbistatin or Y-27632, we speculated that S100A4-induced migration 
may not be NMMIIA dependent.  To justify this speculation, we opted to perform wound healing 
assay along with immunofluorescence with NMMIIA-knocked down Rama 37 cell lines. 
Before conducting any experiments, NMMIIA SiRNA transfections on Rama 37 cells were 
optimised.  It was shown that SiRNA2 is more efficient in knockdown of NMMIIA expression than 
SiRNA1 and NMMIIA expression corresponding to the blot presented shows  reduction of NMMIIA 
expressed in Rama 37 control cells after transfection with SiRNA1 (18.2%) and SiRNA2 
(1.11%)(Figure 4.2.8).  On the other hand, NMMIIA expression in R37 S100A4 WT cells were 
reduced to 71.6% and 4.2% when transfected with SiRNA1 and SiRNA2 respectively (Figure 4.2.8 
B).  
After demonstrating the reduction of NMMIIA expression level in both cell lines, wound 
healing assay was carried out (Figure 4.2.9).  In Rama 37 control cells, the percentage of wound 
closure is 44.9 ± 5.8% whereas after inhibition with SiRNA1, it was demonstrated that there was 
insignificant increase in the wound closure percentage (50.8 ± 10.7%, P = 0.171).  However, as 
level of NMMIIA expression decreases using SiRNA2 knockdown, significant increase in wound 
closure percentage was observed (57.2 ± 9.2, P = 0.004).  It was demonstrated that SiRNA1 is less 
effective in inhibiting the expression of NMMIIA when compared to SiRNA2, this data is consistent 
with the wound healing data where gradual improvement of cell migration was observed in cell 
expressing lower level of NMMIIA (Figure 4.2.8 and 4.2.9).   
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An inverse correlation between level of NMMIIA and percentage of wound closure was 
observed in R37 S100A4 WT cells.  Significant reduction of percentage of wound closure was 
observed in SiRNA2 (73 ± 12.0%, P = 0.012) and insignificant reduction with SiRNA1 treatment 
(81.3 ± 16.0%, P = 0.280) when compared to untreated R37 S100A4 WT (84.1 ±21.5%) (Figure 
4.2.9). 
Since there is an alteration in migratory level after NMMIIA knockdown, it is important to 
investigate if there are any modifications in focal adhesion (paxillin) and cellular structure 
(NMMIIA and actin) using immunofluorescence staining, if any.   
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Figure 4.2.8  Level of NMMIIA expression is significantly reduced after knockdown with SiRNA2.  
Cells were seeded into 6 well plate and left to incubate for 24 hours.  Cells were washed and used 
media were replaced with Opti-MEM® and left for 4 hours before adding the transfection mixture 
prepared.  After 72 hours, cells were harvested and total proteins were quantified and 150 µg of 
total protein were loaded for each sample into 8% (w/v) SDS-PAGE gel and the resolved proteins 
were transferred onto nitrocellulose membrane before incubating the membrane with primary 
antibody (NMMIIA) and then followed by secondary HRP conjugated antibody.  Detection was 
undertaken using the customized detection system (Table 2.12).  A) Blots shown are 
representative data obtained from 3 independent experiments.  B) Percentage of NMMIIA 
expressed corresponds to presented blot using ImageJ after scanning the blots and normalising 
them with its respective controls. Methods are fully detailed in Chapter 2.2.17 to 2.2.20. 
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Figure 4.2.9 Knockdown of NMMIIA has opposing motility effects in Rama 37 control cells and 
R37 S100A4 WT cells. Cells were seeded into 24 well plates and left to incubate for 24 hours.  Cells 
were washed and used media were replaced with Opti-MEM® and left for 4 hours before adding 
the transfection mixture prepared.  After 72 hours, the confluent monolayer of cells were 
scratched, washed and fresh medium were added into the respective wells.  The plates were then 
place in CellIQ machine to run until the gap closes and the raw data were analysed with CellIQ 
Analyser software.  Percentage of wound closure after 8.2 hours post scratching were calculated 
and plotted as above.  Data shown are mean values ± s.e. of 3 regions of triplicates and a 
representative data from 3 independent experiments.  Student t-Tests were done by comparing 
the treated samples to untreated controls.  * p< 0.05, ** p < 0.01, *** p < 0.001.  Methods are 
fully detailed in Chapter 2.2.4 and Chapter 2.2.7. 
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4.2.5 Knockdown of NMMIIA reduces focal adhesions 
Since reduction of focal adhesions has been shown to correlate with increased motility of 
Rama 37 cells, immunofluorescence stainings for paxillin and NMMIIA of the cells after SiRNA 
transfection were performed.  The reduced expression of NMMIIA in Rama 37 control cells 
correlated with the loss of paxillin clusters and filopodia projections were replaced by wide-spread 
lamellipodium when compared to untreated control (Figure 4.2.10 A – A’ and B – B’).  Also, treated 
cells acquired polarised morphology with loss of dorsal stress fibers, but retaining the transverse 
stress fibers.  The knockdown of NMMIIA in R37 S100A4 WT cells resulted in further loss of paxillin 
clusters and multiple pseudopodia projected around the cells’ periphery instead of lamellipodia as 
observed in its untreated counterpart (Figure 4.2.10 C –C’ and D – D’).   
Immunofluorescence stainings of Rama 37 cells against NMMIIA and actin after SiRNA 
transfection were done.  In untreated Rama 37 control cells, it was observed that NMMIIA were 
colocalised along the actin filaments (Figure 4.2.11 A – A’).  Knockdown of NMMIIA in Rama 37 
control cells led to cells acquiring polarised morphology and relocalisation of remaining NMMIIA 
towards the nuclear of the cells (Figure 4.2.11 B –B’).  Cells expressing S100A4 WT protein showed 
some colocalisation of NMMIIA along the actin stress fibers with higher NMMIIA intensities within 
the nucleus of the cells (Figure 4.2.11 C – C’).  After NMMIIA SiRNA transfection, the polarisation of 
the S100A4 WT expressing cells was slightly altered where multiple pseudopodia were observed 
(Figure 4.2.11 C –C’ and D – D’).  Also, the localisation of the NMMIIA concentrated within the 
nucleus of the cells and the previously observed elongated strands of actin stress fibers in the 
untransfected R37 S100A4 WT cells were replaced with speckles of actin entities throughout the 
cell cytoplasmic region (Figure 4.2.11 C – C’  and D – D’). 
Since such a trait is observed, similar experiments were conducted with Cos 7 cells, which 
naturally void of NMMIIA to show if the consistent observations are attainable.    
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Figure 4.2.10  Inhibition of NMMIIA resulted in overall loss of paxillin clusters while promoting 
polarisation of Rama 37 cells.  Cells were seeded into 24 well plates and left to incubate for 24 
hours.  Cells were washed and used media were replaced with Opti-MEM® and left for 4 hours 
before adding the transfection mixture prepare.  After 72 hours, the cells were fixed, blocked, 
incubate with primary antibody (paxillin), and then with secondary antibody (FITC) along with 
phalloidin.  Then, the cells were washed and mounted with DAPI before viewing with confocal 
microscope. Untreated Rama 37 control cells were labeled as A - A’ whereas SiRNA transfected 
cells were labeled as B – B’.  Untreated R37 S100A4 WT cells were labeled as C – C’ and those 
transfected with SiRNA were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused 
regions of the cell. Scale bar = 25μm. Images displayed for each cell line were representative 
image obtained from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.11 Inhibtion of NMMIIA resulted in loss of colocalisation of NMMIIA with actin stress 
fibers.  Cells were seeded and stained for NMMIIA using similar methodology as described in 
figure 4.3.10.  Untreated Rama 37 control cells were labeled as A - A’ whereas SiRNA transfected 
cells were labeled as B – B’.  Untreated R37 S100A4 WT cells were labeled as C – C’ and those 
transfected with SiRNA were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused 
regions of the cell. Scale bar = 25μm. Images displayed for each cell line were representative 
image obtained from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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4.2.6 Optimisation of Cos 7 cells transfections 
Cos 7 cells are of fibroblastic origin and found to be naturally lacked of NMMIIA, hence this 
cell system is used to investigate the effect of S100A4 in cell migration in either absence or 
presence of NMMIIA.  To achieve this, Cos 7 cells were transfected with either NMMIIA-GFP 
expressing plasmid or S100A4 WT-GFP expressing plasmid to demonstrate the independency 
effect of both proteins.  Before proceeding into detailed experiments, the efficiency of different 
transfection reagents was determined. 
 
4.2.6.1  Determination of efficiency of different transfection reagents 
Five different transfection reagents were used to transfected PeCFP plasmid into Cos 7 
cells.  Jetpei produced the highest transfection efficiency (36.3 ± 1.0%), followed by Lipofectamine 
(28.5 ± 2.2 %) gene HP (26.3 ± 5.6 %), Trans 293 (15.1 ± 7.0 %), Gene 9 (4.1 ± 0.9 %) and finally, 
Trans TI (3.1 ± 3.1 %) (Figure 4.2.12 A).  Since the ratio of transfectants to plasmid DNA may affect 
transfection efficiency, the optimum ratio using Jetpei transfectant is established (Figure 4.2.12 B).  
It was demonstrated that with the density of 80,000 cells, the ratio of 0.8 µg of DNA plasmid to 2 
µL of Jetpei gives a transfection efficiency of 42.2 ± 4.8 %, whereas 2 µg of DNA plasmid to 4 µL of 
Jetpei produce an efficiency of 38.3 ± 10.7 %.  Finally, the ratio of 1 µg of DNA plasmid to 1.5 µg of 
Jetpei gives an efficiency of 37.3 ± 10.1 %.  Using Jetpei A ratio, expression of PeGFP NMMIIA 
plasmid and PeCFP S100A4 plasmid in transfected Cos 7 cells were confirmed using western blot 
(Figure 4.2.13).   
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Figure 4.2.12 Jetpei transfection reagents gives the highest transfection efficiency in Cos 7 cells.   A) Equal numbers of cell were seeded into 24 
well plate and left to incubate for 24 hours.  The cells were then wash and fresh medium without antibiotics were added into each well 4 hours 
prior to adding transfection reagents.  Then, cells were left to incubate for 24 hours before being fixed and stained with DAPI.  Images were taken 
with immunofluorescence microscope and GFP transfected cells were manually quantified against the total number of cell present which is 
stained with DAPI.  B) Transfections were carried out as mentioned in A but with respective ratios; Jetpei A : 0.8 µg plasmid DNA and 2 µL Jetpei; 
Jetpei B : 2 µg plasmid DNA and 4 µL Jetpei and Jetpei C: 1 µg plasmid DNA and 1.5 µL Jetpei. Both results are mean values ± s.e from 3 
independent experiments (n > 100).  Methods are fully detailed in Chapter 2.2.5. 
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Figure 4.2.13 High level of NMMIIA and S100A4 protein expression in Cos 7 cells transfected 
with PeGFP NMMIIA and PeCFP S100A4 WT.  Cos 7 cells were seeded in 60mm petri dishes 24 
hours prior to transfection procedure. The cells were washed and fresh medium without 
antibiotics were added into each dish 4 hours prior to adding transfection mixture containing 
either PeGFP C3, PeGFP NMMIIA, PeCFP C1 or PeCFP S100A4 WT with Jetpei.   Cells were left to 
incubate for 48 hours before harvesting.  Total proteins for all four cell lines were quantified and 
equal amount of total protein (80µg) loaded onto 8% (v/v) (for NMMIIA blot) and 10% (v/v) (for 
S100A4 and eEF1A1 blot) SDS Page gels.  Resolved proteins were transferred onto nitrocellulose 
membrane before incubating with primary antibody followed by secondary antibody and finally, 
detection with customised detection system (Table 2.12).  Image shown are representative data 
obtained from 3 independent experiments.  Methods are fully detailed in Chapter 2.2.17 to 2.2.20.   
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4.2.7  Restoration of NMMIIA in Cos 7 cells results in impediment of cell motility and reversible 
effects obtained using NMMII inhibitors 
From the previous sections, we have shown that treatments of Rama 37 cells with 
blebbistatin or Y-27632 resulted in improvement of migration whether or not S100A4 is 
overexpressed.  Here, to show that the changes in phenotype were purely caused by NMMIIA 
introduction in Cos 7 cells, we used myosin inhibitors (blebbistatin and Y-27632) to reinstate its 
original phenotype. 
 
4.3.7.1  Rescue of NMMIIA reduces Cos 7 cells migration 
Cos 7 cells transfected with either control plasmid (PeGFP C3) or PeGFP NMMIIA 
expressing plasmid were succumbed to wound healing assay using CellIQ system.  Wound healing 
images were continuously taken up to 18 hours for data analysis (Figure 4.2.14 A).  Quantification 
of wound closure 18 hours post scratching shows that Cos 7 cells transfected with PeGFP NMMIIA 
has significantly lower percentage of wound closure (23.5 ± 4.5 %) compared to those transfected 
with control plasmid, PeGFP C3 (43.0 ± 7.1 %, P <  0.001)(Figure 4.2.14 B). 
 
Page | 159  
 
 
Figure 4.2.14  Rescue of NMMIIA in Cos 7 reduces migration.  Cos 7 cells were seeded into 24 well 
plates and left to incubate for 24 hours.  Cells were washed and fresh medium without antibiotics 
were added into each well 4 hours prior to adding transfection mixture containing either PeGFP 
C3, PeGFP NMMIIA, PeCFP C1 or PeCFP S100A4 WT with Jetpei.  After 48 hours, the confluent 
monolayers of cells were scratched.  The plates were then place in CellIQ machine to run until the 
gap closes and the raw data were analysed with CellIQ Analyser software.  A) Representative time-
laspe images of Cos 7 cells scratch assays immediately after the scratches had been made and 
then after 18 hours. Scale bar = 200μm.  B) Percentage of wound closure after 18 hours post 
scratching were calculated and plotted as above.  Data shown are mean values ± s.e. of 3 regions 
of triplicates and a representative data from 3 independent experiments.  Student t-Tests were 
done by comparing the treated samples to untreated controls.  * p< 0.05, ** p < 0.01, *** p < 
0.001.  Methods are fully detailed in 2.2.4. 
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4.2.7.2 Treatment with either blebbistatin or Y-27632 restore migrational ability of NMMIIA 
expressing Cos 7 cells 
To verify the specificity of blebbistatin and Y-27632, Cos 7 cells transfected with either 
PeGFP C3 control plasmid or PeGFP NMMIIA plasmid were treated with 25 µM of blebbistatin or 
50 µM of Y-27632.  Acceleration of Cos 7 PeGFP NMMIIA cells were observed after treatment with 
blebbistatin or Y-27632 (Figure 4.2.15).  Quantification of time-lapsed images of Cos 7 PeGFP C3 
showed insignificant changes in wound healing either treated with blebbistatin, Y-27632 or 
untreated (91.8 ± 3.2 %, 79.0 ± 15.3 % and 85.3 ± 8.8 %; P = 0.055 and P = 0.207 respectively when 
compared to untreated control).  However, when Cos 7 PeGFP NMMIIA cells were treated with 
blebbistatin or Y-27632, enhancement of percentage of wound closure is observed (69.7 ± 8.7 %, P 
= 0.010 and 76.9 ± 8.4 %, P < 0.001 respectively) (Figure 4.2.15).   
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Figure 4.2.15  Inhibition of NMMIIA in Cos 7 PeGFP NMMIIA restored its original phenotype.  Cos 
7 cells were seeded into 24 well plates and left to incubate for 24 hours.  Cells were washed and 
fresh medium without antibiotics were added into each well 4 hours prior to adding transfection 
mixture containing either PeGFP C3 or PeGFP NMMIIA with Jetpei.  After 48 hours, the confluent 
monolayer of cells was scratched, washed and fresh medium containing 0.6mg/ml G418 either 
with or without addition of blebbistatin or Y-27632 was added.  The plates were then place in 
CellIQ machine to run until the gap closes and the raw data were analysed with CellIQ Analyser 
software.  A) Representative time-laspe images of Cos 7 cells scratch assays immediately after the 
scratches had been made and then after 18 hours. Scale bar = 200μm.  B) Percentage of wound 
closure after 18 hours post scratching were calculated and plotted as above.  Data shown are 
mean values ± s.e. of 3 regions of triplicates and a representative data from 3 independent 
experiments.  Student t-Tests were done by comparing the treated samples to untreated controls.  
* p< 0.05, ** p < 0.01, *** p < 0.001.  Methods are fully detailed in Chapter 2.2.4. 
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4.2.7.3 Inhibitory effect of blebbistatin or Y-27632 resulted in reduction of paxillin clusters and 
ventral stress fibers 
To verify the restoration of migrational ability after treatment with NMMII inhibitors is 
related to number of focal adhesions (paxillin) and reorganisation of actin cytoskeleton, 
immunofluorescence staining were done on Cos 7 cells treated with either blebbistatin or Y-
27632.  In Cos 7 PeGFP C3 cells, no significant difference was observed in localisation of plasmid 
fused with GFP and stress fibers were still visible (Figure 4.2.16 A – A’ and B – B’).  On the other 
hand, drastic changes were observed in Cos 7 PeGFP NMMIIA treated with blebbistatin.  Inhibitory 
effect of blebbistatin on NMMIIA localisation was clearly noticeable as cells acquired polarised 
morphology with speckles of NMMIIA dispersed throughout the cell cytoplasm and loss of actin 
arcs were observed in blebbistatin treated Cos 7 PeGFP NMMIIA (Figure 4.2.16 C – C’ and D – D’).  
Immunofluorescence staining of paxillin demonstrated that inhibition of NMMIIA expressed in Cos 
7 transfectants resulted in reduction of paxillin clusters along with ventral stress fibers when 
compared to its untreated control (Figure 4.2.17).   
Inhibitory effect of Y-27632 produced similar effect as observed blebbistatin-treated Cos 7 
cells.  Y-27632 has no significant effect on the morphology of Cos 7 PeGFP C3 cells.  However, in Y-
27632 treated-Cos 7 PeGFP NMMIIA cells, reduction of paxillin clusters (Figure 4.2.19 C – C’ and D 
– D’) were observed along with disassembly of NMMIIA and dissolution of actin filaments (Figure 
4.2.18 C – C’ and D – D’).   
All these modifications in cells were consistent with the alteration of wound healing 
properties, suggesting that there may be a strong correlation between cell migration, focal 
adhesions and NMMIIA assisted stress fibers.  
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Figure 4.2.16 Blebbistatin inhibition causes disassembly of NMMIIA localisation along actin 
stress fibers.  Cells were seeded onto coverslips pre-coated with fibronectin and left for 24 hours.  
Fresh medium were added 4 hours prior to adding transfection mixture (either PeGFP C3 or PeGFP 
NMMIIA with Jetpei).  After 48 hours and 4 hours prior to fixing, 25 µM of blebbistatin were added 
into respective wells.  The treated cells were fixed, blocked, incubate with phalloidin washed and 
mounted with DAPI before viewing with confocal microscope. Cos 7 cells transfected with PeGFP 
C3 under untreated condition were labeled as A - A’ whereas blebbistatin treated were labeled as 
B – B’.  Untreated Cos 7 cells transfected with PeGFP NMMIIA were labeled as C – C’ and those 
treated with blebbistatin were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused 
regions of the cell. Scale bar = 25μm. Images displayed for each cell line were representative 
image obtained from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.17 Blebbistatin inhibition causes reduction of paxillin clusters in NMMIIA transfected 
Cos 7 cells.  Cells were seeded and transfected as described in figure 4.2.15 but stained for paxillin.  
Cos 7 cells transfected with control vector, PeGFP C3 under untreated condition were labeled as A 
- A’ whereas blebbistatin treated were labeled as B – B’.  Untreated Cos 7 cells transfected with 
PeGFP NMMIIA were labeled as C – C’ and those treated with blebbistatin were labeled as D – D’.  
Panels A’, B’, C’ and D’ correspond to focused regions of the cell. Scale bar = 25μm. Images 
displayed for each cell line were representative image obtained from 3 independent experiments. 
Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.18  Y-27632 inhibition disassembly of NMMIIA along actin stress fibers in Cos 7 cells 
transfected with NMMIIA.  Cells were seeded, transfected and treated (with 50 µM Y-27632 
instead of blebbistatin) as described in figure 4.2.15. Cos 7 cells transfected with control vector, 
PeGFP C3 under untreated condition were labeled as A - A’ whereas Y-27632 treated were labeled 
as B – B’.  Untreated Cos 7 cells transfected with PeGFP NMMIIA were labeled as C – C’ and those 
treated with Y-27632 were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused 
regions of the cell. Scale bar = 25μm. Images displayed for each cell line were representative 
image obtained from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Figure 4.2.19  Y-27632 inhibition resulted in reduction of paxillin clusters in Cos 7 cells 
transfected with NMMIIA.  Cells were seeded, transfected and treated (with 50 µM Y-27632 
instead of blebbistatin) as described in figure 4.2.15 but stained for paxillin. Cos 7 cells transfected 
with control vector, PeGFP C3 under untreated condition were labeled as A - A’ whereas Y-27632 
treated were labeled as B – B’.  Untreated Cos 7 cells transfected with PeGFP NMMIIA were 
labeled as C – C’ and those treated with Y-27632were labeled as D – D’.  Panels A’, B’, C’ and D’ 
correspond to focused regions of the cell. Scale bar = 25μm. Images displayed for each cell line 
were representative image obtained from 3 independent experiments. Methods are fully detailed 
in Chapter 2.2.8. 
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4.2.8 Introduction of S100A4 enhance migration  
In this section, Cos 7 cells naturally lacked of NMMIIA were transfected with plasmid 
encoding the fusion protein S100A4 WT-CFP to demonstrate the effect of S100A4 protein 
independent on NMMIIA existence.   
Wound healing images at 0 hours and 18 hours post scratching depicted in Figure 4.2.20 A 
showed that PeCFP S100A4 WT expressing cells were more motile.  Quantified data corresponding 
to the images were portrayed as histogram in Figure 4.2.20 B.  Cos 7 cells expressing empty vector 
PeCFP C1 had significantly lower wound closure percentage (36.4 ± 9.7 %) as opposed to those 
expressing PeCFP S100A4 WT plasmids (65.9 ± 15.0 %, P <0.0001).  Also, it was found that Cos 7 
cells transfected with control plasmids (PeGFP C3 and PeGFP C1) showed similar percentage of 
wound closure after 18 hours (P = 0.157) whereas PeGFP NMMIIA expressing cells exhibited 
significantly lower percentage of wound closure (P < 0.001)(Figure 4.2.14 and Figure 4.2.20).  From 
this, it was demonstrated there is a possibility where S100A4 protein orchestrated cell motility 
independently of NMMIIA protein. 
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Figure 4.2.20  Introduction of S100A4 enhance migration.  Cos 7 cells were seeded and 
transfected as described in figure 4.2.14.  The plates were then place in CellIQ machine to run until 
the gap closes and the raw data were analysed with CellIQ Analyser software.  A) Representative 
time lapse images of Cos 7 cells scratch assays immediately after the scratches had been made and 
then after 18 hours. Scale bar = 200μm.  B) Percentage of wound closure after 18 hours post 
scratching were calculated and plotted as above.  Data shown are mean values ± s.e. of 3 regions 
of triplicates and a representative data from 3 independent experiments.  Student t-Tests were 
done by comparing the treated samples to untreated controls.  * p< 0.05, ** p < 0.01, *** p < 
0.001.  Methods are fully detailed in Chapter 2.2.4. 
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4.2.9 Opposing focal adhesions affect of NMMIIA and S100A4 in Cos 7 cells 
Since restoration of NMMIIA protein or introduction of S100A4 protein into Cos 7 cells 
caused significant effect on migration via wound healing assay, we sought to investigate these 
effect on actin cytoskeleton and focal adhesion using immunofluorescence assay.   
In Cos 7 PeGFP C3 and PeCFP C1 cells, it was observed that stress fibers were found across 
the cytoplasm of the cells and the GFP/CFP plasmid were localised throughout the cytoplasm, 
concentrated within the nucleus (Figure 4.2.21 A –A’ and C – C’).  When NMMIIA was restored, it 
was observed that NMMIIA were found colocalised along the actin stress fibers (Figure 4.2.21 B – 
B’).  Cos 7 cells transfected with S100A4 WT-CFP acquired polarised morphology with actin arcs 
localised around the periphery (Figure 4.2.21 D – D’).  Also, it was observed that S100A4 WT-CFP 
were localised throughout the cytoplasm, concentrating at the nucleus and at the edge of the cell 
cytoplasmic membrane.   
Next, we proceeded to investigate if there are any modifications on focal adhesions by 
conducting immunofluorescence staining for paxillin.  It was found that in Cos 7 cells transfected 
with control vectors, PeGFP C3 and PeCFP C1, some paxillin clusters were found around the 
periphery of the cells where the dorsal stress fibers were located (Figure 4.2.22 A – A’ and C – C’).  
Also, the control vector transfected cells appeared to have more wide spread cytoplasm.  In cells 
transfected with PeGFP NMMIIA, there is a significant increase of paxillin clusters with prominent 
appearance of dorsal and ventral stress fibers (Figure 4.2.22 B – B’).   On the other hand, the Cos 7 
cells transfected with PeCFP S100A4 WT has some paxillin clusters within the nucleus and also at 
the edge of the cytoplasm membrane (Figure 4.2.22 D – D’).  Also, Cos 7 cell expressing S100A4 
WT protein acquired polarised morphology which has not been exhibited by the rest of the cells.  
Quantification of paxillin clusters of the respective transfected Cos 7 cells, demonstrated that Cos 
7 cells that expressed NMMIIA protein showed the higher paxillin clusters (25.4 ± 3.9) when 
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compared to its control counterpart, Cos 7 PeGFP C3 (13.2 ± 2.5, P < 0.001) (Table 4.2.2).  
Conversely, Cos 7 cells expressing S100A4 WT protein demonstrated significant decrease of 
number of paxillin clusters when compared to its control, PeCFP C1 (1.0 ± 1.6 and 14.5 ± 3.4 
respectively, P < 0.001).  The student t-Test done on the both controls showed that there were no 
significant difference in paxillin clusters (P = 0.344) whereas the comparison between Cos 7 PeGFP 
NMMIIA and Cos 7 PeCFP S100A4 WT demonstrated significant difference (P < 0.001) (Table 4.2.2). 
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Figure 4.2.21 Restoration of NMMIIA in Cos 7 cells leads to increment of stress fibers whereas 
introduction of S100A4 resulted in polarisation.  Cells were seeded, transfected and stained as 
described in figure 4.2.14 but without any inhibitor treatment. Cos 7 cells transfected with control 
vector, PeGFP C3 were labeled as A - A’ whereas PeGFP NMMIIA transfected cells were labeled as 
B – B’.  Cos 7 cells transfected with control for PeCFP S100A4 (PeCFP C1) were labeled as C – C’ and 
those transfected with PeCFP S100A4 WT were labeled as D – D’.  Panels A’, B’, C’ and D’ 
correspond to focused regions of the cell. Scale bar = 25μm. Images displayed for each cell line 
were representative image obtained from 3 independent experiments. Methods are fully detailed 
in Chapter 2.2.8. 
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Figure 4.2.22 Introduction of S100A4 protein into Cos 7 cells leads to polarisation while 
significant increase of paxillin clusters were observed in NMMIIA expressing Cos 7 cells.  Cells 
were seeded and transfected as described in figure 4.2.14 but without any inhibitor treatment and 
stained for paxillin. Cos 7 cells transfected with control vector, PeGFP C3 were labeled as A - A’ 
whereas PeGFP NMMIIA transfected cells were labeled as B – B’.  Cos 7 cells transfected with 
control for PeCFP S100A4 (PeCFP C1) were labeled as C – C’ and those transfected with PeCFP 
S100A4 WT were labeled as D – D’.  Panels A’, B’, C’ and D’ correspond to focused regions of the 
cell. Scale bar = 25μm. Images displayed for each cell line were representative image obtained 
from 3 independent experiments. Methods are fully detailed in Chapter 2.2.8. 
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Cos 7 cells 
Number of focal adhesions 
(paxillin) per cell ± s.e. (n=10) 
P-valuea P-valueb 
PeGFP C3 Plasmid  13.2 ± 2.5 
  PeGFP NMMIIA Plasmid 25.4 ± 3.9 3.64786E-08 
 PeCFP C1 Plasmid  14.5 ± 3.4 
  PeCFP S100A4 WT Plasmid  1 ± 1.6 7.94897E-11 4.07187E-13 
Table 4.2.2  Introduction of NMMIIA and S100A4 into Cos 7 cells causes opposing effect on focal 
adhesion clusters.   Images for quantification were obtained as described in figure 4.2.21 and 
random images were selected and quantified manually by counting the number of clusters 
localised at the periphery of each cell.  Results are mean values ± s.e. from 3 independent 
experiments (n=10).  
a P-value obtain  from Student  t-Test where number of paxillin clusters quantified in Cos 7 PeGFP 
NMMIIA and Cos 7 PeCFP S100A4 WT were compared to their respective controls (Cos 7 PeGFP C3 
and Cos 7 PeCFP S100A4 WT). 
b P-value obtain  from Student  t-Test where number of paxillin clusters quantified in Cos 7 PeGFP 
NMMIIA were compared to Cos 7 PeCFP S100A4 WT. 
Methods are fully detailed in Chapter 2.2.10. 
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4.3  Discussion 
In depth studies has been conducted to demonstrate the roles of actin and NMMIIA in cell 
migration.  It is generally accepted that the dynamic process of polymerisation and 
depolymerisation of actin is the critical steps in persistence of directive cell migration.  Here, we 
focus on two protrusion structures results from polymerisation of actin at periphery of the cells; 
(1) lamellipodial actin network where Arp 2/3 complex mediating branching of actin filament; or 
(2) filopodial (lateral extension) or microvillus (dorsal extension) projections where Formin 
homology mediate monomeric polymerisation of linear F-actin (Pellegrin and Mellor, 2007, Olson 
and Sahai, 2009).   
In the Rama 37 cell model used in this study, the control cells exhibited higher stress fibers 
along with focal adhesions clusters (paxillin), but lower wound healing properties whereas the 
S100A4 expressing cells were found to be more motile with low levels of focal adhesion clusters.  
As numerous studies had demonstrated the ability of S100A4 to interact with and disassemble 
NMMIIA, loss of dorsal stress fibers observed in the R37 S100A4 WT cell line may be a 
consequence of this interaction.  Actin monomers are polymerised by actin-crosslinking proteins 
such as α-actinin, fascin, espin and filamin into linear polymerised structure known as actin 
filaments (Chen et al., 1999, Wang et al., 1975, Lazarides and Burridge, 1975).  Around 10 to 30 of 
these linear actin filaments bundled alternatingly by NMMIIA and α-actinin into stress fibers.  
Upon phosphorylation, NMMIIA changes its conformation which resulted in acto-myosin 
contractility (Hotulainen and Lappalainen, 2006).  Although this contraction is needed for 
migration, higher stress fibers are often associated with stationary cells and stress fibers are not 
required in migration (Deguchi and Sato, 2009, Burridge, 1981, Hall and Nobes, 2000).  Here, we 
further strengthen this observation where the less motile cells exhibited thicker and more 
organised stress fibers across the cytoplasm (Rama 37 control cells when compared to R37 S100A4 
Page | 175  
 
WT cells and untreated cells to blebbistatin/Y-27632-treated Rama 37/ Cos 7 cells) (Figure 4.2.3, 
4.2.6, 4.2.7, 4.2.14, 4.2.15, 4.2.19 and 4.2.20). 
The treatment of Rama 37 control cells with blebbistatin or Y-27632 resulted in the Rama 
37 control cell line acquiring similar phenotype as those expressing S100A4 proteins; such as loss 
of focal adhesions and stress fibers, increase of cell migration and long trailing ends morphology.  
Interestingly, increment of filopodia around the cells after Y-27632 treatment was not observed in 
blebbistatin treated cells (Figure 4.2.5 and 4.2.4 respectively).  The increase of filopodia is 
consistent with other studies demonstrating the specificity roles of RhoA, Cdc42 and Rac.  It was 
shown that RhoA is specific for formation of stress fibers and focal adhesion, Cdc42 regulates the 
formation of filopodia whereas Rac induces the formation of lamellipodia and membrane ruffles 
(Nobes and Hall, 1995, Hall, 1998).  Since Y-27632 is specific for Rho kinase inhibition, it will only 
affect RhoA, but not Cdc42 or Rac, thus, the increase of filopodia in this case further demonstrate 
the specificity of Y-27632 inhibitory activity (Routhier et al., 2010, Chen et al., 2012, Wheeler and 
Ridley, 2004).   
However, when R37 S100A4 WT cells were treated with blebbistatin or Y-27632, further 
increment of wound healing properties was observed (Figure 4.2.3).  This enhancement was 
supported by the quantification of focal adhesion clusters where significant reduction was 
observed, along with loss of most existing transverse stress fibers when compared to the 
untreated controls (Figure 4.2.4).  These results proposed two possibilities; (1) S100A4 protein 
may have similar affect as blebbistatin and Y-27632 where the disassembly of NMMIIA by S100A4 
had not reached its saturation point in R37 S100A4 WT cells, hence addition of blebbistatin or Y-
27632 resulted in extreme disruption of NMMIIA; or (2) S100A4 acts synergistically with the 
inhibitors to promote migration where NMMIIA disassembly is a consequence of S100A4 direct/ 
indirect interactions with other signaling proteins such as CD44V6, E-cadherin, tissue inhibitor of 
Page | 176  
 
metalloproteinases 2 (TIMP-2) and matrix metalloproteinases (MMPs) (Lakshmi et al., 1997, Ma et 
al., 2010, Sherbet and Lakshmi, 1998, Zhang et al., 2011).   
S100A4 has been shown to cause relocalisation of CD44V6, an isoform of the CD44 cell-
surface glycoprotein which plays an important role in regulating cell-cell and cell-extracellular 
matrix adhesion.  It has been demonstrated that up-regulation of S100A4 in ML8 cell lines resulted 
in clustering of CD44V6 as opposed to uniform distribution in control cells, suggesting the 
possibility of S100A4 regulating localisation of CD44V6 to facilitate cell motility (Lakshmi et al., 
1997).  Recently, specificity of CD44V6 regulation on cell motility has been demonstrated using 
anti-CD44V6 monoclonal antibody where general anti-CD44s antibody resulted in inhibition of cell 
adhesion, motility and invasion indirectly suggesting the possibility of S100A4-induced motility 
could be CD44V6 related (Afify et al., 2009).  Besides, up-regulation of S100A4 were found to be 
inversely regulated with E-cadherin and TIMP2, a type 1 transmembrane protein which takes part 
in cell –cell adhesion and a natural inhibitor of MMPs, matricellular proteins important for matrix 
remodeling respectively.  As TIMP2 was found to be down-regulated in the presence of high level 
of S100A4, increased expressions of MMPs, a group of extracellular matrix degrading protein, 
were detected.  In another study, it has been demonstrated in a pull-down assay that S100A4 
binds to Receptor for Advanced Glycation Endproducts (RAGE) leading to increased expression of 
MMP13 in chondrocytes which led to speculations if S100A4-RAGE interaction is responsible for 
other MMPs regulations (Yammani et al., 2006).  Although the precise mechanisms of S100A4 
regulating the expression of these proteins remained to be solved, these direct/indirect 
interactions highlighted the possibility of S100A4-induced motility may not be NMMIIA-specific. 
In the immunofluorescence staining of actin in untreated R37 S100A4 WT cells, transverse 
arcs were still visible but dorsal and most ventral stress fibers were inhibited.  It has been 
suggested that loss of focal adhesions causes disappearance of dorsal stress fibers as dorsal stress 
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fibers are formed from focal adhesion (Burridge and Wittchen, 2013, Tojkander et al., 2012).  This 
observation indicated the possibility of S100A4 either capable of directly or indirectly inhibit focal 
adhesions, resulting in loss of dorsal stress fibers but leaving transverse arcs intact as arcs 
formation in strictly dependent on NMMII activity (Hotulainen and Lappalainen, 2006).  In the 
experiment conducted with Cos 7 cells, it was observed that transverse arcs were still perceptible 
even in the cells overexpressing S100A4-CFP fusion protein.  However, its focal adhesion clusters 
were significantly lower than Cos 7 cells that either expresses NMMIIA-GFP fusion protein or its 
control which devoid of NMMIIA.  These observations proposed that S100A4 may have higher 
affinity to other signaling proteins which directly or indirectly involved in focal adhesion formation 
rather than NMMIIB.   
Wound healing experiment with Cos 7 cells transfected with plasmid encoding the fusion 
protein S100A4-CFP demonstrated that S100A4 protein was capable of enhancing migration 
independent of NMMIIA.  Although NMMIIB is present in Cos 7 cells and S100A4 has been 
demonstrated to bind to NMMIIB at lower affinity than NMMIIA, its wound healing roles could be 
disregarded as studies has demonstrated that, in NMMIIB-null embryonic stem (ES) cells, there 
was no increment in cell migration whereas in the same study, NMMIIA-null ES cells resulted in 
enhancement of cell migration (Even-Ram et al., 2007).  Also, in the same study, it was shown that 
long trailing ends were observed in NMMIIA-depleted cells and this observation is consistent with 
the morphology observed in our NMMIIA-depleted Rama 37 control cells (Figure 4.3.10 and 
4.2.11).  Similar morphology was observed in immunostaining when either Cos 7 or Rama 37 cells 
when treated with blebbistatin or Y-27632 inhibitor (Figure 4.2.15, 4.2.16, 4.2.17 and 4.2.18).   It 
has been demonstrated that Y-27632, a Rho kinase inhibitor, prevents Rho-GTPase from 
interacting with the COOH terminal of coiled-coil domain of Rho kinase which resulted in 
deactivation of the phosphotransferase activity of Rho kinase and ultimately preventing signaling 
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of RhoA to Rho kinase to regulates the retraction of migrating monocytes which was depicted by 
the long trailing ends of our Y-27632-treated cell system (Worthylake and Burridge, 2003). Also, in 
Y-27632 treated cells, it was observed that the stress fibers localised at the center of the cells were 
affected, but stress fibers at the periphery of the cells were less affected which demonstrated the 
roles of Rho kinase in maintaining stress fibers and focal adhesions at the central of the cells 
(Katoh et al., 2001a, Katoh et al., 2001b, Totsukawa et al., 2000).  Moreover, it was observed that 
in either blebbistatin or Y-27632 treated cells (Cos 7 or Rama 37 cells), significant reduction of 
focal adhesions were observed and pieces of motile cytoplasm were found (determined by no 
staining of nucleus with DAPI) which demonstrate the incapability of NMMII to retract its tail and 
acceleration of cells causes the pieces of motile cytoplasm to be left behind as cell  migrate (Lo et 
al., 2004).   
Fascinatingly, in R37 S100A4 WT cells, knockdown of NMMIIA did not result in increase of 
cell migration, instead, inhibition of cell migration was observed.  Although there was a decrease 
in wound healing properties in NMMIIA-depleted R37 S100A4 WT cells, its overall motility was still 
higher than both NMMIIA-depleted Rama 37 control cells and Rama 37 control cells (+ NMMIIA).  
This showed that in extinction of NMMIIA, S100A4 still retained its ability to promote motility 
although not as efficient.  This observation proposed that functionality of S100A4 is not dependent 
on NMMIIA, but availability of NMMIIA increased its potential to enhance cell motility.  Studies 
have shown that deprivation of NMMIIA (as observed in NMMIIA knockdown Rama 37 cells 
system) resulted in destabilisation of microtubules at the edge of the cells and functional 
polymerised microtubules were associated with increase of velocity which is consistent with the 
trend observed with the exception of NMMIIA-knockdown R37 S100A4 WT cells where reduction 
of migration were observed (Even-Ram et al., 2007, Shutova et al., 2012).  In the same studies, it 
was shown that blebbistatin treatments mimicked this destabilisation to enhance migration which 
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is also observed in the blebbistatin-treated cells in our experiments proposing that blebbistatin 
may be aiding S100A4 to enhance migration by localising NMMIIA monomer to close proximity 
with actin located at the leading edge as the actin binding affinity of blebbistatin-contricted 
NMMIIA monomer was not affected (Goeckeler et al., 2008). 
It has been shown that inhibition of NMMIIA by blebbistatin resulted in enrichment of 
monomeric, MRLC phosphorylated form (pre-powerstroke state) of NMMIIA at the cell periphery 
but polymerisation was inhibited despite the ongoing MRLC phosphorylation where this 
conformation prevented it association but not binding affinity with actin filament (Takács et al., 
2010, Goeckeler et al., 2008, Shutova et al., 2012).  It was suggested that this unpolymerised but 
activated NMMIIA which initiates focal contacts should be a dominant but transient population in 
lamellipodia (Shutova et al., 2012).  This study was supported by the findings that when cells are 
microinjected with a proteolytic fragment of myosin II containing the full motor head (HMM), but 
lacking the most of the rod-like tail and incapable of filament formation, the edge of cytoplasm of 
the cells were enriched with the HMM but little or no NMMIIA were present and this smaller 
fragment could localise to the leading edge of the cells more rapidly than the full length NMMIIA 
(Kolega, 2006).  From this, it is likely that that disassembly of NMMIIA by blebbistatin resulted in 
more efficient localisation of NMMIIA to the leading edge to assist S100A4 to enhance migration.  
However, when NMMIIA level was depleted through SiRNA of R37 S100A4 WT cells, this assistance 
could be disrupted, resulted in less efficient migration. 
As our data shown that both S100A4 overexpressing and non overexpressing cells 
exhibited enhanced migration after blebbistatin treatment, this may possibly suggests that 
S100A4-induced migration is independent of NMMIIA. This hypothesis is supported by the 
experiment using Cos 7 PeCFP S100A4 WT cells where improvement of cell migration in the 
absence of NMMIIA and further reduction of focal adhesions was demonstrated when compared 
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to Cos 7 PeCFP C1 control or Cos 7 PeGFP NMMIIA.  This further reduction of focal adhesion via 
S100A4 overexpression suggested that S100A4 may be interacting with other target proteins to 
maneuver cell motility through reducing focal adhesion formations.    
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5.1 Introduction   
 
High throughput screening (HTS) is a process of screening and assaying a large number of 
effectors against specific target to accelerate drug discovery, especially in pharmaceutical 
industries.  Effectors are usually chemical compounds whereas targets are usually cell membrane 
receptors which make up the largest group (45%), enzymes (28%), hormones (11%), unknowns 
(7%), ion channels (5%), nuclear receptors (2%), and finally target DNA (2%)(Martis et al., 2011). 
HTS assays are categorised into 3 broad ranges; 1) biochemical assays, 2) ion-channel 
assays and 3) cell-based assay.  In this report, we concentrate on cell-based assay which is further 
classified into 4 categories; 1) second messenger assay, 2) reporter gene assay, 3) cell proliferation 
assay, and 4) high content screening (HCS) (Hertzberg and Pope, 2000), or in our case, high 
content imaging (HCI) assay (sub category of HCS), where epifluorescence or light imaging 
platforms, combined with image analysis logarithms is utilised.  In HCI assay, cells are bombarded 
with variety of chemical compounds and any phenotypic effects are captured.  Effects that can be 
observed through this assay include cell cycle status, cell differentiation, nuclear and cell 
morphology, angiogenesis, metastasis  and cell movement (Szymański et al., 2011, Yarrow et al., 
2004).   
As a rule of thumb, only 1% of the compounds tested in preliminary screening HTS will 
demonstrate antagonistic or agonistic effects which are referred to as ‘hits’.  Then, the hits will be 
validated again for reproducibility in secondary screening in which reproducible hits will be 
selected for optimisation.  After optimisation of chemical compound concentration, modification 
will be done on the compound so that it is safe for human use.  Modified chemical compound will 
then proceed to be tested in animal models for safety and effectiveness and finally to be tested in 
human.   
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 Here, we concentrate on cell movement-based HCI assay where pre-treated monolayer of 
cell is wounded and the wound healing process is observed by taking time-lapse images over a 
specific period of time or until wound has completely healed.  Depending on software, data such 
as migrational video, wound healing rate, mitotic index, cell polarisation, and matrix remodeling 
can be analysed.  Screening of effects of drug-like compounds on wound healing has been 
successfully demonstrated with different effects such as inhibiting migration, affecting 
morphology, blocking completion of mitosis, and disrupting the cell monolayer has been observed 
through this assay (Yarrow et al., 2004). 
  As mentioned earlier, HTS assay requires effector against specific targets and here, the 
effectors used are numerous chemical compounds whereas the specific target is the S100A4 
protein.  In vivo studies have shown that the elevated expression of S100 proteins correlates with 
cancer progression and metastatic properties (Davies et al., 1994, Andersen et al., 2011, Andersen 
et al., 2004, Cabezón et al., 2007).  In particular, the S100A4 protein which has been highlighted as 
metastatic promoter and regarded as potent marker for breast cancer prognosis where patient’s 
mortality correlates with its elevation (Ismail et al., 2008a, Boye and Mælandsmo, 2010, Rudland 
et al., 2000).  Recently, niclosamide, a drug initially developed to treat tapeworm infection, has 
been found to be effective against colon cancer via blocking the expression of S100A4 via reducing 
its mRNA expression (Sack et al., 2011, Helfman, 2011). Similarly, an anti-S100A4 blocking 
antibody has been found to suppress metastasis in mice lungs by binding to its recognition site 
which overlapped the target binding interface of S100A4 (Klingelhofer et al., 2012).  Besides, in 
another study, a compound known as phenothiazines has been found to disrupt S100A4-NMMIIA 
interaction by inducing oligomerisation of S100A4 (Malashkevich et al., 2010).  Therefore, using 
Rama 37 control and Rama 37 S100A4 WT cell lines combined with HCI-cell movement based-
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assay, various chemical compounds were tested for their ability to affect S100A4-induced 
migration through wound healing assay to provide more insight of  the protein activity.  
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5.2 Results 
5.2.1 Preliminary screening of drugs effect on S100A4 with regards to wound healing 
In collaboration with the Medical Research Council Technology, UK, more than 1400 
different chemical compounds solubilised in 100% dimethyl sulfoxide (DMSO) were supplied to 
conduct initial screen.  Before bombarding the Rama 37 cell lines with various chemical 
compounds, the effect of DMSO on cells viability were evaluated to establish the inhibitory 
prospects of the vehicle solution.  This optimisation determined that the working concentration is 
5 µM per compound which accounts for 0.5% of DMSO.  
 In the primary screen, different effects on wound healing and cell behaviour were 
observed (Figure 5.2.1).  The wound healing curves obtained in each 24 well plate were compared 
to their respective controls in the plate.  First, the migrational curves of untreated R37 S100A4 WT 
cells were compared to those of the untreated Rama 37 control cells.  The steeper curves 
displayed by untreated R37 S100A4 WT cells, indicate shorter time for wound closure.  After 
comparing the untreated controls, the curves obtained from compound-treated R37 S100A4 WT 
cells were compared to the untreated counterparts (Figure 5.2.1 A).  The effects observed were 
grouped into; slowing of migration, causing cell death, inhibition of migration, acceleration of 
migration and delayed of compound activity (Figure 5.2.1 B).   
Out of all the chemical compounds screened, 30 hits were obtained (Table 5.2.1).  These 
hits were classified into four groups; A) slowing migration, B) causing cell death, C) inhibiting 
migration, and D) accelerating migration.  Chemical compounds that have delayed activity were 
classed into appropriate groups by observing the steepness of the curve after exerting its effects.  
It was observed that 19 of the chemical compounds slowed wound healing process (63.4 %), 4 
compounds inhibit wound healing without causing cell death (13.3 %), 6 compounds caused cell 
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death (20.0 %) and finally, only one compound accelerates wound healing (3.3 %).  Mefloquine, 
the only compound that accelerates wound healing, has no cross therapeutic properties when 
compared to the rest of the 29 hits.  For the rest of the compounds, cross-therapeutic properties 
were observed between the 3 different groups.  Compounds that have antibacterial property were 
shared among the groups that slow and inhibit migration, but not observed in the group that 
causes cell death whereas anti-inflammatory property were shared among the three groups.  In 
the group where the compound causes cell death, pomiferin is the only compound that has 
antioxidant properties.  
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Figure 5.2.1 Preliminary screening showing different effects of chemical compounds on S100A4 
protein through wound healing.  Rama 37 cells (150,000 and 200,000 for Rama 37 control cells 
and R37 S100A4 WT cells respectively) were seeded in 24 well plate (as described in Figure 2.2.4) 
48 hours prior to scratching and addition of 5 µM compound.  The process of wound healing was 
monitored by time-lapse imaging using CellIQ machine for 16 hours.  The images were then 
analysed with CellIQ Analyser Software to obtain the curve table as shown.  The different curves 
obtained were divided into different catergories.  A) Untreated controls are seeded in Column 1 
whereas different chemical compounds were added in Column 2 - 6.  B) Different wound healing 
effects caused by various chemical compounds were observed.  Data shown is a representative 
image from the preliminary screen.  Method is fully detailed in Chapter 2.2.4. 
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COMPOUND THERAPEUTIC PROPERTIES 
SLOWING MIGRATION GROUP 
CETYLPYRIDINIUM CHLORIDE antiinfective (topical) 
ANTIPYRINE analgesic 
APOMORPHINE HYDROCHLORIDE emetic 
CAFFEINE CNS stimulant 
ORPHENADRINE CITRATE muscle relaxant (skeletal), antihistaminic 
OXYBENZONE ultraviolet screen 
PHENINDIONE Anticoagulant 
NOVOBIOCIN SODIUM Antibacterial 
OXYTETRACYCLINE Antibacterial 
1S,2R-PHENYLPROPANOLAMINE 
HYDROCHLORIDE decongestant, anorexic 
NYLIDRIN HYDROCHLORIDE vasodilator (peripheral) 
PARACHLOROPHENOL topical antibacterial (topical) 
PHYSOSTIGMINE SALICYLATE cholinergic, anticholinesterase, miotic 
SALICYL ALCOHOL anesthetic (local), antiinflammatory 
TRIMEPRAZINE TARTRATE Antipruritic 
THIOGUANINE antineoplastic, purine antimetabolite 
PROTOVERATRINE B antihypertensive, emetic; LD50(mouse) 0.21 mg/kg sc 
3-AMINOPROPANESULPHONIC ACID antibacterial; GABA agonist 
NEROL weak estrogen receptor blocker 
CAUSING CELL DEATH GROUP 
COLCHICINE antimitotic, antigout agent 
SULOCTIDIL peripheral vasodilator 
CELASTROL antineoplastic, antiinflamatory, NO synthesis inhibitor, 
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chaperone stimulant 
GAMBOGIC ACID antiinflammatory, cytotoxic, inhibits HeLa cells in vitro 
AMOXAPINE antidepressant, inhibits norepinephrine uptake 
PIROXICAM antiinflammatory 
INHIBITING MIGRATION GROUP 
MEPENZOLATE BROMIDE Anticholinergic 
FENBUFEN antiinflammatory 
FENOFIBRATE antihyperlipidemic 
CEFTIBUTEN Antibacterial 
ACCELERATING MIGRATION GROUP 
MEFLOQUINE Antimalarial 
 
 
Table 5.2.1  Out of 30 hits, compounds that slow migration occupy the largest group, followed 
by causing cell death, inhibition of wound healing and accelerate wound healing.  Experiments 
were conducted as mentioned in figure 5.2.1 and different wound healing curves obtained 
through CellIQ Analyser Software were classified into respective groups. 
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5.2.2 Secondary screening to identify S100A4-specific cellular effects 
Whilst the initial screen had identified differences in wound healing properties, it 
remained to be demonstrated if such phenotypic where cell or protein specific.  We sought to 
establish the specificities of the compounds towards S100A4 protein.  Hence, in the follow on 
screen, the specificity of the drug to S100A4 protein was determined by treating both Rama 37 
control cells and R37 S100A4 cells with the same compound. 
Figure 5.2.2 demonstrated that wound healing based-HCI is capable of distinguishing the 
effects of compound on S100A4 expressing and non-expressing cells.  The Rama 37 control cells 
and R37 S100A4 WT cells, located adjacent to each other, were treated with the same compound 
and all the wound healing curves were compared to the untreated controls wells which were 
located in Row A, Column 1 – 4 (Figure 5.2.2 A).    For instance, in figure 5.2.2 A, it was observed 
that the particular compound has effect only on Rama 37 control cells (Row B, Column 3), but not 
on R37 S100A4 WT cells (Row B, Column 4).  Whereas in Row B Column 5 and 6 demonstrated that 
the compound affected both cell lines.  Through this HCI-based wound healing analysis, the 
specificity of the compound against S100A4 protein can be discriminated.  The distinctive curves 
were then classified into 3 groups as shown in figure 5.2.2 B; A) Affecting both cell lines B) 
Affecting only Rama 37 control cells and C) Affecting only R37 S100A4 WT cells, which only the 
latter is of interest as they correlates with the objectives of this chapter.   
From the wound healing curves obtained, the steepness of the curve is calculated as 
wound closure rate (µm2min-1) and grouped in Table 5.2.2 which highlighted a good reproducibility 
when comparing the two screens.  Since the specificity of the compound on S100A4 protein is of 
the main interest, those compounds that did not show any significant effect on wound healing 
properties of Rama 37 control cells but inhibit or slow down wound healing properties of cells 
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expressing S100A4 protein were selected for further analysis.  Out of the 30 compounds, only 9 
compounds met the requirement and were selected for tertiary screen.  These compounds were 
apomorphine hydrochloride, novobiocin sodium, 1S, 2R-phenylpropanolamine hydrochloride, 
nylidrin hydrochloride, parachlorophenol, salicyl alcohol, trimeprazine tartrate, protoveratrine b 
and 3-aminopropanesulphonic acid.  Mefloquine, the only compound that accelerates wound 
closure showed consistency in secondary screen, but the value obtained was not significant. 
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Figure 5.2.2  Specificity of compounds to S100A4 protein can be shown through wound healing 
based-HCI.  The secondary screen is conducted as mentioned in figure 5.2.1 and the layout of the 
plate is as shown in figure 2.2.5.  The different curves obtained were divided into different 
catergories.  A) Layout of 24 well plate as described in figure 2.2.4 showing wound closure curves.  
B) Different wound healing effects caused by various chemical compounds were observed.  Data 
shown is a representative image from the secondary screen. 
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SLOWING MIGRATION GROUP 
UNTREATED 
Rama 37 Control R37 S100A4 WT 
0.137 ± 0.02 0.213 ± 0.01 
COMPOUND (5µM) 
Wound closure 
rate (µm2min-1) 
P-value a 
Wound closure 
rate (µm2min-1) 
P-value b 
CETYLPYRIDINIUM CHLORIDE death 
 
0.059 ± 0.00 < 0.001 
ANTIPYRINE 0.121 ± 0.01 0.259 0.258 ± 0.04 0.128 
BUSULFAN 0.120 ± 0.02 0.300 0.154 ± 0.02 0.006 
APOMORPHINE HYDROCHLORIDE 0.171 ± 0.03 0.194 0.144 ± 0.03 0.013 
CAFFEINE 0.193 ± 0.04 0.077 0.250 ± 0.06 0.362 
PHENINDIONE 0.141 ± 0.02 0.771 0.186 ± 0.04 0.428 
NOVOBIOCIN SODIUM 0.120 ± 0.03 0.330 0.117 ± 0.01 0.015 
OXYTETRACYCLINE 0.132 ± 0.04 0.832 0.165 ± 0.04 0.186 
1S,2R-PHENYLPROPANOLAMINE 
HYDROCHLORIDE 
0.104 ± 0.02 0.062 0.126 ± 0.02 0.025 
NYLIDRIN HYDROCHLORIDE 0.135 ± 0.02 0.864 0.103 ± 0.03 0.016 
PARACHLOROPHENOL 0.153 ± 0.06 0.605 0.151 ± 0.03 0.086 
PHYSOSTIGMINE SALICYLATE 0.166 ± 0.01 0.004 0.183 ± 0.06 0.436 
SALICYL ALCOHOL 0.131 ± 0.01 0.631 0.097 ± 0.03 0.003 
TRIMEPRAZINE TARTRATE 0.148 ± 0.01 0.410 0.133 ± 0.01 0.001 
THIOGUANINE death 
 
0.080 ± 0.01 <0.001 
PROTOVERATRINE B 0.113 ± 0.02 0.148 0.141 ± 0.03 0.016 
3-AMINOPROPANESULPHONIC 
ACID 
0.157 ± 0.03 0.307 0.118 ± 0.02 0.002 
NEROL 0.283 ± 0.01 0.012 0.268 ± 0.06 0.176 
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CAUSING CELL DEATH GROUP 
UNTREATED 
Rama 37 Control R37 S100A4 WT 
0.137 ± 0.02 0.213 ± 0.01 
COMPOUND (5µM) 
Wound closure 
rate (µm2min-1) 
P-value a 
Wound closure 
rate (µm2min-1) 
P-value b 
COLCHICINE death 
 
death 
 
SULOCTIDIL <20 hours 
 
<20 hours 
 
CELASTROL death 
 
death 
 
GAMBOGIC ACID death 
 
death 
 
AMOXAPINE death 
 
death 
 
PIROXICAM death 
 
death 
 
 
 
INHIBIT MIGRATION GROUP 
UNTREATED 
Rama 37 Control R37 S100A4 WT 
0.137 ± 0.02 0.213 ± 0.01 
COMPOUND (5µM) 
Wound closure 
rate (µm2min-1) 
P-value a 
Wound closure 
rate (µm2min-1) 
P-value b 
MEPENZOLATE BROMIDE 0.141 ± 0.04 0.855 0.173 ± 0.06 0.316 
FENBUFEN 0.176 ± 0.02 0.053 0.180 ± 0.06 0.391 
FENOFIBRATE 0.185 ± 0.04 0.104 0.156 ± 0.06 0.143 
CEFTIBUTEN 0.145 ± 0.01 0.520 0.184 ± 0.02 0.066 
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ACCELERATING MIGRATION GROUP 
UNTREATED 
Rama 37 Control R37 S100A4 WT 
0.137 ± 0.02 0.213 ± 0.01 
COMPOUND (5µM) 
Wound closure 
rate (µm2min-1) 
P-value a 
Wound closure 
rate (µm2min-1) 
P-value b 
MEFLOQUINE 0.197 ± 0.02 0.028 0.229 ± 0.04 0.318 
Table 5.2.2  High reproducibility of primary screen result is achieved and detailed calculation of 
wound area closure rate correlates with the wound healing curves.  Experiment was conducted 
as mentioned in figure 5.2.1 and calculation of rate of wound area closure was as explained in 
Chapter 2.2.5.1.  The calculated rate for each compound were organised in its respective group as 
shown in Table 5.2.1.  Values obtained are mean ± s.e. from three different regions of the well in a 
single screen. 
P-valuea obtain from Student t-Test where the rate of wound area closure of treated Rama 37 
control cells were compared respectively to the untreated Rama 37 control cells. 
P-valueb obtain from Student t-Test where the rate of wound area closure of treated R37 S100A4 
WT were compared respectively to the untreated R37 S100A4 WT cells. 
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5.2.3 Tertiary screening determining reproducibility and specificity of compound to S100A4 
protein 
 In the tertiary screen, the effect on the wound healing observed in both Rama 37 cell lines 
by the compound tested has to be reproducible.  At the same time, the reproducible wound 
healing effect has to be specific to R37 S100A4 WT cells but not Rama 37 control cells so that the 
compound can be presumed to be explicitly targeting S100A4 protein, hence demonstrating the 
effect shown previously.  As mentioned before, from the secondary screen, only 9 compounds 
were selected for tertiary screen.  Out of the 9 compounds, 6 compounds did lower the rates of 
migration in R37 S100A4 WT cells, but the rates lowered were insignificant (Table 5.2.3).  
Interestingly, 3 compounds demonstrated high reproducibility and selectivity towards R37 S100A4 
WT cells while having no significant effect on Rama 37 control cells motility (Figure 5.2.3 A).   
 The three compounds narrowed down were; 1) apomorphine hydrochloride, 2) 1S, 2R-
phenylpropanolamine hydrochloride, and 3) nylidrin hydrochloride where they significantly inhibit 
migrational properties of R37 S100A4 WT cells (P = 0.033, P = 0.009, and P = 0.006 respectively), 
but not Rama 37 control cells (P = 0.084, P = 0.385, and P = 0.564 respectively) while not affecting 
the viabilities of both cell lines at 5µM of treatment (Figure 5.2.3 B).   
To confirm this observation, the wound area healing rates from secondary screen for 
these three compounds were compared to the tertiary screen.  Interestingly, similar trend were 
observed in all three compounds (data not depicted in histogram, refer to Table 5.2.2).  It was 
found that when the untreated Rama 37 control cell were compared to those treated with 
apomorphine hydrochloride, 1S, 2R-phenylpropanolamine hydrochloride, and nylidrin 
hydrochloride, no significant difference were observed ( P = 0.194, P = 0.062, and P = 0.864 
respectively to untreated Rama 37 control) (Figure 5.2.3 A).  However, significant difference were 
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observed when the same compounds were treated with R37 S100A4 WT cells (P = 0.013, P = 
0.025, and P = 0.016 respectively) (Figure 5.2.3 A).  To show that the inhibition of migration by the 
three compounds were not due to reduction of cell viability, MTT assays were performed.  Except 
for Apormophine hydrochloride, which reduced cell viability to 80% in Rama 37 control cells (as 
opposed to 100% of untreated Rama 37 control cells), but not in R37 S100A4 WT cells, the 
remaining compounds did not affect cell viability (Figure 5.2.3 B). 
To further confirm this trend, the wound area closure rates for these three compounds 
from primary screen were calculated (data not shown).  However, in the primary screen, the 
compounds were not treated on Rama 37 control cells (refer to Figure 2.2.4).  Therefore, the 
treated R37 S100A4 WT cells were compared to both untreated R37 S100A4 WT cells and 
untreated Rama 37 control cells.  The T-test comparison on either apomorphine hydrochloride, 1S, 
2R-phenylpropanolamine hydrochloride or nylidrin hydrochloride treated R37 S100A4 WT cells to 
untreated Rama 37 control cells showed no significant difference in wound area closure rate (P = 
0.139, P = 0.064, and P = 0.574 respectively).  On the other hand, when the untreated R37 S100A4 
WT cells were compared to treated R37 S100A4 WT cells, significantly lower wound closure rate 
were demonstrated (P = 0.002, P = 0.001, and P = 0.021 respectively).   
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9 DRUGS SELECTED FROM SECONDARY SCREEN 
UNTREATED 
Rama 37 Control R37 S100A4 WT 
0.083 ± 0.03 0.229 ± 0.06 
COMPOUND (5µM) 
Wound closure 
rate (µm2min-1) 
P-value a 
Wound closure 
rate (µm2min-1) 
P-value b 
APOMORPHINE HYDROCHLORIDE 0.110 ± 0.01 0.133 0.142 ± 0.04 0.054 
NOVOBIOCIN SODIUM 0.104 ± 0.04 0.337 0.240 ± 0.07 0.813 
1S,2R-PHENYLPROPANOLAMINE 
HYDROCHLORIDE 0.066 ± 0.02 0.360 0.130 ± 0.00 0.027 
NYLIDRIN HYDROCHLORIDE 0.106 ± 0.05 0.408 0.122 ± 0.01 0.019 
PARACHLOROPHENOL 0.094 ± 0.01 0.469 0.226 ± 0.10 0.963 
SALICYL ALCOHOL 0.082 ± 0.03 0.950 0.191 ± 0.05 0.370 
TRIMEPRAZINE TARTRATE 0.035 ± 0.01 0.084 0.225 ± 0.08 0.947 
PROTOVERATRINE B 0.123 ± 0.01 0.147 0.189 ± 0.03 0.439 
3-AMINOPROPANESULPHONIC 
ACID 0.060 ± 0.02 0.389 0.282 ± 0.12 0.456 
Table 5.2.3  Tertiary screen showing 3 drugs having significant specificity towards R37 S100A4 
WT cells but not Rama 37 control cells.  Experiment was conducted as mentioned in figure 5.2.1 
and calculation of rate of wound area closure was as explained in Chapter 2.2.5.1.  Values 
obtained are mean ± s.e. from three different regions of the well in a single screen. 
P-valuea obtain from Student t-Test where the rate of wound area closure of treated Rama 37 
control cells were compared respectively to the untreated Rama 37 control cells. 
P-valueb obtain from Student t-Test where the rate of wound area closure of treated R37 S100A4 
WT were compared respectively to the untreated R37 S100A4 WT cells. 
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Figure 5.2.3 Compounds demonstrating reproducibility and specificity for S100A4 protein whilst 
not affecting cell viability.  Experiment was conducted as mentioned in figure 5.2.1 and 
calculation of rate of wound area closure was as explained in Chapter 2.2.5.1.  The wound closure 
rates for compounds that show reproducibility and specificity to S100A4 protein were depicted in 
histogram above.  A) Rate of untreated, apomorphine hydrochloride, 1S, 2R-phenylpropanolamine 
hydrochloride and nylidrin hydrochloride treated Rama 37 cell lines from tertiary screening.  
Values obtained are mean ± s.e. from three different regions of the well in a single screen. *P < 
0.05. B) Percentage of cell viability 24 hour post treatment.  Equal number of Rama 37 cells was 
seeded and left to incubate for 24 hours.  Then, specific compounds were added to each well and 
24 hours later, MTT assay were conducted as mentioned in Chapter 2.2.3.  The first time points 
were taken at 100% viable and values were converted to percentages.  Values obtained are mean 
± s.e. from three different wells form a single experiment. 
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5.2.4 Optimising working concentration of Apomorphine hydrochloride, 1S, 2R-
phenylpropanolamine hydrochloride and Nylidrin hydrochloride 
Having confirmed the effects of apomorphine hydrochloride, 1S, 2R-phenylpropanolamine 
hydrochloride and nylidrin hydrochloride on Rama 37 cell lines at 5µM, we proceeded to 
determine a dose-response curve using same assay.  Concentration of the compound ranges from 
0.04 to 25.00 µM were tested in both Rama 37 cell lines. 
 This experiment demontrated 5µM as the optimal working concentration to inhibit wound 
healing (apomorphine hydrochloride, 1S, 2R-phenylpropanolamine hydrochloride and nylidrin 
hydrochloride) (Figure 5.2.4).  At 25µM, Rama 37 control cells were more susceptible to 
apomorphine hydrochloride and nylidrin hydrochloride as cell death were observed in wound 
healing assay whereas there is no significant difference in wound healing in 1S, 2R-
phenylpropanolamine hydrochloride treatment (Figure 5.2.4 A).  However, when R37 S100A4 WT 
were treated with similar concentration, significant reduction in migration were observed when 
compared to untreated sample, but not cell death (all compounds showed P < 0.001) (Figure 
5.2.4B).  Consistently, when the three compounds were added to Rama 37 control cells, no 
significant difference in wound area closure rate were observed in concentration of 5µM or less.  
On the other hand, treatment of R37 S100A4 WT with 5µM of apomorphine hydrochloride, 1S, 2R-
phenylpropanolamine hydrochloride and nylidrin hydrochloride significantly affected wound 
healing properties as observed in all the previous screens (P = 0.046, P = 0.002, P = 0.012 
respectively) and this concentration is the lowest active concentration as all the compounds 
showed no effect on R37 S100A4 WT migration below this concentration. 
Also, R37 S100A4 WT cells treated with 1S, 2R-phenylpropanolamine hydrochloride and 
nylidrin hydrochloride showed significant difference within the group, indicating that higher 
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concentration of these drugs will affect its wound closure rate (P = 0.003 respectively).  However, 
in Rama 37 control cells, only 1S, 2R-phenylpropanolamine hydrochloride treated cells showed 
significant concentration dependent response (P = 0.004), but not nylidrin hydrochloride-treated 
Rama 37 control cells (P = 0.674).  From this, it showed that apomorphine hydrochloride is less 
likely to affect motility in higher concentration as there are no significant differences in both 
treated-Rama 37 control cells and -R37 S100A4 WT cells (P = 0.968 and P = 0.173 respectively).  
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Figure 5.2.4  Optimisation of working concentration of the selected compounds through wound 
healing assay shows 5µM as optimal. Experiment was conducted as mentioned in figure 5.2.1 
with different concentrations (ranges from 0.04 to 25µM) of apomorphine hydrochloride, 1S, 2R-
phenylpropanolamine hydrochloride and nylidrin hydrochloride and calculation of rate of wound 
area closure was calculated as in Chapter 2.2.5.1.  The wound closure rates of A) Rama 37 control 
cells and  B) R37 S100A4 WT cell lines treated with different concentrations.  Values obtained are 
mean ± s.e. from three different regions of the well in a single screen.  Statistical analyses were 
conducted using single factor ANOVA.  *P < 0.05, ** P < 0.01 and *** P < 0.001.   
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5.3 Discussion 
 Since the development of high throughput screening (HTS), the major aim has been set to 
miniaturise samples to produce higher efficiency.  Wound healing assay, one of the HTS, has 
routinely been used to study cell migration and its underlying mechanisms such as polarisation, 
matrix remodelling, and chemotaxis (Lampugnani, 1999, Fischer et al., 1990, Herren et al., 2001, 
Huang et al., 2003, Lu et al., 2004).  As mentioned before, S100 proteins, especially S100A4, has a 
well established reputation as metastasis promoter in carcinoma ranges from oral, esophageal, 
lung, breast, gastric, colorectal, pancreatic to skin.  Due to this, numerous work has been 
dedicated on this protein in an effort to provide more insights and ideally, to generate new 
avenues for therapeutic purposes.   
Here, we set to investigate if wound healing could be used with our cell system to provide 
more insight about S100A4 proteins and its effect on cell migration.  Using Rama 37 cell lines 
combined with HCI-based assay, specificity of chemical compounds to S100A4 protein can be 
tested.  Surprisingly, given that the primary and secondary screen were conducted a year apart, 
relatively high reproducibility was demonstrated with this assay.  From primary to tertiary screens, 
similar wound healing trends were exhibited by the 3 chemical compounds selected (apomorphine 
hydrochloride, 1S, 2R-phenylpropanolamine hydrochloride (also known as phenylpropanolamine) 
and nylidrin hydrochloride (also known as tolazoline).  These three compounds were found to 
affect the migratory properties of S100A4 overexpressing cells but not its control counterpart.  
Therefore, this result suggests that these compounds affect S100A4-induced wound healing, 
although the mechanisms regulating such properties are currently unknown.   
 There were no therapeutic links found between these three compounds as they were 
prescribed as emetic (apomorphine hydrochloride), decongestant (1S, 2R-phenylpropanolamine 
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hydrochloride) and vasodilator (nylidrin hydrochloride) respectively.  Their taxonomy 
substructures revealed that these three compounds shared 3 substructures among themselves; 1) 
Benzene and derivatives, 2) Phenetylamines and 3) Aromatic compounds and act as agonist to 
Class A of G-protein coupled receptors (GPCRs) (Zhu et al., 2012).  GPCRs form the largest family of 
membrane proteins, characterised by the presence of seven transmembrane-helices separated by 
alternating intracellular and extracellular loops (Rosenbaum et al., 2009, Foord et al., 2005).  
Coincidentally, these three compounds act as agonist to Class A of GPCRs which is also known as 
rhodopsin-like class.  Apomorphine hydrochloride was found to be exerting its agonist effect 
through D2, D3 and D4 dopamine receptors, α- (2C and 2B) and β-adrenergic receptors (Kvernmo 
et al., 2008, Kim et al., 2001, Millan et al., 2002) .  On the other hand, the other two compounds, 
were found to promote activity of α- (1A and 2A) adrenergic receptors (Imming et al., 2006, 
Wellman et al., 1997, Flavahan, 2005, Niemeyer et al., 1987, Santala et al., 1990).   
Generally, GPCRs acts as a transducer where extracellular stimuli produced through 
binding of cell surface ligands is sent into the cell to secondary messengers known as 
heterotrimeric guanine nucleotide-binding protein (G-proteins), which consists of Gα, Gβ, and Gγ 
subunits (Gong et al., 2010).  The activation of GPCR by extracellular ligand causes conformational 
changes in the GPCR which in turn activate G-proteins by acting as guanine nucleotide exchange 
factor (GEF), where GDP is replaced by GTP.  This causes the GTP bound-α subunit of the G-protein 
to dissociate from the βγ-complex (Neer, 1994).  The dissociated Gα subunit and Gβγ-complex 
(combinations of 7 different β and 12 different γ subunits) can independently activate 
downstream effectors such as adenylyl cyclase, phosphodiesterases, phospholipase C, and ion 
channels (Svoboda et al., 2004).  Although Gα subunit consists of more than 20 members that are 
divided into four main groups, there are only two main downstream pathways; 1) the cAMP signal 
pathway and 2) the phosphatidylinositol signal pathway (Figure 5.3.1). 
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Apomorphine hydrochloride is a dopamine 2 receptor (DR2) agonist prescribed to treat 
acute poisoning by inducing potent emetic as well as to treat alcoholism by suppressing craving for 
alcohol (Scherkl et al., 1990, Dent, 1949).  Dopamine receptors are divided into two main groups 
according to their biochemical and pharmacological properties; 1) D1-like(comprises of D1 and D5) 
receptors release Gs subunit proteins which stimulate adenylyl cyclase while; 2) D2-like (comprises 
of D2, D3, and D4) receptors releases Gi/o subunits which inhibit adenylyl cyclase (Prou et al., 2001) 
(Figure 5.4.1).  DR2 has been shown to interact with FLN-A (non-muscle filamin or actin binding 
protein ABP280) which resulted in inhibition adenylate cyclase activities and subsequently, 
modulating activities of potassium (K+) and calcium (Ca2+) channels (Li et al., 2000, Seabrook et al., 
1994).  Cross-talk between DR2 and intracellular Ca2+concentrations, [Ca2+], was established in a 
study where it was demonstrated that influx of Ca2+ resulted in elevation of [Ca2+] which inhibit 
DR2 through interaction with calmodulin (Bofill-Cardona et al., 2000).  Inhibition of adenylate 
cyclase (ADC) by DR2 agonist (in this case, apomorphine hydrochloride) could possibly resulted in 
decrease of intracellular cAMP, which directly reduces protein kinase A (PKA) and  ultimately 
causing reduction in intracellular [Ca2+] (Sontag et al., 1990, Bigornia et al., 1990).  Interestingly, 
DR2 levels are usually low in normal mammary gland tissue, but this level were found to be 
aberrantly upregulated in malignant breast carcinoma (Carlo et al., 1986).  Since the level of DR2 
has never been assessed in these cell systems, but it would be worth to further investigate if this 
level is increased.  However, in the current state of the work, the primary focus is on S100A4 
induced motility. 
On the other hand, the other two compounds (1S, 2R-phenylpropanolamine hydrochloride 
and nylidrin hydrochloride), are known to agonise α2a adrenergic receptor (A2AR); member of G-
protein-coupled family of transmembrane receptors (Zhu et al., 2012).    Binding of A2AR agonists 
to such receptor has been shown to induce release of Gαi subunits leading to inhibition of adenylyl 
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cyclase and phospholipase C (PLC) activities and causes depletion of intracellular [Ca2+].  PLC 
hydrolyses phospholipid phosphatidylinositol 4,5-biphosphate (PIP2) into diacyl glycerol (DAG) and 
inositol 1,4,5-triphosphate (IP3).  While DAG remained on the membrane to activate protein kinase 
C, IP3 is released into the cytosol to bind with IP3 receptors located on the smooth endoplasmic 
reticulum (ER).  IP3 receptors which is a Ca
2+ channel, will therefore, release Ca2+ stored in the ER 
(Figure 5.4.1) (Teoh et al., 2012, Billington and Penn, 2003, Pohl et al., 1997).  However, since PLC 
activity is inhibited by A2AR agonists, the level of [Ca2+] in the cytosolic region should be depleted 
(Haenisch et al., 2010, Ma et al., 2005). 
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Figure 5.3.1.  Mobilisation of calcium through GPCRs triggered pathway.  Intracellular Ca2+ is 
released through multiple action of secondary messengers.  Extracellular ligands bind to GPCRs 
causing the release of different isoforms of G-α subunits and βγ-complexes.  Here, D2-like 
receptors (stimulated by apomorphine hydrochloride) as well as A2AR (stimulated by 1S, 2R-
phenylpropanolamine hydrochloride and nylidrin hydrochloride) resulted in release of GαI subunits 
which inhibit ADC.  Gαs subunits, antagonist of GαI subunits, released through dopamine 1-like 
receptors activate ADC which in turn produces cAMP to activate PKA.  Activation of PKA 
phosphorylate RYR2, a Ca
2+ release channel.  On the other hand, Gq subunits release are 
stimulated by M1-3 receptors which activate PLCβ to cleave PIP2 into DAG (which remain bound to 
the membrane) and IP3 which diffuse into the cytosolic region and bind to IP3R, another Ca
2+ 
channel located on the ER. This activation release Ca2+ from ER into the cytosolic region.  Gα12/13 
subunits released will bind to Rho GEFs which in turn activate small GTPases and finally activate 
Rho kinase.  Depending on the isoforms of Gβγ subunit, it can either directly bind to ion channels 
or activate PLA. GPCR, G-protein coupled receptor; D2-like, Dopamine 2-like receptor; A2AR, α-2-
adrenergic receptor; ADC, adenylyl cyclase; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; 
RYR2, ryanodin receptor 2; M1-3, muscarinic 1-3 receptor; PLC, phospholipase C; PIP2, Phosphatidylinositol 
4,5-bisphosphate; DAG, diacylglycerol; IP3, phosphatidylinositol (3,4,5)-triphosphate; IP3R, IP3 receptor; ER, 
endoplasmic reticulum; PLA, phospholipase A2. 
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 Through profiling the three compounds, depletion of [Ca2+] in the cytosolic region seemed 
to be their mutual effect.  While it is highly unlikely that overall intracellular depletion of [Ca2+] 
could be the reason behind the inhibitory effect observed in R37 S100A4 WT cells, one cannot rule 
out the possibility that localised intracellular levels of Ca2+ may potentially play a role in regulating 
S100A4 activities.  Relocalisation of S100A4 from the perinuclear towards the cell periphery upon 
[Ca2+] increase has been demonstrated in both MDA MB231 cells and HELA cells using 3 different 
approaches, but showing the same results; 1) ionophore A23187 which serves to transport Ca2+ 
through the plasma membrane, 2) cyclic ADP-ribose which induces the release of Ca2+ from IP3-
insensitive ER stores and 3) thapsigargin (TG) which induces the release of Ca2+ from IP3-sensitve 
ER stores (Mueller et al., 1999).  Therefore, it is possible that the depletion of intracellular [Ca2+] 
could potentially inhibit relocalisation of S100A4 which subsequently affected its interactions with 
target proteins located at the cell periphery. 
Interestingly, it has been demonstrated that apomorphine can specifically reduce S100B 
secretion in three different rat brain preparations (hippocampal slices, cortical astrocytes and C6 
glioma cells) (Nardin et al., 2011).  Although the direct or indirect modulation of apomorphine on 
S100B remained unknown, it was proposed that this effect could possibly be regulated by 
dopamine receptor and/or serotonin receptors.  Since S100A4 and S100B share 48% of identity, it 
is possible that apomorphine hydrochloride could affect S100A4 in similar manner.  Similar to 
dopamine receptor, serotonin receptors (also known as 5-hydroxytryptamine (5-HT) receptors) 
belongs to Class A of GPCRs, consisting of 14 or more subtypes, where binding of 5-HT (substrate) 
to 5-HT receptor resulted in dissociation of Gα subunit and Gβγ-complex as mentioned in figure 
5.3.1. 
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 Although there is no work relating S100A4 to dopamine receptors, it has been shown that 
S100A4 is regulated by both 5-HT receptor and serotonin reuptake transporter (SERT) (Lawrie et 
al., 2005).  SERT are dependent on extracellular sodium and chloride ions, where it selectively 
binds a sodium ion followed by a chloride ion extracellularly resulting in the transporter flipping 
inside the cell, releasing 5-HT (serotonin) intracellularly.  Then, a potassium ion binds to the 
transporter intracellularly which caused the transporter  to flip outwards of the cell, continuing the 
cycle (Figure 5.3.2)(Stahl, 1998).  In their study, it was found that addition of exogenous 5-HT to 
human artery pulmonary smooth muscle cells (hAP-SMC) resulted in stimulation of 5-HT receptors 
to secretion of S100A4 into media.  It was found that inhibition of 5-HT 2A and 5-HT 2B receptors 
did not block S100A4 secretion, but inhibition of 5-HT 1B receptor resulted in inhibition of S100A4 
secretion.  In SERT SiRNA-transfected hAP-SMCs, addition of 5-HT did not induce S100A4 
secretion, showing that both SERT and 5-HT receptors are essential in regulating secretion of 
S100A4 through an unknown mechanism (Lawrie et al., 2005).  It was speculated that 5-HT 1B 
receptor mediates phosphorylation of extracellular signal-regulated kinases (ERKs) while 5-HT 
transporter allows translocation of phosphorylated ERK to the nucleus to stimulate S100A4 
expression which led to its secretion.  In the Rama 37 cell system used, extracellular S100A4 
concentrations were not determined prior and post treatment with the 3 compounds, hence it is 
possible that these 3 compounds inhibit the expression and/or secretion of S100A4 into 
extracellular matrix mediated by 5-HT receptor in conjunction with SERT to induce migration. 
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Figure 5.3.2 Mechanism of uptake of serotonin through SERT.  Extracellularly, SERT is bound to 
one of each sodium and chloride ions resulting in opening of SERT transporter to recruit serotonin 
into the cytoplasm.  Binding of a potassium ion upon release of bound sodium and chloride ions 
causes closing of transmembrane transporter.  
 
If expression of S100A4 is lowered as speculated, the inhibitory effect observed in wound 
healing assay could be due to unavailability of S100A4 protein to exert its effect on intracellular 
targets such as NMMIIA, actin, TMs, liprin β1 and yet to be identified proteins to induce cell 
motility.  Besides, it has been demonstrated that expression of S100A4 is inversely correlated to 
the expression of E-cadherin and this similar trend has been repetitively exhibited by different 
carcinoma cell lines, such as skin, breast, lung, gastric, prostate, esophageal and thyroid 
(Keirsebilck et al., 1998, Perl et al., 1998, Yonemura et al., 2000b, Andersen et al., 2004, 
Moriyama-Kita et al., 2005).  This correlation was further demonstrated with reduction of E-
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cadherin expression after transfecting oral squamous cell carcinoma (OSCC) cell lines (expresses E-
cadherin) with S100A4-expression vector (Moriyama-Kita et al., 2005).  Down-regulation of E-
cadherin has been linked to reduced cell-cell adhesion which led to mesenchymal morphology, 
increased cell migration, invasion as well as metastasis (reviewed by Rodriguez et al., 2012). 
Besides, suppression of S100A4 expression has also been linked to suppression of matrix 
metalloproteinase (MMP) 2, MMP 3 and MMP 9 (Zhang et al., 2011, Gao et al., 2005, Bjornland et 
al., 1999, Andersen et al., 2011, Saleem et al., 2006).  As its name suggests, MMPs are proteinase 
that degrades extracellular matrix proteins to facilitate matrix remodeling (Nagase et al., 2006).  If 
the chemical compound exerted their effect through suppression of S100A4 expression, it is 
possible that E-cadherin could be up-regulated whereas MMPs could be down-regulated.   
Although the interactions between S100A4 and MMPs remained unresolved, it has been 
clearly demonstrated that addition of exogenous S100A4 induces MMP 3 expression whereas 
transfection of S100A4-expression vector increases MMP 2 and MMP 9 expressions (Andersen et 
al., 2011, Mathisen et al., 2003, Saleem et al., 2006).  Interestingly, upregulation of these three 
MMPs has been shown to induce epithelial-mesenchymal transition (EMT) which led to carcinoma 
malignancy (Sternlicht et al., 1999, Tester et al., 2000).  It remained elusive as to how exogenous 
S100A4 induce MMP 3 expression, nonetheless, this finding highlighted the role of extracellular 
S100A4 in inducing cell motility.  
 From all these observations, there is a possibility that the 3 compounds (apomorphine 
hydrochloride, 1S, 2R-phenylpropanolamine hydrochloride and nylidrin hydrochloride) inhibit 
expression and/or secretion of extracellular S100A4 mediated by 5-HT receptor in conjunction 
with SERT which resulted in overall reduced cell motility observed?  Although these speculations 
remain vague, we have demonstrated that HCI-based assay as an effective drug discovery method 
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and in the future, these compounds could possibly be tested in animal models to demonstrate its 
efficacy in inhibiting metastasis cause by S100A4 overexpression. 
  
Page | 214  
 
 
 
 
 
 
Chapter 6:  
General Discussion 
  
Page | 215  
 
Chapter 6: General Discussion 
 Due to diversity of S100 protein family’s functions, they have been intensely studied in 
researches from all areas including neuroscience, cardiovascular, oncology, proteomic, 
immunology, histology, biochemistry, and even dermatology.  Through these various areas of 
research, in depth understanding of these proteins have been exploited to realise their potentials 
in generating new therapeutic avenues.  So far, S100A1 has been introduced in clinical trial for 
gene therapy to combat heart failure as diminishing level of S100A1 correlates with heart failure 
(Most et al., 2013).  On the other hand, S100A4 is now regarded as a powerful palliating tool and 
an important marker of patient prognosis (Ismail et al., 2008a, Rudland et al., 2000, Andersen et 
al., 2011, Xue et al., 2003, Wang et al., 2010, Yonemura et al., 2000b, Ikenaga et al., 2009, Kimura 
et al., 2000, Zou et al., 2004).  In an attempt to combat S100A4 promoted metastasis, an anti-
S100A4 blocking antibody has been identified as a potential therapeutic avenue as animal models 
treated with this antibody has lower incidence of lung metastases.  This antibody is generated in 
such as way that it binds to the recognition site which overlapped the target binding interface of 
S100A4 (Klingelhofer et al., 2012).  Besides, another compound known as niclosamide has also 
been identified as a potential candidate where it has been found to be effective against S100A4-
mediated colon cancer as it significantly reduce mRNA expression of S100A4  (Helfman, 2011, Sack 
et al., 2011). 
 To further diversify our therapeutic arsenal, first, we have to acquire more understanding 
of the proteins’ structure and functions, including its different binding partners and subsequent 
downstream effects within cells.  Therefore, we aimed to provide more insights on molecular 
mechanism of mediated by S100A4 to facilitate migration.  While there are abundant reports 
demonstrating the potential role for NMMIIA in the S100A4-dependent migration, the direct link 
between the proteins in vivo remains elusive (Badyal et al., 2011, Elliott et al., 2012, House et al., 
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2011, Ismail et al., 2008b, Kiss et al., 2012, Chen et al., 2001, Ford et al., 1997).  No studies, for 
instance, have shown if S100A4 is capable of promoting migration in the absence of NMMIIA or 
when activity of NMMIIA is inhibited; both of which are the aims of this work. 
 Initially, we demonstrated that overexpression of wild type S100A4 in Rama 37 cells 
resulted in more efficient wound healing when compared to Rama 37 control cells.  This is the first 
time, to our knowledge that S100A4 can promote wound healing in breast tumourigenic cells, 
providing yet another evidence for this protein to promote cellular migration.  However, 
overexpressions of truncated versions of S100A4 (Δ2 and Δ6 from C terminus of S100A4 protein) 
did not improve migration, revealing the importance of the C terminus of this protein (Figure 
3.2.1).  Consistently, enhancement of migration due to overexpression of wild type S100A4 
proteins was observed along with reduction of matured focal complexes (Figure 3.2.3 and 3.2.4), 
replacement of stable filopodia by out-spread lamellipodium (Figure 3.2.5 and 3.2.6) and loss of 
stress fibers.  However, none of these traits were observed in the Rama 37 cells overexpressing 
truncated versions of S100A4 and the Rama 37 control cells.  This observation suggested that only 
full length S100A4 could exert such effects and the truncation of C-terminus resulted in loss of 
S100A4 activity either by; 1) preventing the dimerisation of the protein, 2) preventing them from 
binding to NMMIIA or other target proteins, 3) calcium binding abilities and 4) other unknown 
functions. 
So far, no work has been done to show if deletion of 2 or 6 amino acids from C-terminus of 
S100A4 protein will prevent dimerisation of the protein, but it has been demonstrated that this 
deletions led to reduced binding affinity of S100A4 to NMMIIA (Ismail et al., 2008b, Ismail et al., 
2010).  Two independent reports, has shown that only amino acids from region 72 – 91 
contributed to the dimerisation in vitro whereas in vivo, only Phe 72, Tyr 75, Phe 78 and Leu 79 
were essential (Tarabykina et al., 2001, Ismail et al., 2010).  From this, we speculated that the 
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truncation of 2 or 6 amino acids from C-terminus of S100A4 protein should not prevent 
dimerisation, thus leaving three other possibilities.  The EF hand motifs (helix E-loop-helixF) of 
S100A4 flanked from amino acids 12 – 47 and 50 – 84, proposing that deletions of 2 or 6 amino 
acids from the C terminus end should not inhibit its calcium binding capability (Kiss et al., 2012).  
However, we could not rule out the possibility that deletion of 2 or 6 amino acids could possibly 
alter the conformation of S100A4, thereby reducing its affinity for calcium or alternatively, limits 
its target proteins range or prevent its binding to NMMIIA.  Following this, we aimed to 
demonstrate if inhibition of NMMIIA could result in reduced motility, as exhibited by truncated 
versions of S100A4 as it is impossible to demonstrate if the range of S100A4’s target proteins is 
reduced, unless all of its binding partners have been identified.   
 As mentioned previously, overexpression of S100A4 led to modifications of several 
structures within the Rama 37 cells.  It is unknown whether S100A4 directly resulted in the loss of 
stress fibers through NMMIIA disassembly or this loss is a consequence of reduction of matured 
focal complex by S100A4.  Contradictory reports have demonstrated that loss of stress fibers could 
result in reduction of focal complex and vice versa.  It has been demonstrated that dorsal stress 
fibers emerge from focal adhesions via actin polymerisation mediated by mDia formins where F-
actins were crosslinked by α-actinin 1 (Cramer et al., 1997, Hotulainen and Lappalainen, 2006, 
Burridge and Wittchen, 2013, Kovac et al., 2013).  Directly bonded behind the dorsal stress fibers 
are transverse arcs; generated via assembly of short actin bundles by Arp 2/3 complexes where 
NMMII and α-actinin are incorporated at the same time to produce a more regular structure and 
occasionally, extra NMMII may be added to generate a centripetal shape (Hotulainen and 
Lappalainen, 2006).  It has been demonstrated that during contraction mediated by dorsal stress 
fibers-transverse arcs structure (having at least two focal adhesions from corresponding dorsal 
stress fibers), the transverse arcs regions that were not associated to the two dorsal stress fibers 
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began dissociating, leading to formation of ventral stress fiber; characterised by having focal 
adhesion at either end (Hotulainen and Lappalainen, 2006, Naumanen et al., 2008).  Ambiguous to 
this, it has been reported that although dorsal stress fibers arose from focal adhesions, this 
structure served nothing more than a structural template as inhibition of actin polymerisation via 
mDia or knockdown of α-actinin prevented the maturation of focal adhesion even though tension 
exerted by NMMII in transverse arcs remained unaffected (Oakes et al., 2012).  This work also 
demonstrated that reduction of tension by 80% did not prevent maturation of focal adhesion, 
proposing that maturation of focal adhesion could be a NMMII-independent process.  Due to this 
contradiction, we could not conclude if overexpression of S100A4 inhibits maturation of focal 
adhesion which led to disassembly of stress fibers or vice versa.  Following this, we set out to 
investigate if S100A4-induced motility is a NMMIIA-dependent process or a consequence of focal 
adhesion reduction. 
Using live cell analysis, it was demonstrated that reduction of filopodia was not due to 
incapability of filopodia formation in R37 S100A4 WT cells, filopodia formation was, in fact, 
accelerated in this cell lines when compared to either Rama 37 control or the truncated versions 
(Table 3.2.9).  Further investigation indicated that filopodia formed were not able to adhere stably 
to the extracellular matrix.  This observation suggested the possibility of S100A4 preventing the 
adherence of filopodia rather than inhibiting its formation.  Since NMMIIA is not present in 
filopodia, it may be possible that S100A4 is exerting this effect through other target proteins which 
may directly or indirectly facilitate filopodia formation (such as fascin, Arp 2/3 complex, Cdc42, 
IRSp53, Ena/VASP, actin, etc.) causing filopodia destabilisation.  It has been demonstrated that 
stably adhered filopodia are essential for subsequent maturation of focal adhesion via recruitment 
of focal adhesion proteins such as talin, paxillin, vinculin and focal adhesion kinase to activated 
integrins located at the tip of filopodia (Wiesner et al., 2005, Mitra et al., 2005, Calderwood, 2004, 
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Tomar and Schlaepfer, 2009, Schaller, 2001, Humphries et al., 2007).  If S100A4 is regulating other 
target proteins, does this mean that NMMIIA disassembly is just a consequence of focal adhesion 
reduction in order to facilitate migration? 
To address this, experiments were conducted to establish a direct link between NMMIIA 
and S100A4 in facilitating migration.  First, it was observed that NMMIIA expression was reduced 
in S100A4 WT overexpressing cells and contractile forces exerted by these cells were significantly 
lower than those exerted by R37 S100A4 Δ2, R37 S100A4 Δ6 and Rama 37 control cells (Table 
3.2.10).  It is unclear whether this lower contractile force generated by R37 S100A4 WT cells is due 
to lower level of NMMIIA expression or inability of S100A4 WT overexpressing cells to generate 
contractile forces.  As numerous reports have demonstrated that S100A4 is capable of regulating 
E-cadherin or MMPs expressions, we speculated that the down-regulation of NMMIIA could 
possibly be regulated through the same mechanism, which is yet to be solved.  It has been 
demonstrated that expression of E-cadherin was reduced in oral squamous carcinoma cells 
(OSCCs) when transfected with S100A4 expressing vector whereas MMP 2 and MMP 9  were up-
regulated, thus proposing that NMMIIA expression could be regulated in the same way 
(Moriyama-Kita et al., 2005, Mathisen et al., 2003, Saleem et al., 2006, Andersen et al., 2011).  
Moreover, as contractile force arose from tension generated by NMMII interacting with actin, 
disassembly of NMMII filaments by S100A4 could possibly be the culprit behind this observation 
(Chen et al., 2001, Ismail et al., 2010, Li and Bresnick, 2006, Badyal et al., 2011, Elliott et al., 2012, 
House et al., 2011).  Overall, these observations remained consistent that expression of S100A4 
resulted in lower contractile forces in cells possibly due to lower number of matured focal 
complexes and reduced NMMIIA expression. 
Since it has been demonstrated that highly motile R37 S100A4 WT cells generate lower 
overall contractile forces, reduced focal adhesions as well as disorganised actin filaments, we set 
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to establish if such S100A4-induced effects were NMMIIA dependent.  For this, two NMMII 
inhibitors were used; 1) blebbistatin, a NMMIIA specific ATPase inhibitor and 2) Y-27632, a Rho 
kinase inhibitor.  Interestingly, we found that inhibition of NMMII led to increase of migration in 
Rama 37 cell systems with further enhancement of motility in S100A4 overexpressing cells (Figure 
4.2.8).  This, therefore, indicates that S100A4 could promote cellular motility even in an 
environment where NMMII contractibility is inhibited and such enhancement after inhibitors 
treatment could possibly be due to; 1) amount of NMMII surpasses that of S100A4, hence 
inhibitors facilitate S100A4 to disassemble NMMII or 2) S100A4 is regulating other target protein 
to facilitate cell motility and inhibition of NMMII by inhibitors synergistically facilitate this activity.  
It was also observed that the enhancement of motility in the R37 S100A4 WT cells treated with 
NMMII inhibitors, also present further reduction of focal adhesions (paxillin) through 
immunofluorescence staining (Figure 4.2.9 and 4.2.10).  This observation appeared to be 
consistent with the previous experiments conducted where motility were found to be inversely 
correlated with number of focal adhesions.   
However, these experiments could not directly establish whether enhancement of wound 
healing in cells overexpressing S100A4 protein is indeed NMMIIA dependent.  Thus, we resorted to 
Cos 7 cell lines as alternative to provide more conclusive evidences.  These cells have been widely 
used as they are the sole experimental system available where NMMIIA expression is ablated, 
whilst no changes are seen for NMMIIB and/or NMMIIC.  In the wound healing assay conducted, 
the increase in S100A4 levels resulted in significant improvement in wound healing when 
compared to its control counterpart (Figure 4.2.25).  This result therefore clearly demonstrated 
that S100A4 could promote cell migration in the absence of NMMIIA.  At cellular level, Cos 7 
overexpressing S100A4 protein showed significant reduction in focal adhesions number whereas 
restoration of NMMIIA in Cos 7 cells led to increment of focal adhesions and impediment of 
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wound healing (Table 4.2.2).   Also, it was observed that in S100A4 expressing (Cos 7) cells 
retained its transverse arcs, but no dorsal or ventral stress fibers were observed.  Contrasting 
effect were observed in NMMIIA expressing (Cos 7) cells; where visible dorsal and ventral stress 
fibers were observed along with numerous focal adhesions (Figure 4.2.26).  Even though NMMIIA 
has been shown to be the dominator in transverse arcs, presence of NMMIIB were still detectable 
proposing that in the absence of NMMIIA, NMMIIB could be incorporated into actin filaments 
along with α-actinin to form transverse arcs observed in Cos 7 cells (Vallenius, 2013).  It has been 
shown that S100A4 has 9-fold higher affinity for NMMIIA than NMMIIB, hence we hypothesised 
S100A4 can selectively bind to NMMIIB in the absence of NMMIIA in Cos 7 cells. However, the 
presence of transverse arcs in Cos 7 PeCFP S100A4 WT cells proposed there could be other target 
proteins in which S100A4 could interact with to regulate the maturation of focal adhesions and/or 
facilitate motility as it has been demonstrated that inhibition of NMMIIB in NMMIIA-null ES cells 
causes remaining stress fibers to disintegrate (Li et al., 2003, Zhang et al., 2005, Even-Ram et al., 
2007).  Furthermore, it has been demonstrated that ventral stress fibers are rich in NMMIIB but, 
the disappearance of ventral stress fibers (characterised by having focal complex located at either 
end) and retention of transverse arcs (characterised by having no association with focal complex) 
in S100A4 overexpressing Cos 7 cells indicated that S100A4 did not disassemble NMMIIB, but 
instead, the loss of focal adhesions leading to disappearance of ventral stress fibers deemed more 
appropriate. 
To determine if this NMMIIA independent effect of motility was a cell-specific feature, we 
justify this effect using NMMIIA SiRNA technology in Rama 37 cell system.  Knockdown of NMMIIA 
expression by over 80% resulted in increased cell migration along with reduction of focal adhesion 
(Figure 4.2.15 and 4.2.16). Consistent with our other findings in Cos 7 cells, this demonstrate that 
presence of NMMIIA in cells resulted in lower cellular migration and more mature focal adhesion 
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and similar observations have been demonstrated in the same cell line by Even-Ram et al. in 2007.  
Interestingly, it was observed that knockdown of NMMIIA causes reduction of cell motility in cell 
expressing high level of S100A4 but the rate of migration were still significantly faster than those 
of the control cells (Figure 4.2.15).  This intermediate wound healing properties of R37 S100A4 WT 
(- NMMIIA) cells when compared to R37 S100A4 WT (+ NMMIIA) and Rama 37 control (+/- 
NMMIIA) cells proposed the possibility of NMMIIA providing assistance to S100A4 in regulating cell 
motility as R37 S100A4 WT (- NMMIIA) was slower than R37 S100A4 (+ NMMIIA) cells.  However, 
as R37 S100A4 (- NMMIIA) cells exhibited faster wound healing rate than both Rama 37 control 
(+/- NMMIIA) cells we speculate that S100A4 could also regulate cell motility independent of 
NMMIIA as shown previously using Cos 7 cell lines.  The inhibitory effect observed in wound 
healing assay conducted on R37 S100A4 WT (- NMMIIA) as opposed to R37 S100A4 WT (+ 
NMMIIA) as well as further enhancement in NMMIIA inhibitors-treated cells proposed that 
disassembly of NMMIIA could assist S100A4 in cell migration but is not essential.  It has been 
demonstrated that treatment of cells with blebbistatin caused NMMII to be constricted in a pre-
powerstroke monomeric conformation which was more efficiently localised to the periphery of 
the cell where it was proposed that this monomeric-unpolymerised NMMII conformation should 
be dominant but transient population in the lamellipodia to initiate focal adhesions  (Takács et al., 
2010, Goeckeler et al., 2008, Shutova et al., 2012, Kolega, 2006).  Furthermore, NMMIIA has been 
found to directly interact with α4β3 integrins and α4β1 integrins where association of NMMIIA- α4β1 
integrin has been demonstrated to facilitate cell motility in CHO cells (Sajid et al., 2000, Rivera 
Rosado et al., 2011).  Due to these associations, it was proposed that α4β3 integrins and α4β1 
integrins may not be the only integrin isoforms that interacts with NMMIIA.  On the other hand, 
blocking of α5β1 integrins has been shown to reduce S100A4-mediated motility (Wang and Griffin, 
2013) which led us to presume that the reduction of cell motility in R37 S100A4 WT (-NMMIIA) as 
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opposed to R37 S100A4 WT (+ NMMIIA) could be due to unavailability of NMMIIA to interact with 
integrins to further assist S100A4-mediated motility.  As it has been shown that fragment of 
NMMII consisting only of the full motor head were more efficiently localised to the cell periphery 
than the full length of NMMIIA, the enhancement of motility post blebbistatin treatment in all 
Rama 37 cells seems befitting as monomeric NMMIIA should be more efficiently localised to 
associate with integrins to facilitate motility.  However, the exact mechanism employed by S100A4 
to facilitate migration remained elusive.   
In the final chapter, Rama 37 cell system was used in HCI based assay to identify 
compound that may be capable of inhibiting cell migration induced by overexpression of S100A4.   
Interestingly, after rounds of selection and analysis, 3 independent compounds were found to be 
capable of affecting wound healing properties of R37 S100A4 WT cells but not Rama 37 control 
cells, highlighting their specificity for targeting S100A4-mediated motility.  These compounds 
could possibly shed some light on how S100A4 regulate cell motility if not develop for in vivo 
treatment in animal model.  One of the compounds, apomorphine hydrochloride, was found to 
regulate the secretion of S100B to extracellular matrix and these three compound were found to 
affect the GPCRs and this proposed that setting NMMIIA aside, there could be other S100A4 
potential targets to regulate cell motility (Nardin et al., 2011, Carlo et al., 1986, Scherkl et al., 
1990). 
Although we have demonstrated that S100A4-induced motility is NMMIIA-independent, 
the exact mechanism utilised by S100A4 to maneuver motility remained elusive.  In the future, the 
possible mechanisms should be explored.  Therefore, we proposed that treatment of Rama 37 
cells and Cos 7 cells with exogenous recombinant S100A4 protein and anti-S100A4 blocking 
antibody could shed some light if extracellular S100A4 is responsible for S100A4-induced motility.  
Also, using co-immunoprecipitation or pull down assay to investigate if S100A4 could be directly/ 
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indirectly interacting with focal adhesion-related protein such as; 1) different integrin isoforms 
(especially α5β1 integrin as it has been shown to be up-regulated when S100A4 is overexpressed 
with reduced motility when blocked), 2) fascin, as S100A4 has been shown to destabilise filopodia 
and fascin is present within the shaft, 3) Ena-VASP and Arp 2/3 complex, as these proteins has 
been shown to be the precursor to lamellipodium and filopodium formation, and 4)paxillin, 
vinculin, talin and FAK as they are primary proteins to be recruited to activated integrins to form 
focal complex.  These approaches could further identify the binding partners of S100A4 as well as 
investigate the potential role of exogenous S100A4 in facilitating motility. 
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